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BSHP Annual Spring Conference 
Berkeley Hotel, Worthing, Friday 4 to Sunday 
6 April 2008 
All members should have received details . After 1st 
March accommodation cannot be guaranteed in the 
hotel. For late bookings and day visitors , contact Dr 
Shirley Ellis , 1 Willis Way, Bottisham , Cambridge 
CB25 9BS. 
Wednesday 7 May 2008 
' Indigenous people and drug development: From 
local knowledge to new medicines' by Professor 
Michael Heinrich. Lambeth , 6 .30 p .m. 
Wednesday 18 June 2008 
Visit to 17 Bloomsbury Square , former home of the 
Pharmaceutical Society. Details to be circulated. 
Wednesday 24 September 2008 J 
'History of Aspirin ' by Mr Diarmuid Jeffreys. 
Lambeth 6.30 p.m. 
Wednesday 19 November 2008 
To be announced . 
Obituary 
William (Bill) A Jackson 
We report with regret the death of Bill Jackson, who 
died on 24th December 2007 at the age of 80 . He was 
a distinguished and active pharmaceutical historian , 
who was known around the world for his research 
and expertise on medical and pharmaceutical 
devices . He was president of BSHP 1991-3 and 
committee member for much longer, a member of 
the International Academy for the History of 
Pharmacy and a recipient of the Society's Leslie 
Matthews medal. 
He was cheerful in spite of his disabilities and 
frequently attended our annual spring conferences. 
He had a humorous disposition and was an amusing 
speaker and writer. His collections of artefacts were 
in demand for exhibitions and his many papers in the 
Pharmaceutical Historian were a joy to edit. A 
typical example was his article on Elephant's Milk 
(2003 , 33.4, 64-65) . 
After a career in community pharmacy he was for 
many years the honorary curator and emeritus curator 
of Manchester University medical museum, where 
he arranged many exhibitions. 
Our condolences go to Audrey and their family. 
www.bshp.org 
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New tools on the ISHP Website 
Dr Christiane Staiger 
Neu-lsenburg, Germany 
The homepage of the International Society for the 
History of Pharmacy (ISHP) has recently established 
two new tools for scientific searches. A database of 
oral presentations and short introductions to national 
online search tools may help to strengthen the 
network of ISHP members. The homepage 
www.histpharm.org has a new category 'Tools ' . 
Oral presentations 
several countries related to the history of pharmacy 
and medicine. The General Information includes 
name, web address (URL), a short description of the 
database content , and the available languages. The 
search strategy for each database is explained 
comprehensively and an example is given. A direct 
link takes you to the related website. 
The new content of the ISHP-homepage is being 
improved and enlarged constantly. In particular, 
pharmacy historians are invited to use the ISHP 
website to notify their talks by email so that they can 
be included in the oral presentation database . 
Under 'Tools ' , users will find the database ' ISHP 
oral presentation list '. The page will lead to all the 
notified talks given since 2005 related to the history 
Author's address: ch.staiger@grnx.de 
of pharmacy worldwide. Beside the title the database 
contains the keywords, the name of the 
author and a contact email address. The 
date , place and occasion of the talk are also 
given. At present , the database contains 
more than 500 entries, but more need to be 
added. Many presentations that are given 
never reach publication and valuable 
information may be lost. 
The makers of the website focused on a 
comfortable and user-friendly design. 
Visitors can choose between a simple or an 
advanced search mode. The simple search 
offers a first orientation; the advanced 
allows one to specify the findings in more 
detail. The search fields will be connected 
by the 'AND' operator. 
ISHP developed this new online tool in 
order to bring international pharmacy 
historians closer together. Therefore, the 
search modes offer an automatic 
conversion function on international 
Search in ISHP - oral presentation list 
Llhe_lm_s_to_dt_er __ __,1 1 Search j [switch to advanced mode J [Back to ISHP Homepage J 
Please enter yow· search! 
- Separate search strings using'+' 
- Use either correct (M:unchen) or internationalized (Munchen) spelling 
- Use '_' when leaving out a single letter 
- Search will be performed in all fields, including date 
Yow· talk on the history of pharmacy is ~nissing? 
Please, simply drop an email to helmstaedter<@em. WU-frankfurt. de and state 
- name 
- first name 
- title of yow- talk 
- date 
- occasion 
- place 
-keywords 
- and a contact email address. 
W e will be pleased to add your presentation to the database as soon as possible! 
spelling variations . For example, instead of ~-----------------------~___J 
the letters s, ~. or s used in other European 
languages a simple 's ' will link to the 
correct finding. If the user is searching for 
'Franc;;ois ', either the correct spelling or 
the simplified 'Francois ' will find the 
relevant database results. When searching 
for 'Millier' , simply entering 'Muller' will 
do . 
The database is located on a public 
server to save money for the ISHP. 
However, most public servers can annoy 
users with regular advertisements or pop-
up windows. ISHP managed to find a less 
aggressive server. On opening the page , 
only one window pops up . After closing 
this , users can search undisturbed for the 
rest of the session. 
Databases 
The second new tool on the ISHP 
homepage offers short introductions to 
worldwide literature databases from 
2 
?'•"""'\ Search in ISHP - oral presentation list 
~ -
• > ':; %,,.~ ____ ::::,,l jhelmsto.dter I~ [switch to advanced mode] [Back to ISHP Homepage) 
. '}-__ , ..... ,<i. 
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Cow Bells and Cold Chains: the 
Spread of Smallpox Vaccine and 
Vaccination before Refrigeration 
p eoff Miller 
Pharmacist and Historian, Western Australia 
The histories of transmissible diseases that have 
afflicted mankind and their containment do not have the 
happy ending that we can attribute to the history of 
smallpox, and this is what makes it unique. 
When I first started my career in pharmacy in the 
1950s, the concept of a 'Cold Chain ' for all perishable 
medicinal products hadn 't really been thought of. One 
exception however was the recognition of the special 
~angements required to handle Smallpox Vaccine, 
smce the Commonwealth Serum Laboratories in 
Australia insisted th~t, to preserve potency, the vaccine 
had to be stored 111 the frozen state , at as low a 
temperature as possible. Wholesalers despatched the 
boxed capillary tubes wrapped in layers of newspaper 
and the parcel was kept apart from other o-oods in an 
. 0 
msulated box in the delivery van. In those days a 
dispensary refrigerator was a rarity, and most 
pharmacies stored this vaccine in the freezer of a 
neighbouring butcher's shop or ice cream parlour. 
With such specific storage directions for Smallpox 
Vaccine, I began to wonder how this product was 
transported around the world in the days before 
refrigeration, and on voyages through the tropics often 
lasting over 3 or 4 months. 
The surgeons of the First Fleet, that was sent from 
England in 1788 to establish the Colony of New South 
Wales and a new convict settlement, are said to have 
brought out 'variolous matter' with them. Exactly what 
'variolous' matter means is not clear, but in any case 
there is no record of their ever having made use of it. 
Smallpox was the first disease to which an artificial 
immunity was created by deliberate inoculation with the 
causative organism, obtained from the skin blisters of 
mild cases, This was known as 'variolation', a process 
which originated in Asia in ancient times. By this 
deliberate inoculation of smallpox material into a 
human arm it was hoped that a mild form of smallpox 
would develop to give immunity in the patient. 
The role of Doctor Edward Jenner in the smallpox 
story is well known, as he was the first to prove 
scientifically that vaccination (vacca - Latin for cow) 
with cowpox gave protection from smallpox. He also 
demonstrated that cowpox could be transmitted 
artificially from one human to another, so vaccination 
was not dependent on the existence of cowpox in a 
community. He made these observations public in 1797, 
only nine years after the colony of New South Wales 
was established. 
Transporting the vaccine 
Although Jenner's publications and ideas were spread 
relatively quickly, there were some difficulties in 
exporting the vaccine even over short distances or in 
cool climates. 
Edward Jenner 
The commonest methods used in the 19th century included: 
(1) Drying the vaccine on points 
Lancets made of silver; gold or ivory. Sometimes the 
liquid lymph on the ivory point was enclosed within a 
wax ball, and in some Eastern countries, the dried 
thorns of a bush were used instead of ivory points. 
(2) Drying the vaccine and sealing it between small 
glass plates 
A pool of Vaccine was dried on a glass plate and when 
it was perfectly dry a thin coat of mucilage of Gum 
Arabic was applied. Alternatively another glass plate 
was placed over the dried vaccine and the edges sealed 
with wax 
(3) Using lengths of thread to soak up the vaccine, 
which were then dried 
___ Initially this was the 
commonest method, 
and it was similar to 
the variolation pro-
cess using threads or 
clothing impregnated 
with material soaked 
up from smallpox 
pustules. Again the 
dried threads were 
sometimes sealed 
between two glass 
plates, or sealed in 
tubes with wax. 
Dried vaccine on threads in sealed glass tubes 
( 4) Dried crusts or scabs 
Edinburgh surgeon James Bryce, discovered in 1809 
that the crust or scabs which form at the vaccination 
site also contain viable vaccine virus. 
In 1813 Dr Russell , of Calcutta, sent some dried 
scabs from pustules of cowpox to Dr D'Arcy 
3 
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Wentworth in Sydney, and he cautioned that these had 
to be reconstituted with cold water. He also despatched 
ivory lancets that had been moistened with the vaccine 
but in his view the desiccated form would better 
withstand the rigours of transport from India to Australia. 
By these methods vaccine was soon distributed 
throughout Britain and to North America, southern and 
central Europe and the Mediterranean basin by 1800, 
and by 1801 to Scandinavia and Russia. 
For longer distances, particularly in warmer climates , 
a different method was used. Weekly arm-to-arm 
transfer through volunteers or children maintained the 
vaccine. This had the advantage that the immune 
population could be increased at the same time, and this 
was how the majority of the British forces in India were 
vaccinated. 
The most famous exploitation of this procedure for 
the long-distance carriage of vaccine, was during an 
expedition, commissioned by King Charles IV of Spain, 
in 1803. Twenty orphan children were carried on the 
ship to provide a succession of susceptible subjects for 
vaccination to the Spanish colonies in the New World, 
China and the Philippines. However, more convenient 
methods were clearly needed. 
In Great Britain the National Vaccine Establishment 
took over the responsibility for maintaining serial arm-to-
arm transfers in 1808, as well as distributing several 
thousand preparations to physicians each year on ivory 
points or glass slides . Later, capillary tubes filled with 
vaccine diluted with 50% glycerol were used, but ivory 
points were still being employed in Great Britain as late 
as 1898. 
A French researcher, M. Bretonneau of Tours , 
described a method of using fine glass tubes with a 
small expansion in the middle to collect and store drops 
of fluid from a punctured vesicle. 
The Vaccinator of the Public Dispensary in 
Edinburgh, Dr William Husband, published another 
method of preserving lymph in capillary tubes in July 
1851. He demonstrated the method of filling and sealing 
fine tubes of glass containing lymph, which had a long 
shelf life and could be carried in a doctor's bag without 
refrigeration. Husband advocated strongly the keeping 
of exact records of the source of the vaccine as well as 
the success or failure of the vaccination. 
Small Pox and Vaccine in Australia 
On board the flagship Sirius , which was part of the First 
Fleet carrying convicts , their guards and some free 
settlers to New South Wales, was Surgeon Thomas 
Jamison, who holds several special places in the history 
of Australian medicine. Jamison's tour of duty in the 
Antipodes was an incredible 21 years , and during that 
time he had only one trip home to England in 1801 , 
during which time he encountered first-hand experience 
with Jenner's new discovery of cow pox vaccination, 
and became a total convert. 
In New South Wales the first settlers at Sydney Cove 
became very alarmed when smallpox disease was seen 
on a large scale among the indigenous population and it 
4 
had wreaked havoc among the unprotected tribes. The 
question then arose as to the source of the outbreak, as 
Australia had enjoyed a natural isolation by virtue of its 
geographical position up until that time. It was thought 
that this outbreak could have been attributed to a 
previous visit to the east coast of New Holland (now 
Australia) by Captain James Cook, or landing parties of 
early French explorers, but this was only conjecture. 
When Dr Jamison returned to Sydney after his leave 
in 1802, he was appointed Principal Medical Officer in 
the Colony. He shared with the Governor, Captain 
Phillip Gidley King RN, a great concern over the threat 
of smallpox to the white population. 
In May 1803, a letter was sent to the Secretary of 
State , in London, suggesting that ' vaccine matter ' 
should be sent urgently to the colony. In response , a 
supply of vaccine lymph, obtained from the Royal 
Jennerian Society, was despatched to Dr Jamison in the 
transport ship Coromandel, which arrived in May 1804. 
A second packet of lymph also arrived on the same 
vessel , addressed to Assistant Surgeon John Savage, 
which was 'put up in a different way from that sent by 
the Royal Jennerian Society.' 
On receipt of the lymph, Dr. Jamison immediately 
vaccinated three children at the 'Orphan Asylum' and 
some other persons were vaccinated by Mr. Savage. 
Their efforts were successful, for a notice appeared in 
the Sydney Gazette on 3rd June , 1804 stating that ' the 
cow-pox is now fully established in the Colony,' and 
invited parents to have their children vaccinated. 
Thomas Jamison was one of the founders of 
preventative medicine in Australia, and he showed great 
concern for the welfare of children in the colony. On 
October 14th 1804, Dr Jamison published a paper 
entitled 'General Observations on the Small-pox ' in the 
Sydney Gazette in an attempt to make parents and carers 
of children aware of the dangers of smallpox and the 
benefits of vaccination. This article was quite lengthy 
and it has further interest in the fact that it was the first 
medical paper ever published in Australia. 
By the 1820s, the most serious problem was the 
failure of imported smallpox vaccine, as several people 
who had been vaccinated in New South Wales 
contracted smallpox on their return to Europe. After the 
middle of the nineteenth century, Western Australia was 
the only Australian colony still receiving convicts from 
Britain , and the Surgeons Superintendent on board 
those convict ships coming to Australia were given 
written instructions as to their duties whilst at sea, which 
in part read 'you are to keep such a succession of 
vaccinated cases as may enable you to convey fresh 
virus to the colony and to obtain an acknowledgement 
from the medical officer of the Colony, stating whether 
you have delivered to him any recent virus consequent 
upon vaccination of individuals during the voyage.' 
Up until 1881 , the New South Wales Government 
received regular despatches of Calf Lymph from 
Bombay, as well as a constant , though small supply, 
of glycerolated vaccine from England, which it 
sometimes shared with the newer colonies of South 
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Australia and Western Australia. It was about this time 
that the American physician and surgeon Henry Austin 
Martin introduced the production and use of non-
humanised smallpox vaccine from the calf. 
Unlike human lymph transmitted arm to arm, vaccine 
propagated seriall in calves preserved potency, 
avoided vaccinal syphilis , and enabled manufacture in 
commercially profitable quantities . Martin was also 
credited with standardising the vaccine virus. No lymph 
was 'cultivated' in New South Wales , which could have 
been disastrous should an epidemic have occurred, but 
after 1881 supplies were obtained from vaccine stations 
in Victoria and New Zealand. 
Victorian production was first started by a 
veterinarian, Graeme Mitchell , who produced calf 
lymph for smallpox vaccination privately on the site 
occupied by the present day Commonwealth Serum 
Laboratories in Victoria , near Melbourne. However, 
strict regulations were then in force to prevent anyone 
but a qualified medical practitioner giving vaccinations. 
The original wooden building and stables for the calves, 
known initially as the 'Calf Lymph Depot' and later as 
the 'Vaccine Depot', was taken over by the Victorian 
Government in 1883 and then by the Commonwealth 
Government in October 1911. 
COMMONWEALT~ ~~ OF AUSTRALIA 
JENNERIAN LYMPH (VACCINIA VIRUS) 
The Lymph issued by these Laboratories is carefully 
cleaned by Glycerine Treatment and is of high potency 
i,, •1; ·,,;,. ~ ·~" 1,. ., , •• ,.- I !•,,,., ·, .. 
Oir,ctor Commonwealth Serum laboratories, .. ,., ,.,., ........... . 
. 1,: ., ·" ,; . . , ,·•... . ' . •' , .. , .. ,., . ~ ,. , ... ~, .. , .. .. . 
l 'l'O,. rr . ,~. P,o,010,1,u1 L.-.. , . 1. , , . 1·: .,1,..-., ., ..... ,. . ,. · ,t u ... , 8,01i....., , Lid.: "' 1 
T ... " ••l•• I •" O•wt Co- \.II 
M(\~~~-~,Nt ·_ ~-"'~".:~: T~'';,.:•:;--;:~:: • -~:~ ';' .• ,~;-•·:3.~.· ~~~"~!1!"C~C, l~"~'l; ,,I, I'~;• ~~:•7.'.'~·~ ~~=:!1 c.,. 
AO[lAIDI , A, ~ . · ·~ \lc •4 a. l c~a. Ltd .• T ••I <" • 1:1 a , , ., • J F H . r .... , "II • Co . ,., . 
P[ .. ,.M F. loO ( o,.lo"v" C.. t • ~ · • ·•" T . ; •.; • .'\.U . I 
L,r;V~tESTOl'rl h•llt "' L•.,. 1. •. ' 
As vaccine supplies became more reliable in the 
mid-fifties , all of the Australian States except New 
South Wales and Queensland had passed Acts requiring 
the compulsory vaccination of children below varying 
ages. In addition, all of the Australian States had 
established Vaccine Districts and appointed Public 
Vaccinators to ensure that protection against smallpox 
was widely available . 
Routine smallpox immunisation in Australia came to 
an end in the 1970s, but the Commonwealth Serum 
Laboratories kept the vaccine on its inventory right 
through until the early 1990s when the decision was 
finally made to discontinue the product. 
The outlay required to develop a modern production 
process , along with the clinical trials and regulatory 
requirements could not be justified commercially, and 
the Australian government would have to rely on an 
overseas supplier, should vaccination against smallpox 
ever become necessary again. 
We have now come full circle. Advances in refrig-
eration technology meant that a freeze-dried vaccine 
could be produced which was more potent and stable 
than the original vac;cine, allowed easier transport and 
reduced the cost of bringing large amounts of vaccine to 
remote areas. As a result, in 1967, the World Health 
Organization began implementing its plan to 
intentionally eradicate a biological species from the 
earth. By 1979 this was achieved and the demise of 
smallpox was regarded as one of the great triumphs of 
modem science. However, we must also recognise the 
achievements and the ingenuity of the early pioneers of 
smallpox prophylaxis in the eighteenth and nineteenth 
centuries, which are even more remarkable when it is 
remembered that their work was accomplished before 
the cause of the disease was known. 
This paper was presented to the 37th Congress of the 
International Society for the History of Pharmacy, 
Edinburgh June 2005 . 
Author's address: gcmiller@iinet.net.au 
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Antoine-Augustin Parmentier: 
Pharmacist Extraordinaire 
Dr Brian P Block 
London 
Antoine-Augustin Parmentier, who lived in the 18th 
and early 19th centuries, rose to considerable e_m.mence 
in the fields of pharmacy, agriculture and nutntion. He 
was on friendly terms with the king, various aristocrats 
and many eminent scientists, and his name was a 
household word throughout France where he lived and 
worked. Today, however, outside culinary circles he is 
little recognised in France and he is virtually unheard of 
in Britain. 
He studied pharmacy and joined the army at t~e 
beginning of the Seven Years War in order to further his 
career whilst avoiding the unaffordable expense he 
would have had to incur as a civilian in order to qualify. 
He rose to be chief pharmacist in the army and never 
relinquished his military career even after beco~g 
chief pharmacist at the prestigious Hotel des lnvalz_des, 
the hospital for wounded and retired indigent soldiers, 
and later being given a sinecure, lodgings and an 
income for life by the king himself. He died still a 
soldier in 1813 . He never married. 
His enthusiasm for work was boundless. He willingly 
did whatever was asked of him: problem solving, 
investigations, surveys and analyses ~aused -~ to 
travel all over France and this was m addition to 
pursuing his own interests in the field '.111d in the 
laboratory as well as a prodigious output with the pen. 
Although he became increasingly interested m 
ao-riculture - an interest engendered by the frequent 
c;op failures and subsequent famines in France in his 
day - he never forgot he was a pharmacist and _ma~e 
important contributions to hospital hy_g_iene and w_itl_i ~s 
production of pharmacopoeias for rmlitary and civilian 
use. He was a founder of the Pharmaceutical Society of 
Paris and of the Pharmacy Bulletin which became the 
Journal of Pharmacy and Chemistry by amalgamation, 
and he later founded a school of baking at which he 
taught. 
His concern was specifically directed to the poorer 
people who had inadequate food; the staple diet w~s 
bread and when wheat crops failed people starved. This 
state of affairs caused him to research the possibility of 
using other vegetables instead of or as a suppl~i:rient to 
bread and he was a pioneer in the study of nutrition and 
in the analysis of various foodstuffs at a time wh~n 
nutrition was virtually an unknown term and organic 
chemical analysis was barely in its infancy and 
extremely basic. 
His researches led him eventually to consider the 
potato, a vegetable that was despised in France ~here it 
was occasionally fed to cattle, but eaten widely m other 
European countries and, of course, in South America 
where it originated. 
By dint of hard work and with the backing of the king 
he showed that the potato could be used as a partial or 
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total substitute for flour in bread-making and could be 
eaten when boiled, baked or roasted in embers . There is 
little doubt that Parmentier single-handedly popularised · 
the use of the potato in France against very stron_g 
opposition and prejudice and it is with the po_tato that ~s 
name in France is associated. Any French dish with his 
name attached, for example,potage Parmentier (potato 
soup), indicates that potatoes are a main ingredient. 
Early Life 
Largely due to the prosperous cloth trade together with 
the well-watered soil that produced wheat and later 
maize in abundance , Montdidier (Somme) was home to 
a good many bourgeois families among which were the 
Parmentiers. Jean-Baptiste~Augustin was the son of 
Sebastien Parmentier, the husband of Fran~oise 
Lefebre, and on 6 June 1735 he married Marie-
Euphronsine Millon, daughter of Antoine Millon '.111d 
Suzanne de Beauvais. For many years the Parmentiers 
had been the backbone of the bourgeoisie: there had 
been a Parmentier cannon-maker, a maker of tin pots 
and since the tenth century the family had produced 
several mayors. But over the years the Parmentiers ~ad 
slid down the socio-economic ladder and Jean-Baptiste 
was a modest draper with a small lingerie shop (now a 
HiFi and TV repair shop) situated on rue Mercerie, now 
rue Parmentier, which was and still is the main street of 
the town. The shop occupied all the ground floor and 
the family were confmed to two modestly sized rooms 
on the floor above. 
The first born of the new generation was Marie 
Suzanne, born on 14 April 1736, and the first son, 
Antoine-Augustin, was born sixteen months later on 12 
August 1737. Three other children followed: Char_les-
Nicholas-Sebastien on 4 November 1739, Antome-
Sirnon on 28 October 1741; and Paul Luglien on 10 
January ] 744. A few years later, however, a double 
tragedy struck the family. Charles-Nicholas-Sebastien 
and Paul Luglien both died within a few months of each 
other, Charles aged eight in August 1748 and Paul aged 
five in January 1749. 
The church of St Sepulchre, next door to the house 
where he was born, was where Antoine-Augustin was 
baptised on the same day as his birth , which is clearly 
shown in the register. 1 Parmentier 's mother had 
received a o-ood education and she, aided by Abbe b . 
Daughy who taught religion and the basics of Latin to 
him and his sister, educated the children herself. But the 
death of the two youngest children when Antoine-
Auo-ustin was eleven affected her health and it was time 
to ;tart thinking about his professional future: it was 
necessary for him to have a good job to secure his own 
future and to contribute to the needs of his family. 
When he was thirteen years old in 1750, having 
sufficient education for entry into the pharmacy 
profession, he found a job at the pharmacy of Frison at 
the Place de la Croix Bleue in Mondidier (now Place 
Parmentier). His job was to carry out galenical and 
chemical preparations under guidance. He got bed, 
board and laundry and shared his life with his patron. 
His lifelong devotion to pharmacy had begun. 
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Apprenticeship 
Although Parmentier had no particular vocation to 
become a pharmacist, Prison's right-hand man, Paul-
Felix Lendormy, was a distant cousin and friend of the 
family who in the future would become the patron. He 
knew Antoine-Aug tin and was aware of his need to 
help his family ; he also appreciated his intelligence and 
his curiosity. Parmentier stayed at Prison's pharmacy 
for five years and then , at the age of eighteen, made his 
first trip to Paris with a letter of recommendation in his 
pocket from Lendormy to his next employer.2 He was 
installed in the home of Jean-Antoine Simonnet whose 
apothecary's shop was in a busy part of Paris , which 
pleased Parmentier, and he was treated with kindness by 
the pharmacist, himself from Picardie and possibly 
related to the Sirnonnet family. 
At that time in the mid-eighteenth century, the time of 
the enlightenment, there was a scientific explosion , and 
pharmacy as a science was just beginning. Apoth-
ecaries, like spicers and herbalists , were receiving drugs 
and spices from the Orient and Africa and were 
ceaselessly battling to receive recognition of the 
scientific character of their profession. They had begged 
for, and obtained statutes of incorporation after a long 
struggle that had begun under the reign of Louis XN. 
At the time of the Sun King a deficiency in the 
regulations governing poisons came to light; in certain 
dispensaries anybody could obtain dangerous products . 
This abuse had been sanctioned by an edict of July 1682 
that regulated the movement of toxic products . The 
position of apothecaries regarding 'miracle cures' which 
flourished at Court and in certain institutions such as the 
Hotel des Invalides was also reinforced. The healing art 
was all the rage, especially in monasteries and convents 
where secret concoctions were made. 
There was a useful career path for pharmacists that 
enabled them to accede to the title of 'master pharm-
acist' (rnaftre pharmacien) after serving a four year 
apprenticeship under a master who himself had had at 
least six years experience in the dispensary. An 
accompanying examination comprised a viva lasting 
three hours during which the candidate had to answer 
questions from six guardes de la corporation, two 
doctors and six other 'jurors' . Following this was a 
paper on herbs. The final hurdle consisted of writing 
five compositions and answering questions from the 
examiners. If each stage was passed successfully the 
candidate was invited to take the oath and deposit his 
tally with the rnaftres de la confrerie after which the new 
pharmacist could be installed. However, a rule 
prevented him for five years from opening a business 
close to the dispensary where he had trained. There were 
further rules governing widows or yo'ung children 
taking over the business from their spouse or father. 
Although apparently reasonable, these rules actually 
placed a constraint scarcely noticed by the pharmacists: 
the permanent guard1anship of the doctors . Since the 
13th century royal command had placed pharmacists 
under the authority of the doctors , so that pharmacists 
had to content themselves with dispensing prescriptions 
under their supervision. Like his fellows on entering the 
profession Parmentier was an impotent witness; in the 
second half of the century he would become a vital man 
of action. By the end of 1756 Antoine-Augustin 
Parmentier had worked for a year at the dispensary at 
the Croix-des-Petits-Champs. His seriousness, care and 
precision plus his passion for work impressed 
Simonnet: the young man from Picardie had the 
makings of a great pharmacist. But these gifts were not 
enough. To achieve their goal, luck and protection at 
Court were needed, which is why among the 
apprentices the children of master pharmacists or of the 
rich bourgeoisie were the ones to open their own 
dispensaries. Consequently, in order to canvass for their 
status as master the apprentice had to undertake all 
manner of obligations. He had to tip the jurors and 
himself buy the plants, powders and liquors needed for 
the final examination. Then he had to buy meals for all 
the jurors and food for the doctors and apothecaries who 
were his judges, or dinner during the preparation for the 
final examination, which could last several days.A final 
and considerable expense was for the successful 
candidate to provide a reception and a dinner to which 
the jurors, the local aldermen, master pharmacists, 
doctors and their wives were all invited. 
These regulations and customs were insurmountable 
for many apprentices, and if too poor to take and pass 
their final examinations, they had to spend the rest of 
their lives serving their patron. Subjects of contempt and 
condescension, they were known as 'master-valets'. This 
is what lay in wait for Parmentier. When he entered 
apprenticeship in Montdidier it was primarily to lighten 
the financial load on his family, but he had reached a 
stage where he knew he could not afford to finance his 
studies in Paris . This was nothing new to Simonnet who 
had himself undergone similar difficulties. Nor was he 
unaware that his protege would have to take a different 
road. In his youth he had been an aide apothicaire at the 
Hotel Royale des lnvalides. He had remained on good 
terms with the military and had kept himself informed 
about what was going on in the army health corps. 
Sirnonnet was convinced that it was there that the future 
lay for Parmentier; he knew that Antoine-Augustin could 
not afford to complete his apprenticeship and take the 
examinations and realised that the preparations for a 
military expedition (what became known as the Seven 
Years War) enabled him to give the young man from 
Picardie a nudge in the right direction. 
Soldier 
Although apothecaries had been officially admitted into 
the army from January 1747, ten years later they were 
still not fully integrated. Originally providers, then 
examiners, of drugs , by 1757 they were dispensers of 
familiar remedies but still under the orders of the 
doctors. Recruitment was poor and early in 1757 at the 
beginning of the Seven Years War there were 
insufficient numbers. 
When Sirnonnet suggested that he seize this 
opportunity to progress by joining the army, Parmentier 
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was twenty years old. There is no evidence that he 
hesitated even though he knew nothing of military life. 
There was only one hurdle: to pass before an examiner 
who selected boy pharmacists. Parmentier's examiner 
was Louis-Claude Cadet de Gassicourt who was known 
to Simonnet as he was apothicaire major at the 
lnvalides during a time when Parmentier's patron was 
probably there. 
Cadet, who would later become a familiar of 
Parmentier, was the third of thirteen children of the 
surgeon Claude Cadet. When he met Parmentier Louis-
Claude was himself only twenty-six but energetic and 
enthusiastic. The passion, will and expertise of Antoine-
Augustin impressed him and he was soon assigned to 
the army at Hanover as pharmacist 3rd class. 
Parmentier was twenty when he joined the army; he 
never left it and fifty-six years later when he died he 
was still a soldier, probably the longest-serving soldier 
ever in the French army. 
The war had begun a year before Parmentier joined 
up with a brilliant expedition to Minorca where the 
English were routed. This venture revealed the talent 
and ingenuity of one of the pharmacists, Pierre Bayen, 
who had been recommended by the head doctor in 
Richelieu's army, Fran~ois Imbert*. Rejoining Imbert 
at Marseille, Bayen immediately began to assemble the 
drugs needed for a mobile hospital. He returned to 
Minorca and with his reputation still fresh he was sent 
to Germany in 1757 with the rank of Chief Apothecary. 
He discovered there that the health services were totally 
disorganised.3 After signing a new treaty with Austria, 
Louis XV sent two armies to Germany, one of 24,000 
men under Prince Soubise, a friend of the king , and the 
other of 70,000, which included Parmentier, and this 
latter, under the command of Marshall Estrees, had as 
its goal the crossing of the River Weser and invading 
Hanover, then a territory ruled over by George II of 
England. Camped on the wide plains the army quickly 
ran out of provisions and troops began to die of hunger. 
Parmentier was relatively lucky as stationed in Hanover 
he was embroiled with the sick and injured in the 
annexes of the King of England's palace, transformed 
into a military hospital. But this was only a brief respite 
from the slow advance to meet up with the other army. 
Frederick II was on the look-out, aware of his numerical 
inferiority; the King of Prussia knew that he had to 
move quickly to exploit the weakness of the enemy. He 
seized his chance on 5 November 1757 at Rossbach 
near Leipzig where he deceived the army of Soubise 
and that of Saxe-Hildburghausen. 
It is commonly believed that Parmentier and Bayen 
were taken prisoner at Rossbach but there is no textual 
evidence for this, particularly as Bayen destroyed his 
papers during the Terror and Parmentier described his 
campaign only to his colleagues in the . Bulletin de 
Pharmacie , which first appeared on 1 January 1809. 
But it was after Rossbach that the destinies of the two 
* This Richelieu was the great nephew of the cardinal and 
grandfather of the minister. 
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pharmacists were linked. The day following the defeat 
at Rossbach Bayen's assessment of the situation 
revealed catastrophe. The services were decimated ,· 
provisions were non-existent, entire regiments were 
down with dysentery, the wounded on the way to 
hospital were dying with their horses and the number of 
resignations and the number of apothecaries still at 
work were not clear. 
Totally discredited , Richelieu gave up his command 
in favour of the Count of Clermont who hurriedly wrote 
to the king that he found the army divided into three: the 
first third, above ground, he said, was composed of 
thieves and ragged from head to foot, the second was 
below ground and the third were in hospital. Clermont 
clearly had a talent for laconic reportage, if for little else. 
His first task was to re-establish discipline and, being 
inexperienced, appointed three Lieutenant Generals as 
advisors, but all three were jealous of him and all three 
forgot about the enemy. Frederick II took advantage of 
this godsend and inflicted a total defeat on the French 
who lost 3,000 men. 
In this unbelievable muddle, where the chiefs did not 
hide their disagreements, where the commissars dreamt 
only of their profit, where hot water was served as soup 
to the wounded at the hospital at Wesel, Bayen noticed 
Parmentier. He had already heard how he had not 
hesitated to seek out the wounded under fire . His courage 
and humanity earned him promotion to Pharmacist 2nd 
Class in January 1758. Bayen knew how he had stopped 
an epidemic of dysentery that had infected the whole 
hospital, and he knew also of his indefatigability, his 
attendance at the bedsides , his support of hospital 
personnel, his reassuring words of encouragement to the 
wounded and his reviving the embers of hope among the 
dying. Everywhere Parmentier went he cared about the 
conditions of life among the survivors. According to him, 
hygiene was paramount for the health of the army and 
recovery rooms had to be kept clean, airy and neither too 
warm nor too cold. 
It has been stated on a number of occasions that 
Parmentier was taken prisoner five times .4 Although 
this may be technically correct, except for the last 
occasion he was not a prisoner in any meaningful sense. 
On the first occasion he was inspecting the state of the 
ambulances and replacing drugs when he was surprised 
by a group of enemy horsemen who stripped him of his 
clothes and ' took him prisoner '. He joked later that they 
took only his money and clothes and then released him. 
During the course of the war the same thing happened 
on three further occasions, twice with Bayen; but on the 
fifth, he was actually incarcerated for two weeks . On 
several occasions he also suffered minor wounds. In 
June 17 60 he was promoted to pharmacist 1 st class, and 
Bayen was made pharmacien aide-major. 
Back in France the situation was deteriorating and the 
public could not understand the alliance between Louis 
XV and Austria. The king was always in conflict with 
parliament and the minister who became the strongman 
of the moment was the Duke of Choiseul who claimed 
that France had no money, no resources , no sailors , no 
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soldiers , no generals and no ministers . His advice was 
to negotiate peace no matter what the cost. When he 
became Minister of War in 1761 Choiseul found the 
army in such a state that he decided on administrative 
reform and established a corps of inspectors. On 3 
Febmary 1761 Piarron de Chamousset was appointed 
superintendent of army hospitals and his first decision 
was to recruit health personnel on merit , not by favour. 
He went to Germany with two assistants , Claude-
Frarn;ois Grandelas , sometime doctor to King Stanislas , 
and Louis-Claude Cadet de Gassicourt who he 
nominated inspector of pharmacies; Parmentier was 
surprised to come face to face again with his erstwhile 
examiner. Chamousset's methods quickly bore fruit , he 
took total control and the situation improved rapidly. In 
this environment, enhanced by Cadet de Gassicourt's 
making contact with scholars from occupied towns , 
Pannentier flourished and turned his attention to a study 
of the chemistry of food. Chamousset came from two 
grand families and when his father died in 1737, the year 
of Paimentier's birth, he succeeded him as maftre 
ordinaire de la Chambre des comptes, but preferred to 
consecrate his life to good works. So he resigned in 
favour of his younger brother and, having a knowledge of 
pharmacy, medicine and surgery, opened a hospital where 
he received no fewer tha11 two hundred patients a day. 
Balland pointed out that Parmentier met two worthy 
men in the army, Bayen and Chamousset. He quotes 
Parmentier: 'His [Chamousset's] house could have been 
called the temple of benevolence.' Bayen, who was a 
kind of mentor to Parmentier, was an inspector 
pharmacist who worked also with Lavoisier. Such was 
Parmentier's respect for him that when, much later, he 
was nominated a member of the council of physicians 
in preference to Bayen, he refused.5Chamousset left his 
job in April 1762 leaving in Choiseul's hands a manual 
for military hospitals, while Cadet de Gassicourt was 
sent to Spain as apothicaire-major for the army. In 
Germany there was an end to hostilities. 
At just this time Parmentier was taken prisoner for the 
fifth tin1e but on this occasion no exchange was 
foreseen and he wallowed for two weeks in a dungeon 
with only a sort of potato gruel for meals . This frugal 
diet was to prove an important stimulus in his later work 
a11d something of a turning point in future French 
cuisine. Then conditions improved and he became a 
prisoner of war with conditional liberty, authorised to 
work in a pharmacy in Frankfurt. It was here that he 
came across Meyer, a chemist-pharmacist who 
researched the chemistry of food. 
Not only did the two men get on famously but 
Antoine-Augustin was not unaware of the charms of the 
daughter of the house. He improved his German, which 
he had randomly picked up in the camps. Meyer was so 
impressed with the young Frenchman's personality and 
competence that he offered his daughter in marriage 
together with his laboratory and Prussian nationality as 
dowry. Parmentier declined all three gifts, on the basis 
of his patriotism. Meyer's daughter 's views are not 
recorded. 
Meyer was not convinced by Parmentier's refusal and 
determined to return .to the subject, but he was soon to 
be astonished by a proposition by the greatAlembert: he 
proposed that the young Parmentier replace the chemist 
Margraff in Berlin who was going to retire as a 
pharmacist-in-chief to the Prussian army. That 
proposition surpassed all understanding. For Meyer, 
refusing such an offer was unthinkable, but not for 
Parmentier. So Meyer lost the son-in-law of his dreams 
and now he would have only the memory of an 
exceptional pharmacist with a great future ahead of him. 
Peace 
The war was formally ended on 10 February 1763 by 
the Treaty of Paris and Parmentier was sent back to 
France with a small sum in his pocket and an uncertain 
future. He was twenty-six . Most of the pharmacists who 
had signed up for the army at the end of hostilities were 
returned to civilian life. There was no question of his 
returning to Simonnet , who had no place for a 
pharmacist First Class. As to Bayen, he took a job near 
the Spanish border where the Secretary of State for War 
instructed him to analyse the waters. From time to time 
he returned to Paris where he lived in a boarding house 
and it was there that he would meet his old army 
comrades. He often saw Parmentier and Chamousset 
there and it was these friendly discussions and 
encouragement that led Parmentier to continue his 
studies before seeking another job. 
So as a pharmacist First Class, with little more than a 
reputation for his competence and humanity, he took 
courses in botany with Bernard de Jussieu and studied 
chemistry with the brilliant Rouelle whose legendary 
blundering enhanced meetings at the Academy of 
Science. In this milieu he bumped into Jean Darcel, 
sometimes met Cadet de Vaux, the younger brother of 
Gassicourt. And he also came across the young 
Antoine-Laurent Lavoisier. 
With the money he had brought back from the war 
fast running out , Parmentier took a job in the 
apothecary's shop of Bernard Laccreu, a friend of 
Rouelle , at the rue des Petits-Champs, close to 
Simonnet. He stayed only for a short time as he heard 
from Chamousset and Bayen that the position of 
apothicaire major gagnant maftrise at the Invalides 
would soon become available by examination. This was 
rather revolutionary since hitherto the medical corps of 
that institution recruited by co-option or patronage, or 
the king himself made the appointment. The change was 
one of Chamousset's first decisions and one of the first 
reforms of military administration under the Duke of 
Choiseul. This new decision was faithful to the 
prevailing view in the previous century when in 1670 
the hospital, which became L'Hotel des Invalides 
Royale, was first mooted. Louis XN wanted a building 
that would receive all soldiers including the maimed 
and those in declining health , and to avoid the disasters 
of earlier military hospitals. 
Furthermore , the general staff of the hospital, 
which comprised a physician, a surgeon and a 
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pharmacist had been placed entirely under the control of 
the Daughters of Charity (Les Filles de la Charite). 
Known as the Grey Sisters on account of their habit, 
they had been installed on 7 March 1676. They were in 
charge of the pharmacy and prepared all the medicines 
and purchased all the necessary medicaments . 
When he heard that the position of apothicaire major 
gagnant maitrise would soon become available 
Parmentier presented himself for examination, was well 
received , and on 16 October 1766 took up his duties at 
the age of 29, the first Chief Pharmacist to be chosen on 
merit. The Hotel des Invalides was a miniature town. 
Within its walls were some 3,000 patients and 500 staff. 
It had its own clergy, medical personnel, management, 
bakery, police and administration under the governor 
who was appointed for life by the king. The entire 
organisation was run on military lines underpinned by 
its religious foundation. But it was no ordinary military 
hospital. It was created to assist old soldiers who were 
forced into begging or living on church charity. The 
institution of Invalides was created in 1670 and 
construction was completed in 1676. 
To be admitted into the Invalides the soldier had to 
have served for at least twenty years . Furthermore, he 
had to be unfit for service by reason of age or severe 
disability due to wounds or incurable illness. 
A similar situation existed in England. In 1681 the 
king issued a Royal Warrant authorising the building of 
the Royal Hospital. Christopher Wren was 
commissioned to design the building to be erected in 
Chelsea, and it was finally completed in 1692. 
The appointment was perfect for Parmentier. He 
could continue his research and his daily routine gave 
him useful experience. By the time he took up his duties 
there were 300 beds in six large rooms, four of which 
were arranged in the form of a cross around an altar, so 
that the sick could follow the mass from their beds. 
Unlike in other hospitals , each bed had only one 
occupant. 
Nursing was carried out by thirty-seven Sisters of 
Charity who also prepared the medication and 
confections. The responsibilities of the Sisters were 
clear. They managed the sick rooms in the hospital, the 
laundry, the care of the sick and they ran the pharmacy. 
They had a vital role. When Parmentier arrived he could 
accept the subordination of the apothecary to the orders 
of the Sister Superior. In the course of six years he set 
up an acceptable compromise and profited from his 
enforced leisure. 
Parmentier made a daily tour of the hospital and 
visited the blind, the badly wounded, the one-armed and 
all incapable of feeding themselves. He examined 
everything: the rules of hygiene , the quality of the meat 
served, the way cereals and water were kept, the 
cleaning with water in the main building, the water 
outlets in the fifteen courtyards of the hospital where 
water ran permanently to eliminate the smell of urine, 
the baths reserved for the sickrooms, the grain stored in 
heaps , the functioning of the bakery and the temperature 
of the well water. 
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In a very short time everyone, from the governor to 
the pensioners ,knew him. They all praised his kindness , 
his humour, his competence and his enterprising spirit. 
He mixed freely with the old soldiers and often joined 
them in the refectory for meals. Some even recognised 
him from the battlefields of Westphalia as one who had 
risked his own life to save theirs. 
His helpfulness was recognised throughout the 
hospital . Rather than disturb the doctor or the assistant 
surgeons it was easier to resolve minor problems in the 
pharmacy. He could always be found in his laboratory 
or in the little courtyard where the sisters allowed him 
to go. Although he worked hard at his job during the 
day he devoted the nights to his writing. On his return 
from Germany he was influenced by the repeated years 
of famine and imposed on himself a humanitarian 
mission . He wrote later: 'My research has no other goal 
but the progress of the art, and general good. The 
feeding of the people is my concern and my wish is to 
improve the quality and reduce the price [ of bread] ' .6 
He covered hundreds of pages with his writing. Under 
the kind eyes of a few Grey Sisters who played the role 
of his assistants , his research put on a spurt and his first 
published writing appeared in 1771 and told the story of 
the friendship between a patient and a sparrow.7 As 
mentioned earlier, the Grey Sisters had the governance 
of the pharmacy at Invalides and with it the authority to 
prepare and administer medicaments from the most 
simple to the complex. Parmentier found this strange 
and he was reduced to following the doctor, noting his 
prescription and placing the order at the Sisters' 
laboratory. With his civility, modesty and friendliness 
with everyone, he treated even the Sisters as almost the 
equals of their director. However, this bon accord did 
not last. He asked the king for permanence at the 
lnvalides and to be chief apothecary. This would end the 
bizarre situation whereby he, apothicaire maftre, that is 
master pharmacist and pharmacist First Class, was 
operationally subordinate to the Sisters, none of whom 
was even a qualified pharmacist. The king agreed and 
he received his brief on 17 July 1772. This was not at all 
to the Sisters ' taste and a battle began between them and 
Parmentier. They complained to everyone including the 
bishop and the queen. The king, tired of all this 
squabbling, withdrew Parmentier 's brief on 31 
December 1774 but, showing how weak he was, as 
compensation gave him an annuity and lodging at the 
Invalides for life. This apparent demotion proved the 
turning point in his career. Relieved of his 
pharmaceutical duties (he could let the Sisters get on 
with that), in his own room and small garden he could 
carry on with much important work, and treatise 
followed treatise for the next twenty years.8 
The relative freedom and leisure that Parmentier now 
enjoyed enabled him not only to write but also to think. 
And his thoughts led him to conflate two experiences: 
one was the famines that had frequently plagued France 
not only in the past but several times in his own short 
lifetime; the other was his experience as a prisoner of 
war, when he survived for two weeks on potato gruel 
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and nothing else. Had the Grey Sisters been more 
accommodating he might have spent the rest of his life 
running the Jnvalides pharmacy. Instead, he carried out 
. research into agriculture; he developed ways of making 
better bread; he wrote pharmacopoeias; he developed 
potato flour for us in breadrnalcing; he inspected 
phannacies in hospitals and made recommendations for 
their improvement; and carried out research and 
inspections all over France at the behest of the 
government; he wrote more than fifty papers and 
numerous books. All this whilst he was still a soldier, 
and eventually chief pharmacist of the French military. 
Grain, Flour & Bread 
Parmentier knew the value of bread from his youth. 
When his father 's shop was not doing well bread was 
rationed , and he lacked it during his captivity. In May 
1775 he was particularly animated. 
The bakers were cheating on their weights and the 
governor of Jnvalides installed balances in each 
refectory. Moreover, the bread was too hard, too brown 
and tasted bad. On his visits the king and the princesses 
were invited to taste the bread, which often led the 
administrator of the hospital to be reprimanded .9 
Parmentier was no longer satisfied with his 
commission as pharmacist and he undert6ok work on 
the use of the potato , improving the quality of bread, 
and in particular, how grain was stored at Jnvalides. He 
was sent to Poitou by the Compte de Muy to study the 
quality of grain and bread. He talked to farmers and 
bakers and took samples of grain and flour and tasted 
the bread. 
In 1775 wheat in the fields around Montdidier were 
infected by 'black disease ' (malaise noir). Parmentier 
got hold of some of the grain, found a means of 
cleansing it and wrote a paper Analyse de la carie de la 
froment , which he published in 1776 and was one of his 
earliest publications. 10 
Parmentier spent the whole of March 1776 back in 
Montdidier giving a course on baking. By this time he 
was an established figure: Pensionnaire du Roi; Maftre 
en Pharmacie de l'Academie Royale des Sciences, 
Belles Lettres et Arts de Rauen; ancien Apothecaire-
Major de l'Armee Saxonne et de l'Hotel des lnvalides. 
Following his journey around France he became 
aware of the poor quality of bread. He improved " 
methods of milling in a more economic way, and 
received from Brittany a medal struck to commemorate 
this philanthropic act. When he returned to Paris he 
opened a school of baking with himself as director. 
By the end of the 1770s the poor lad from Picardie 
had already come a long way. Apart from his post at les 
lnvalides he was pharmacist in chief of the army in 
Brittany, of the army in Geneva from 1782 and of the 
army in St Orner from 1788. In his 'civil' life he was 
deputy-head, and demonstrator in botany at the College 
of Pharmacy, professor at the School of Baking, 
government expert in pharmacy, agriculture and the 
chemistry of food. As an author his output was 
formidable and his workload ever greater. 
His work on grain, flour and bread undoubtedly 
improved the quality of bread in France beyond 
recognition and it is possible that the reputation that 
France enjoys today for the quality, consistency and 
variety of its bread owes much to Parmentier's work 
two hundred years ago, although it is not for this that he 
is remembered. But he also realised what few of his 
contemporaries did: that no matter how much the 
quality of flour and bread could be improved, when the 
wheat crops failed with resulting . scarcity (disette) or 
even famine, there would be little or no bread at all for 
the poor, of any quality. This realisation led to his 
dominant obsession: how to find a substitute for bread 
that would adequately nourish the poor when there was 
no wheat. This resulted in his most innovative work and 
established his eminence and reputation; but whether it 
led to his greatest achievement remains to be examined. 
Pharmacy 
Notwithstanding his growing interest in agriculture 
Parmentier had not forgotten that he was a pharmacist, 
and if he had been inclined to forget, his friend and 
mentor Bayen kept him busy with more and more 
difficult tasks such as formulating tonic pills for the 
army and analysing secret remedies proposed for use in 
military hospitals. He was a frequent visitor to Bayen's 
laboratory at the rue du Bae for he knew that his friend 
and master, in attempting to reveal the nature of 
mercurial precipitates, had found a fallacy in the 
sacrosanct phlogiston theory of de Stahl. Bayen 
realized that when oxides of mercury were carefully 
heated in the absence of carbon they lost weight and 
11 
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emitted a gas. Had he gone further and tested the gas 
with a flame he might have discovered oxygen. The 
English cleric Priestley and the Swedish pharmacist 
Scheele both came close to success but it was Lavoisier 
who on 26 April 1775 revealed the nature of carbonic 
acid and of oxygen to the Academy of Sciences. What 
upset Parmentier was that Lavoisier did not refer to the 
path traced by his friend Bayen even though he knew of 
Ba yen 's work.But he knew that Ba yen applied the same 
rule as himself: forget scoffers and dishonest rivals and 
get back to work as quickly as possible.11 
Parmentier did not have to go back to work for he 
seemed to be a man altogether without leisure and for 
the next twenty-five years he devoted himself to studies 
on the potato and on bread-making. But at the tum of 
the century, after producing a book concerned with Eau 
de Vie and vinegar, and collaborating with three 
colleagues in writing a massive 585-page tome giving a 
detailed description of every aspect of wine and 
vinegar-making from the vines to the vessels used,12 he 
turned again to his first love, pharmacy.13 
In 1803 two pharmacopoeias were published. The first 
is extremely comprehensive and well laid out and is in 
two sections with the first section divided into three 
parts .14 The first part comprises descriptions of plants 
and plant products. The second part is concerned with 
formulations from animal sources, including deer horn, 
sponge, milk and fish glue. The third part is concerned 
with formulations of mineral origin such as metals and 
chemicals. 
The second section is devoted to made-up recipes of 
medicaments with a final few pages of instructions on 
how to store them. Curiously , Parmentier's name does 
not appear in this publication but his authorship has been 
authenticated by Barbier et al.15 It is unlikely , however, 
that anyone else at that time would have been capable of 
producing such a comprehensive volume. 
In the same year another pharmacopoeia appeared , this 
time under his own name.16 This tome of 526 pages is 
somewhat different from the other, being more practical 
than descriptive. It is divided into three parts: Materia 
Medica; Official Medicaments; and Prescriptions. 
In an introduction Parmentier points out that there have 
been a number of pharmacopoeias and that in order to cut 
down on useless length he has left out items that are 
available elsewhere and comments that one 'waits 
patiently for a work that will unite all available 
knowledge [ of pharmacy] .. . a pharmacopoeia where all 
medicaments will be properly evaluated, and which 
merits being called "Pharmacopee nationale" '. 
The first pharmacopoeia in French is probably the 
translation of 'De medicamentorum simplicium delectii ' 
translated as la pharmacopee qui est la maniere de bien 
choisir et preparer des simples .17 
Possibly the first universal pharmacopoeia (though 
without 'nationale' in its title) was Pharmacopee 
raisonnee, ou traite de pharmacie practique et 
theoretique.18 But the earliest publication meeting 
Parmentier's requirements was Codex, pharmacopee 
.franr;aise published by order of the government 
12 
commission composed of professors of the faculty of 
medicine and the School of Pharmacy in Paris (1837). 
Conclusions 
What can a disinterested and objective posterity 
conclude about the life and work of Antoine-Augustin 
Parmentier? 
From an early age he showed great diligence towards 
any activity in which he was engaged. As an apprentice 
apothecary he aroused the admiration of his apprentice 
master; as a very young soldier-pharmacist of humble 
rank he attracted the attention of his superiors by his 
compassion and hard work. He used his time at the 
Hotel des lnvalides not only to perform his work 
supremely well but also to widen its scope, to make the 
residents more comfortable and to enhance the quality 
of their food and conditions. Throughout his lifelong 
military career he was promoted to and entrusted with 
various jobs in his capacity as chief pharmacist and later 
as inspector-general ofhe army's health service; he was 
elected to membership of various departmental 
agricultural societies and was director of the Royal 
Society of Agriculture; he founded the school of baking; 
he founded the Bulletin of Pharmacy; he was a founder 
member and teacher at the School of Pharmacy in Paris; 
he was appointed an officer of the Legion of Honour by 
Bonaparte. Throughout his life it seems that all who 
came into contact with him were charmed by his good 
nature, compassion and concern for the people. 
His job in later life as a pharmacist and later as 
premier pharmacist to the army would have been a 
full-time job for most people. But over and above his 
duties as a military pharmacist he made many important 
contributions to pharmacy, notably his insistence on a 
high standard of cleanliness and correct temperatures in 
hospitals , and the publication of two pharmacopoeias, 
the quality and comprehensiveness of which cannot be 
over-rated. 
He was very interested in and concerned about the 
quality of bread and its availability for poor people. He 
studied the subject closely and wrote copiously on 
various types of grain, their cultivation, diseases to which 
they were prone, their harvesting and milling. He 
redesigned flour mills and ovens and showed how they 
could be run with greater economy. Using the bakery at 
Les lnvalides he experimented with various grains and 
flours so as to obtain the highest quality of bread with 
most nourishment and the best flavour. It is possible that 
the high quality and great variety in bread available in 
France today owes much to Parmentier's early work. 
He was one of Europe's first true agronomists. He 
was fascinated with agriculture and made many studies 
of vegetation used as food. He was very aware that the 
frequent famines were due to failures of the wheat 
harvest, mostly due to bad weather, and he desperately 
wanted other sources of food to be available. These 
interests led him into early attempts at food analysis;20 
his work was meticulous , painstaking and 
scrupulously recorded. He also investigated such 
diverse foodstuffs as sugar, wine, grape syrup , beet 
sugar, milk and water. 
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From 1771 he wrote continually; from then until his 
death he published fifty-three items , many of them 
scientific or agricultural papers but in addition , a 
substantial number of, often, very long books. A 
number of unpublished works were also found after his 
death . 1 
Statue of Parmentier at Montdidier 
In addition to a workload and output that would have 
occupied several other people the leitmotif of his life for 
which he is remembered above all else was his work on 
the potato. From his days in the army in Germany he 
had considered that potatoes were a useful source of 
food, particularly in times of famine or scarcity, despite 
the great prejudice against them throughout most of 
France. He was successful in cultivating them himself, 
after persuading the king to let him use a large plot of 
land outside Paris for the purpose. He attempted to 
analyse them and got a number of things wrong, but this 
is hardly surprising given the level of chemical 
knowledge at the time. This led him to assert that 
potatoes were more nutritious than they actually are. It 
would have been simpler, to persuade people to eat 
potatoes as he himself had , in broth , boiled, baked, as an 
accompaniment to meat or with salt and lard. But his 
aim was to use potatoes to make bread. Whether this 
became merely an obsession or whether he felt 
instinctively that the French public were such zealous 
bread-eaters that the only way he could get them to eat 
potatoes would be to incorporate them into bread is not 
known, but he (and others) experimented with the idea 
and he published in great detail a method for making 
bread using potatoes wholly or partially in place of flour. 
Much has been made of Parmentier as the inventeur 
(inventor) or more accurately the vulgarisateur 
(populariser) of the potato , and outside historical circles 
it is his name alone that is known in this context. He 
was certainly not the first. Duhamel du Monceau and 
Mustel 19 each have an earlier claim than Parmentier, 
even in the making of bread from potatoes. But 
Duhamel du Monceau and Mustel did a little work on 
the potato, each published a paper and went on to do 
something else. Parmentier worked on various aspects 
of the potato and its use in breadmaking, refining and 
publishing his results until the topic was exhausted. The 
use of potatoes in the making of bread never really 
caught on, partly because it is still a fairly time-
consuming procedure and because by the time 
knowledge of the method · became widely known, 
wheat and maize grown elsewhere were able to be 
transported to where they were needed. Sadly, potatoes 
did not have much impact on the effects of famine and 
fortunately byl800 famines in France became rare. 
Paimentier was not always right, not always relevant 
and not always even first, but his many 
accomplishments made a real difference to many 
people in many fields. For his outstanding contributions 
to pharmacy, agriculture, nutrition and chemistry -,--
together with his humanitarian and benevolent 
approach to society- he must surely be included among 
the great Frenchmen of the eighteenth and · early 
nineteenth centuries. 
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Ane Breve Description of the Pest 
Dr Peter M Worling 
Edinburgh 
The plague, known in Scotland as the Pest and 
sometimes as the Black Death, first occurred in China 
in the 1330s. At that time China was a world-wide 
trading nation . By 1347 ships from Europe arrived in 
the Black Sea where they linked with the China trade 
and carried the disease to Sicily and then on to the rest 
of Europe. There was a mortality rate of between 25 and 
40%, which reduced the European population and had 
far reaching economic influences. 
The disease reached England in 1348 through the 
port of Southampton and lasted until 1350. There were 
further outbreaks in 1361-1362, mostly affecting the 
young, in 1369 when some 13% of the gentry and 
clergy in England died and also in 1379-1383 and 
1389-1393. By the 15th Century the disease had 
become endemic, with its centre in the middle of 
Europe, and cases continued to occur. Consequently 
when Gilbert Skeyne published his work there was a 
considerable amount of knowledge about the 
appearance and effects of the plague. 
Gilbert Skeyne was born around 1522 in Aberdeen, 
Scotland. He was educated at the Grammar School and 
at Kings College, Aberdeen University, where he 
gained a Master of Arts degree. He then went on to 
study medicine and in 1556 he was appointed 
Mediciner (that is a Doctor) at the University. It was 
during his time at the University that his treatise on the 
plague was published in 1568. He is known to have 
published one other work in 1580, 'Ane brief 
description of the qualities and effects of the well of the 
Woman Hill beside Abirdene ' . 
In 1569 Gilbert married Agnes Lawson, the widow of 
an Edinburgh Burgess, and in 1575 he moved to 
Edinburgh and set up a medical practice in a house in 
Niddrie Wynd. His practice prospered and he became 
well known locally. On the 16th June 1581 he was 
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appointed a physician to King James VI and he was 
granted a pension of £200 Scots. He died in 1599. 
His treatise is particularly interesting because it gives 
us an insight into both the philosophy of medicine , as 
well as the drugs in use at the time. It is written in 
Middle Scots and it is the first medical treatise 
published in Scots. All other medical works were 
published in Latin and it meant that this work was 
available to a much wider public. A copy of the work is 
held in the National Library of Scotland. The treatise is 
divided into eight chapters: 
Chapter 1 A Description of the Plague 
2 The Causes of the Plague 
3 Signs 
4 The Most Dangerous Places to Be 
5 Recognition of the Infection 
6 Signs of Death 
7 Prevention of Plague 
8 Cure. 
The last two chapters are the main sections, giving 
instructions on how to treat the patient together with 
many prescriptions which he recommends. While the 
body of the text is in Scots the prescriptions are in Latin. 
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Europe at that time was strongly influenced by the 
church and religious belief. It is not surprising that the 
first cause of the plague is seen as a scourge and 
punishment of the most just God , so that heaven which 
is the admirable instrument of God, blows that 
contagion upon the face of the Earth. 
Gilbert then continues by listing the secondary causes 
of the plague: 
The cause of the plague in a city is the stink and corruption 
and filth which occupies the common streets and gutters, the 
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great reek of colis(smoke from coal) without the wind to 
despatch the same, corruption of herbs sic as Cail and 
growand treis (trees), moist hevie sauer (smell) of lint, 
hemp, and ledder (leather) stepit (soaked) in water. Ane 
privat house infectis other of stink and closetis (toilets) 
or corrupt carioun <lead animals) therein of near by if 
the inhabitant 's hes invi seit (visited) other infected 
townis or drinking corrupt water. 
There was consequently a clear understanding that the 
filthy conditions in which people lived in the cities 
contributed to ill health and the spread of plague, 
although they did not know how the infection was spread. 
In chapter 3 Gilbe1t describes the physical conditions 
most likely to bring about an epidemic. He believes that 
these include a wet spring, the eclipse of the sun, meteor 
showers and following the sickness in poultry. He 
emphasises the influence of bad weather conditions, but 
shows in his remarks that, at that time, there was little 
understanding of how the infection was spread. 
Gilbert describes in chapter 4 those places where the 
plague is most likely to occur and those most likely to 
succumb. The places are those near the sea, situated 
towards the South and where there is an abundance 
ofstanding water and where dead are buried. As the 
plague epidemics generally started in Continental 
Europe and the infection was carried to the ports in the 
South of England and Scotland before travelling up 
through England to Scotland, this confirms his 
observation that the disease travelled from the South. 
The next two chapters deal with the diagnosis of the 
plague and the signs of death . He describes the plague 
symptoms as a high fever, headache, depression , pain in 
the stomach and the heart, coupled with heavy intakes 
of breath. He describes the appearance of the swellings, 
which he caJJs 'BUBONES ' of the lymph glands under 
the arms and in the groin, and remarks that if a number 
appear it is considered more deadJy. 
Signs of im-
pending death are 
given as abdo-
minal cramp and 
pain, the body 
being covered 
with red spots -
which tum black, 
(thus the name the 
Black Death)' 
, refusal 
of food, a black 
tongue and a dry 
mouth. He comments that he treats his patients with the 
help of God who is the onJy true mediciner for the body 
and the soul. He ends by explaining that he has of 
necessity to write his prescriptions in Latin as they cannot 
be easily translated into the vuJgar language. This may 
make these obscure for the unJeamed reader but he can 
obtain any of these prescriptions from the apothecary 
prepared with all good faith and diligence , as they are 
prescribed with benevolence. 
Chapters 7 and 8, which are the main chapters, deal 
with the preservation (prevention) and cure of the plague. 
He recommends two actions: the first is to prepare the 
body 'for purging of the superfluidity or corruption of 
humours ' . Evacuation is then recommended before or 
after anyone has been in a suspect place by drawing blood 
from the median vein of the right arm taking a quantity 
that is determined by the strength , temperament, 
constitution and the age of the patient. 
He makes the point that man must live in a fresh 
atmosphere and where there is stink and corruption it 
must be dealt with by fire and fumigation with aromatic 
materials. He quotes Hippocrates who lit fires in Athens 
to combat the plague brought over from Africa and 
Ethiopia on the prevailing wind. He gives a long list of 
materials to use in fumigation: 
A fire is first made of fir or a similar timber and added to 
it various herbs such · as Aloes, Callamus cal led 
Aromaticall , (Calarnus rotang - dragons blood) , 
Asa.rum, the scruff of Citroun , Saifroun, (Crocus sativa), 
Canel Cypir, Coste, Galange, (possibly Kaempferia 
galanga[), Caryophillis (Clove) , the tre and Granis of 
Juniper, Rosemarie , leavage (lovage) , Balme tre, Laure 
tre, Squinathe calles luncus· odoratus, Ladanu , myrrhe, 
Minte, Origanum, the root of Valeriane, Pulege , Saige, 
Sauine, Tamarisce , Rosait , Acorus (Acorus calamus) , 
Aspic, Basil ic , Tyme, Calamint, Mariolane, Finkill, 
Hysop or others of such quality as the time shall require 
such as hot and dry in winter, cold and humid in summer. 
He also says that these ingredients can be used to 
make compositions in the form of lozenges , thick 
powders, candles or 'pomis odorative'. He gives a 
number of prescriptions for these, for example: 
R Yrios Florentine 
Majoranae 
Calami aromatici 
Lapdani 
Benioni 
Cpri gariophillorum cuisop drach duas 
Moschi grana quatuor 
Fiat pulvuis gum traganti; quatu sufficere posse artifice 
videtur; 
praescripta in massae formam temperet, fomenter deinde 
pilae suffisimi odoris qui principi pestis causae ex diametro 
repugnant. 
He suggests the use of sheets soaked in vinegar as 
hangings, dipping a sponge in vinegar in which rue 
has been soaked, and other remedies but he points out 
that these are not as efficient as the preservative 
remedies he recommends. 
There are many other prescriptions recommended 
in the chapter, some for use in the winter, others in 
summer. An interesting suggestion is that those 
patients that do not know with which disease they are 
infected should take a drachm of Pill Aggregative 
followed the next day by a dram of Theriac. 
However, he says, these days Theriac is not well 
dispensed and not good and two drachms of the 
following electuary could be taken instead: 
R Ros siccaru rad gentianae 
Squinathi , 
Trifolii 
Thuris, sing 
Sanquinis s icci anseris 
Haedi 
drachma duas. 
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Anatis maris et feminae 
Rutae sylvestris feminis 
Fenicoli, Cumini, Anethi, 
Napi sylvestris vel rapi hortensis cuisop drachmem 
Et feminis---------------------------------------------
M yrrhe 
Nardi sing drachmas tres 
Piperis albi et longi : 
Costi, phu, cinamomi, anisi sing drachmam 
Benzoi , afari, amoniaci cuisop drachma et semis 
Ireos, croci, rhei, gigib, Mistiches sing drach. Semis. 
Stoecados drach tres 
Agarici, mari , ana drachma 
Carpobalsami grana numero v1gmti 
Fiat pulvis tenuissimus ex omnibus. 
Mix with four parts of honey, well mixed and pour into a 
silver vessel , as a most precious medicine, which not only 
preserves from the pest but is also good for curing the same 
and is an antidote for all other poisons or bite of serpent. 
A prescription he recommends for older people or 
those with a humid temperament: 
R Castorei veri 
Aristolochia rotundae sing drachma duas 
Gebtianae drachma 
Baccharus lauri drach 
Ex omnibus fiat pulvus, ane drachma thereof as age and 
nature of the resauer (patient) requires with wine or some 
convenient liquid once daily for prevention and twice daily 
for cure. 
The final chapter eight is headed 'Cure of the 
Pest'. Gilbert begins by recommending the patient is 
given a good fat fowl with two fresh eggs and three 
ounces of 'rosate' honey. This is followed with a 
dose of the 'antidote cordial' (because the venom to 
the most part draws to the hart) . The vital faculties 
must be carefully observed and the patient should be 
allowed to rest. If there is deterioration then give the 
following prescription: 
R theriace optimae septem ad minus annod 
Optima venetii tantu , 
eao legitima c6fictus 
boli Armenan 
diarrhodi abbayis sing drac una 
rheib electi drac semis 
cinnnamomi opti 
trochiscoru de spodio 
triu sand lorn 
terrae sigillatae 
et camphorae recentis fin 
unciae semis 
serupulu sacchari ros et bugloss ros 
enuity --- croci orientalis scrupuli semis 
in pulverem quae debent iatricu vertantur, qui in aquis 
cardui benedicti, scabiosae, buglossae , rosaru et 
plantaginis sing unc. semis quae tande colata, per 
manicam Hippocratis ferantur, fiat antid. capiat infirrnus 
una , vel tres uncias vt ratio postulat singulis matutinis 
horis , noctis hora media. 
Within three hours of taking this antidote if any aposteme 
(lump) appears, affix a ' ventose' there , if it does not appear 
fix the same to the ears, under the oxter (arm pit) and by the 
secret members. Draw blood from the arm copiously, if the 
patient can suffer this. If swelling appears on the head, open 
the cephalic vein on the exterior part of the arm , if between 
the head and the secret members Leuer vein on the inner 
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part of the arm, if beneath the secrets the interior vein of the 
foot called saphena must be opened. 
Following bleeding he recommends a number of 
prescriptions which can be used , for example: 
R aloes electe unc . duas 
aristolochiae rot 
croci drac . 
tormetilae 
dictani 
semisacetose 
seminis pomtrei 
rheib 
uncia 
semis 
sesquidrachma 
ana drac seminis 
drach duas 
salisimae spicae sing drachmam 
cu serapio de acido ori succo 
In globu redigatur pro pilulis 
Ane sufficient dose to be taken twice or thrice for 
prevention or at the beginning of infection . 
He recommends that the patient should be kept quiet 
in a room with a big fire and vinegar and rose water 
thrown on the fire. He gives a prescription for a hot 
application for the chest. He recommends that the 
patient should abstain from sleep the first night but 
as frequent sickness and fainting will make it 
difficult to retain the medicine he suggests that the 
stomach can be settled by giving a prescription 
which includes olei ros and myrrh. 
On the second day he reports that Avicenna gave 
two ounces of rose water, an ounce of small white 
wine and bol armen in powder. If the patient retains 
this he may be safe but if he vomits it is a deadly sign. 
The third day he is given a drachm of the previous 
antidote and any swelling, fomented with a decoction 
of the root of lilies althe , camomile, anete and adiante 
fixed in a cataplasma of flour and fresh butter. He also 
discusses the best way to deal with the swellings; he 
recommends they should be opened by a surgeon 
because of the infectious material contained in them. 
There are many other prescriptions . In only one is 
aquae vitae mentioned and this is in a prescription to 
be given to aid recovery after the plague has 
subsided. From these prescriptions we can get some 
idea of the more popular treatments . There is an 
emphasis on the use of Theriac with a multitude of 
ingredients . Items frequently used are aloes, myrrh , 
honey, Armenian bole, rosae rubrae (the fresh dried 
petals of Rosa gallica), oil of roses, cinnamon, 
camphor, flowers of violets, bugloss, aristolochia , 
scabious, gentian and vinegar, together with many 
other herbs, most of which are familiar to us today. 
Among the more unusual ingredients he mentions 
are oil of scorpions and vipers . It is significant that 
while he recommends purging and bleeding his 
pharmacopoeia is largely a herbal one and he does 
not use the more esoteric remedies that have been 
reported by some other authors at this time. 
Author's address. p .worling @virgin.net 
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2006 Relating to Pharmacy and 
Chemistry 
This annual digest collects information from over 
two hundred record repositories throughout the 
British Isles about manuscript accessions received in 
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(www.nationalarchives .gov.uk). The indexes of the 
National Register of Archives can be consulted at the 
National Archives, Kew, Richmond , TW9 4DU or 
online . 
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Plymouth and West Devon Record Office, Unit 3, 
Clare Place, Plymouth , Devon PL4 OJW. Samuel Ley 
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(MS.8451) ; Charles Charnley, chemist and druggist, 
Wilmslow: recipe books 19th cent-20th cent 
(MSS .8437-8438) 
https://doi.org/10.24355/dbbs.084-201803131618
Review 
Popular Medicines: An illustrated history 
Homan, Peter G; Hudson, Briony; Rowe, 
Raymond C. London: Pharmaceutical Press, 
2008, pp 182 and viii. ISBN 978 0 85369 782 2. 
Price £24.95. 
This colourful book is likely to provoke nostalgia in 
anyone concerned with pharmacy and its products over the 
last 50 years. There are chapters for 21 popular branded 
medicines that were introduced and widely advertised, 
some over more than 300 years, and a handful are still in 
use. Many have declined in popularity since the Medicines 
Act 1968 and its licensing requirements and a general 
reduction in the use of harmful ingredients. 
Looking at these popular medicines with hindsight, the 
range of activity of what were little more than laxatives or 
purgatives is incredible and a testament to the power of 
large advertising budgets to influence the gullibility of a 
medically ignorant population. Though the medicines were 
disdained by the medical profession and many pharmacists 
(who preferred to make their own nostrums), were 
orthodox medicines much better? Many of the products 
were criticised or denounced as worthless in their time not 
least by the BMA's Secret Remedies investigation;,but 
most remained popular with the public. 
The main theme running through the oral products is 
purifying the blood, the liver and the body generally. The 
claims evoke today's advertisements for 'holistic 
detoxing', colonic irrigation and spa treatments. The 
analytical results produced in the 19th and early 20th 
century contain many unknowns and would benefit from 
re-analysis by today's super-sensitive methods. However, 
ingredients were frequently changed over time. 
Many of us will have taken these remedies in the past. I 
was given Golden Eye Ointment (mercuric oxide), and 
Steedman's Soothing Powders for teething in the days 
when it contained calomel. Some of the products, such as 
Singleton's Eye Ointment (Golden Eye Ointment) and 
Woodward's Gripe Water, could still be considered 
effective, even if not sterile or suitably packed. Others 
caused numerous deaths over the years from use in 
children or enthusiastic overdosage. Products containing 
opium and antimony could be particularly dangerous. 
The text is lavishly illustrated with colour pictures of the 
originators, the products, their labels, advertisements and 
many interesting promotional leaflets, mostly from the 
invaluable collections of the Pharmaceutical Society's 
Museum. The authors are experienced in their fields and 
are to be congratulated on bringing these medicines back to 
life. The chapters on products from Anderson's Scots Pills 
Pharmaceutical Historian Back Issues 
to Zam-Buk have a consistent structure that describes: the 
inventor and origins of each product, often with quotations 
from advertisements and contemporary reviews; the 
formulas and how they vaiied and were copied over time; 
the claimed uses; ownership of the remedy from its origins 
to recent years. The fascinating histories of the products 
and the fortunes some of them produced are well 
researched. Several products have musical connections, 
from the well known music produced by Beecham's (Hark 
the herald angels sing, Beechams Pills are just the thing) , 
through Bile Beans and Lydia E Pinkham's Vegetable 
Compound (Lily the Pink), to Elgar's Mrs Wmslow's 
Soothing Syrup. Besides those already mentioned there are 
chapters on Burgess Lion Ointment, Carter's Little Liver 
Pills , Clarke's Blood Mixture, J Collis Browne's Chloro-
dyne, Dalby's Carminative, Fennings' Children's Cooling 
Powders , Holloway's Pills and Ointments, Dr James's 
Fever Powders, Morison's Pills , Mother Seigel's Syrup, 
Poor Man 's Friend Ointment, and Dr William's Pink Pills. 
The book was an informative read where the illustrations 
were as interesting as the text, and it should appeal to 
anyone who has worked in a pharmacy or is interested in 
medical, social and pharmaceutical history. I would also 
commend it to the general public, who over the centuries 
have kept these medicines in business. Ainley Wade 
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available for £8 UK or £10 Ove~seas (including post and packing) . The Indexes for 1967 to 1995, 1996 to 2000 
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E~il: peter.homan@lineone.net Cheques , Banker 's Orders , etc. to be made payable to the British Society for the I 
History of Pharmacy. Payment can on]ybe accepted in Pounds Sterling. 
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Review 
Nature's Alchemist. John Parkinson, 
Herbalist to Charles I 
Anna Parkinson. London: Frances Lincoln, 
Nov 2007, Hardback, pp 336. ISBN: 978-0-
7112-2767-5; Price £25. 
The title of Anna Parkinson 's recent biography of her 
illustrious ancestor, the botanist-apothecary John 
Parkinson (1567-1650) , sets him perfectly in the context 
of his day. To describe him as 'Nature's Alchemist' was 
an inspired conceit, bedded as it is in the 16th-century 
Paracelsian belief in the act of creation as the work of 
God as alchemist. A Catholic by religious conviction 
and family tradition , Parkinson saw God made visible 
in the natural world around him. As a botanist he sought 
to discover, identify and classify plants and flowers; as 
a horticulturist and gardener he endeavoured to grow, 
nurture and show them, many from seed, both native 
and from overseas; as a latter-day alchemist he achieved 
wonders in transmuting existing species and creating 
new varieties; and as an apothecary he determined their 
pharmacological value and medicinal virtues and 
devised recipes for the preparation of drugs and 
draughts for the benefit of rich and poor alike. 
In the literature of alchemy, the alchemical process 
was often likened to the agricultural cycle of sowing, 
growing and harvesting, and alchemical thought was 
characterised by the concepts of progress , growth, 
improvement and ennoblement.' All this was reflected 
in John Parkinson's two-acre plot at Long Acre in 
Covent Garden, which in many ways was a precursor to 
the Society of Apothecaries ' physic garden at Chelsea. 
He spent the greater part of his life toiling tirelessly and 
patiently away in his 'garden laboratory ' , applying 
scientific method to his investigations and experiments, 
and painstakingly recording the results in what became 
two hugely important and beautifully illustrated works . 
Paradisi in Sole Paradisus Terrestris ('Park in Sun' 
being a pun on his name), published in English in 1629, 
was dedicated to Queen Henrietta Maria of France, 
Charles I's young bride. It was a horticultural treatise on 
the cultivation of plants generally and was divided into 
three main sections: the flower, kitchen and orchard 
gardens. The missing fourth garden , of simples or 
medicinal herbs , became a stand-alone volume: a 
Continued on p . 32 
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Bismuth Usage down the Decades 
Andrew Hardy" and Ragini Vaishnav" 
*centre for Medical History, School of Humanities 
and Social Sciences, University of Exeter, UK 
.. College of Medicine, Sultan Qaboos University, Box 
35, AI-Khod 123, Sultanate of Oman 
Who first discovered elemental bismuth, and exactly 
when, is unknown. However, the element was being 
referred to in the late 15th century in Germany by a 
specialised guild of metal workers.' Its compounds 
have had many uses down the centuries, often as 
medicines or cosmetics . 
The non-medicinal/cosmetic uses of bismuth and its 
salts have varied over time. In December 1896, shortly 
after the discovery of x-rays, laboratory animals were 
fed bismuth salts so that the functioning of their 
intestines could be observed on a fluorescent screen.2 
Prior to this, in the 1860s, the price of bismuth on the 
UK metal market rose dramatically. This was directly 
related to a fraudulent method for 'transforming' 
bismuth and aluminium into silver, perpetrated by the 
Hungarian refugee Nicholas Papaffy.3 More recently 
bismuth has found various uses in metallurgy; by 
mixing the element with other elements such as lead, 
tin and cadmium an alloy of low melting point (e.g . of 
about 70° C) can be obtained. 4 One use of such an 
alloy is in anti-fire sprinklers - where a water nozzle 
contained by this alloy becomes free of obstruction if 
a fire causes its temperature to exceed its melting point. 
Bismuth oxychloride (BiOCl) was used as a (white) 
face cosmetic in the 18th and 19th centuries - often 
known as 'Pearl Powder' or 'Spanish White' .5 Apart 
from the potentially adverse toxic effects of bismuth 
compounds on human health (see later), there was also 
the unfortunate tendency of this pearly-white face 
powder to turn black (BizS3 being formed) if the user 
was too close to the sulphurous fumes emitted by the 
ubiquitous coal fires of the period. 
Bismuth compounds have been used in medicine for 
at least 200 years in the treatment of syphilis/yaws, 
diarrhoea, indigestion/heartburn, nausea, dysentery, 
gastric and duodenal ulcers , as suppositories in the 
treatment of hemorrhoids, in surgical dressings and 
(externally) as a dusting-powder/ointment for eczema 
and burns .6 Comments on the usage and dosage of 
particular bismuth compounds will be covered later in 
this article. 
The biochemical modification of metals and 
metalloids such as bismuth via formation of volatile 
metal hydrides and alkylated species (volatile and 
involatile) performs a fundamental role in determining 
the environmental processing of these elements. The 
formation of such species can increase the 
environmental mobility of the element, and can result 
in bio-accumulation in lipophilic environments. The 
inorganic form of bismuth exhibits low toxicity, 
however the more lipid-soluble organo-metallic form 
(which is less characterised) may be highly toxic. Data 
on the geno-toxicity (and the neurotoxicity) as well as 
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the mechanisms of cellular action of organo-
metal(loid) compounds are limited.7 
Inorganic bismuth salts are poorly soluble in wateE 
Regarding the pharmacokinetic aspects of bismuth, 
the normal concentration of bismuth in blood is 
between 1 and 15 µg/L, but absorption from oral 
preparations can produce a significant rise . 
Distribution of bismuth to vari.ous parts of the body 
does not depend on the compound or on the route of 
administration. The concentration and retention of 
bismuth is highest in the kidney where it is bound to a 
bismuth-metal binding protein. In addition to the renal 
1 
route it is also excreted by the faecal route. 
In humans , toxic effects of bismuth compounds i 
include nephropathy, encephalopathy, osteo-
arthropathy, gingivitis , stomatitis and colitis. Central 
nervous system toxicity, including encephalopathy, 
has been associated with the intake of inorganic salts 
including bismuth subnitrate, subcarbonate and 
subgallate. Difficulties in walking, standing or writing, 
deterioration of memory, changes in behaviour, 
insomnia, muscle cramps and psychiatric symptoms 
have been reported. These recover spontaneously after 
discontinuation of bismuth. A safety level of 50 µg/L 
and a toxic level of 100 µg/L (in blood) have been 
suggested.8 
Thus acute and chronic toxic effects can arise from 
ingesting bismuth-containing medicines ( or 
cosmetics). Acute effects include: loss of appetite; 
headache; (mild) jaundice; blue line on the gums; 
some gastrointestinal disturbance and even some 
nephrotoxicity and neurotoxicity. Chronic effects can 
include: deterioration of mental ability; tremor and 
impaired co-ordination.9 
Three bismuth-containing medicines, covering the 
time period 1899 to the present-day, have been 
chemically analysed in order to determine the exact 
bismuth compounds present and their approximate 
percentages per tablet. Knowing these (approx.) 
percentages and the formulae of the bismuth I 
compounds present the approximate weight of 
bismuth per tablet can be calculated. Dosages were 
given with all of these medicines and so comments can 
be made regarding possible toxic effects, and also on 
how or if the weight of bismuth per tablet/dose/day has 
changed over time. As the chemistry of bismuth can be 
complex we will give exact chemical formulae for the 
bismuth compounds identified in these analyses. In 
particular we will use ' sub' in a chemical name only 
when the oxide or hydroxide is known to be present. 
All three medicines were analysed using the 
techniques of LVSEM (Low Vacuum Scanning 
Electron Microscopy) and XRPD (X-Ray Powder 
Diffraction) . The former technique gives quantitative 
elemental analysis for atomic numbers (Z) of 6 (i.e. 
carbon) and above, and the latter technique can 
provide identification of the (crystalline) compounds 
present and their semi-quantitative percentage 
presences .10 
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Tablets BH3 
The first bismuth-containing medicine (labeled by the 
authors as 'BH3 ' ) was in a glass container in an 
American-made medicine chest dated to 1895-1899. 
The chest was labeled: 'Prepared and supplied by: 
Fraser and Co . of New York, USA' . The glass cont-
ainer 's label had the date '9.21.99 ' (that is 21st 
September 1899) and had the name 'Dr. J. H . Clark' 
written on it. The dosage information written on the 
bottle's label was: 'For diarrhea, one every two hours 
until better, after every four hours until relieved'. No 
mention was made of its chemical composition . Each 
tablet was white in colour and weighed 325 mg [5 
grains]. 
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The LVSEM results were (in decreasing order of 
weight percent): 0 and/or N (uncertainty from peak 
overlap) , Bi, C, Si , Mg. The XRPD results were (with 
approximate percentages in brackets): 
Bismuth subnitrate hydrate of formula: 
[Bi/;Os(OH)3)(N03)s .3H20 ( 47%) 
Bismuth subnitrate hydrate of formula: 
[Bi<i06(0H)3)(N03)J.l .SH20 (13%) 
Phenyl salicylate ('Salol') (C 13Hw0 3) (30%) 
Talc (Mg3St401o(OH)2) (5 %) 
Unknown (5%) 
In a 1978 publication 11 it was stated that 'About 
fifteen bismuth basic (that is our 'sub ') nitrates have 
been described in the literature since the 17th century ' 
and it listed the five that had been 'most adequately 
characterised ' . It then went on to describe the crystal-
structure analysis of one such subnitrate -
[B~O s(OH)3 ](NOJ),JH20 (now called 'A') - the 
major component in BH3. This compound (A) is one 
of the most easily and commonly made subnitrates; 
where all such compounds are synthesied by the 
hydrolysis , at varying pHs, of bismuth nitrate 
pentahydrate (Bi(N03)3.5H20). In a later (2000) 
publication,12 the number of such compounds, with 
known compositional and (at least some) crystallo-
graphic data, is nine - which includes the two bismuth 
subnitrates synthesied and studied (by XRPD) in the 
publication. One of these two compounds is the 
second bismuth subnitrate found in the tablet (at 
approx. 13%, and now called 'B'). 
It is possible that some ' bismuth subnitrate', for use 
in the tablets for this American-made medicine chest, 
was purchased commercially and locally. Merck & 
Co. , Inc. was located in New York city in 1899 and 
does list bismuth subnitrate in its Merck J 896 Jndex 13 , 
and so could be a possible commercial source. 
Bismuth subnitrate (BSN) was probably the first 
bismuth compound to be used, in the Middle Ages in 
Europe , as a medicine (it was also being used as a face 
cosmetic and as a pigment in paintings). By the 19th 
century it, along with other bismuth compounds, was 
being used in both Europe and the USA for various 
gastric disorders. However, extensive medicinal use of 
very high oral doses (sometimes 10g or more a day for 
months , even years) of BSN lead to toxicity in several 
countries in the 1970's. In France, by 1979, almost 
1000 cases of bismuth-associated encephalopathy had 
been reported, of which 72 were fatal.6• 9 
It was recently shown that BSN was sparingly 
soluble ( < 0 .5 % ) in human gastric juices, that bismuth 
was barely absorbed(< 0 .01 %) into the blood stream 
and that it was inactive against Helicobacter pylori. 
However, when it was used in viva with antibiotics 
(i.e. triple therapy) it was effective in partially (74%) 
eradicating H. pylori .14 
Using the above values for: the weight of the tablet; 
the (approx.) percentages and molecular formulae for 
the bismuth compounds . in the tablet; the 
recommended dose and the maximum number of 
tablets per day - then the total weight of the bismuth 
compounds (and of their associated bismuth) can be 
variously calculated. Thus, for this medicine (BH3) 
the (total) weight of the bismuth compounds and of the 
bismuth present are respectively: for the tablet and a 
single dose (1 tablet) , 195mg and 141mg; and for the 
max. daily intake (8 tablets), 1.55g and 1.13g. 
The other (assumed) 'active' ingredient in BH3 is 
salol (phenyl salicylate) . Its concentration of approx . 
30% is too high for it to be present merely as an enteric 
coating; it was probably present as an internal 
antiseptic and/or as an antipyretic . Its use at this 
concentration would now be questionable, as it can be 
toxic from the liberation of phenol.15 The talc found 
(at approx. 5%) was assumed to be present as a tablet 
lubricant. 
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Bismuth Dyspepsia Tablets (Meggeson) 
The second bismuth-containing medicine was from a 
glass bottle , of SW UK origin , named on its label as 
'Bismuth Dyspepsia Tablets (Meggeson)' (labeled by 
the authors as 'WSM3') and dated to the 1940s. On the 
bottle 's label was the dosage information: 'For 
Indigestion & Flatulence. One or two tablets after 
meals' . The name of the dispensing chemist was also 
given as: 'Lewis Wing Ltd., chemists , Weston-Super-
Mare' . 
The composition, on the bottle's label , was partly worn 
away (an * or ? is given where it is either unreadable 
or partly readable respectively): 
Bismuth Carb. Gr. * 
Soda Bicarb. Gr. 3 
Sp. Chlorof. 01. Lavand. AA? qs? 
Gr. is an abbreviation for Grain (64.8mg). Each 
tablet was yellow-white in colour and weighed 729mg. 
The LVSEM and XRPD results were (as before, plus 
the element given in brackets for the former is at the 
1 % level or less): 0, C, Bi, Na (Ca) and: 
Bismuth subcarbonate of formula: (Bi0)2(C03) (20?) 
Sodium bicarbonate (NaHC03) (20?) 
Unknown (but thought to be 'lozenge base', see below) 
(60?) 
The ' ?' after the above approx . percentage values 
reflect the following: there was some peak overlap in 
the diffraction pattern; the possibility of various 
impurities being present (e.g. hydrates of both the 
sodium and bismuth compounds); that some of the 
original constituents had evaporated over time (the 
chloroform and lavender) and the unknown nature of 
the 'lozenge bas.e' (see below). 
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For this tablet (WSM3) it was assumed that all the 
lavender and chloroform (i .e. the spirit of chloroform 
used as solvent for the oil of lavender) had totally 
evaporated. Thus its weight now (729mg; that is 11 .25 
grains) is less than its original weight. If its original 
weight is assumed to have been 13 grains (0 .842g) 
then the 3 grains of sodium bicarbonate on the label 
represents 23 .07% of the (original) tablet by weight. 
This percentage exactly matches the percentage given 
for the proprietary medicine 'Meggeson Brand 
Bismuth Dyspepsia Tablets ' in the 22nd Edn (1943) of 
The Extra Pharmacopoeia.16 Also given in this recipe 
are the percentages for bismuth carbonate, at 7.69%, 
chloroform, at 7 .23% and 'Lavender lozenge base ' to 
100%, that is at 62.01 %. The percentage of 7.69% 
represents exactly 1 grain of our (original) 13-grain 
tablet, and 1 is thus most likely the number worn away 
on our bottle's label. The ' lozenge base' is most likely: 
a mixture of sugars, plus possibly acacia and/or 
tragacanth , and sometimes gelatin ,17 which we have 
assumed is the 'unknown' in our XRPD results above. 
Thus our tablet is assumed to have been made 
according to the (1943) recipe (where the bismuth 
carbonate given on the label and in the recipe should, 
in reality, be termed subcarbonate). However, whilst 
the recipe-expected percentages for two of the tablet 's 
components (i.e. the sodium bicarbonate and the 
lozenge base) are reasonably close to those found from 
our XRPD data ( and after allowing for the evaporation 
of the original chloroform and lavender) , the (XRPD) 
percentage value calculated for the bismuth 
subcarbonate (20%?) is higher than that given in the 
recipe (7.69%; which becomes 8.89% for the present 
tablet weight). This discrepancy could have arisen 
from one or more factors , such as: severe, rather than 
mild, peak overlap in our XRPD data; a random 
'aberration ' in the manufacturing process for this 
particular tablet; or a deliberate deviation from the 
1943 recipe by this chemist. We consider the first of 
these factors to be the most likely, although the last is 
a possibility (unfortunately no prescription recipe 
books from the chemist have survived). 
The compositional chemistry of the bismuth 
subcarbonate (BSC) is not as complex as for the 
subnitrate, and it does exist as the secondary mineral 
' bismutite' (discovered in Saxony in 1841). Also , a 
few of its hydrates exist, as do a few mixed metal 
subcarbonates ( e.g. where the bismuth is partially 
replaced by calcium and/or lead).18 As for BSN, it was 
used extensively ( often listed as basic bismuth 
carbonate) in the 19th century for various gastric 
disturbances, sometimes in large short-term doses of 
10g, three times daily. Even higher doses (20g at 
4-hour intervals) were apparently used for the 
successful elimination of threadworms. 15 Again , like 
BSN, both the aqueous solubility and blood stream 
absorption of bismuth from BSC is very low. 
However, its absorption relative to BSN is variously 
described as 10 - 20 times less or as comparable.19 Its 
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toxicity is sometimes stated to be less than for BSN· 
although the relative toxicities may well var; 
depending on the exact formulae of the bismuth 
compounds being compared. 
Using the same calculations as used previously for 
BH3 , on the data fo{ this medicine (WSM3), then the 
weight of BSC and of its associated bismuth can be 
variously determined as before. Thus , for this 
medicine the weight of BSC and of bismuth present 
are respectively: for the tablet, 65mg and 51mg; for the 
maximum single dose (2 tablets) , 130mg and 102mg; 
and for the max . daily intake (6 tablets) , 390mg and 
300mg. 
The other (assumed) active ingredients in the 
original WSM3 tablet are: the sodium bicarbonate 
(antacid), chloroform (carminative, sweet-tasting) and 
lavender (as for chloroform and is sweet-smelling) .1s 
Pepto-Bismol 
The third bismuth-containing medicine was the OTC 
American medicine 'Pepto-Bismol' (labeled by the 
authors as 'PB l '), and was bought in the USA for us 
in 2005. Each tablet was light pink in colour and 
weighed 993mg. The LVSEM results were (as before): 
0, C, Ca, Bi , Si (Mg, Al) . The XRPD data obtained 
allowed identification of five of the eight listed ( on an 
enclosed leaflet) inactive ingredients - that is for: 
calcium carbonate, magnesium stearate, mannitol, 
saccharin sodium and talc - and not for: flavour, 
povidone and red 27 aluminium lake; plus to confirm 
the presence of the listed active ingredient, bismuth 
subsalicylate [C7fii03(Bi0H)] .20 However, as the 
diffraction pattern was extremely complex and had 
multiple overlapping peaks it was not possible to 
estimate the percentages of the compounds identified. 
Thus , in all future discussions and calculations, the 
amount/percentage of bismuth subsalicylate present in 
this sample will be that given on the medicine's 
accompanying leaflet (i.e. 262mg/tablet, that is 
26%/tablet) . Apart from the above compositional data 
there was also dosage and usage information on the 
nclosed leaflet; stating that it could be used to relieve: 
'heartburn, indigestion, upset stomach, nausea and 
diarrhea' and the dosage for adults and children over 
12 was given as: ' 2 tablets every~ to 1 hour as needed 
and do not exceed 8 doses (16 tablets) in 24 hrs, and 
use until diarrhea stops, but not more than 2 days'. 
The original Pepto-Bismol was invented (and 
initially called 'Mixture Cholera Infantum') in 1901 
by a doctor in New York , USA. He used it for treating 
'cholera infantum' (that is a sudden onset of vomiting 
and diarrhoea in infants). The original recipe (which 
he later gave away to Norwich Pharmacal Company in 
Norwich, New York) consisted of bismuth salicylate , 
pepsin , zinc salts , salol , oil of wintergreen and a 
colourant to make it pink. Once it was realised that the 
active ingredient was the bismuth (sub)salicylate then 
the medicine's recipe was changed to that used today. 
The name Pepto-Bismol was first used by the 
company in 1919 in order to sell it to adults .21 
The compositional chemistry of bismuth 
subsalicylate (BSS) is less complex than for the 
subcarbonate or subnitrate; and whilst bismuth sub-
sa!icylate is not as old a medicine as the subnitrate, it 
was being used as early as 1857 for the management 
of several diseases of the digestive tract.22 As found for 
both BSN and BSC, the aqueous solubility and blood 
absorption of bismuth from BSS is very low.23 
However, the salicylate end of the molecule is signi-
ficantly absorbed (approx. 90%) into the blood and 
can give rise to poisoning, and even death , if BSS or 
other salicylates are used to excess.24,25 BSS was, and 
is still , extensively used for treating travellers ' dia-
rrhoea . It has been found that whilst it does have a 
modest effect on acute diarrhoea of young children, 
there is currently uncertainty concerning its efficacy in 
preventing the associated persistent diarrhoea.22, 26 It 
has also been successfully used , either alone or in 
combination with antibiotics (i .e. triple therapy) , for 
the eradication of H. pylori:6 · 
Extended dosing of Pepto-Bismol (3 .l 4g BSS daily) 
for up to 6 weeks produced a mean blood-bismuth 
concentration of 16.1 +/- 7 .9 ng/g, considerably below 
concentrations in blood that have been reported to 
cause neurotoxicity. Neurotoxicity studies in animals 
and human safety data indicate that Pepto-Bismol can 
be used safely for its acute indications and for up to 3-4 
weeks of extended dosing.27 
Using the compositional and dosage data provided 
in its (PB 1) accompanying leaflet, then the weight of 
the bismuth compound (BSS) and of its associated 
bismuth can be variously determined as before. Thus, 
for this medicine the weight of BSS and of bismuth 
present are respectively: for the tablet, 262mg and 
153mg; for a single dose (2 tablets) , 524mg and 
304mg; and for the maximum daily intake (16 tablets), 
4.19g and 2.43g. 
Comparison 
Thus the weight range of bismuth ingested from these 
three analysed medicines per dosage/day varies from 
100mg/300mg (subcarbonate in WSM3 , 1940s , UK) 
to 140mg/1.13g (subnitrate in BH3 , 1899, USA) to 
300mg/2.43g (subsalicylate · in PBl , present-day, 
USA). These numbers compare well with those found 
in recent case studies: 160mg/160mg for bismuth from 
BSC in 'Dignodenum', used once on healthy 
volunteers with no toxic effects;19 410mg/1 .23g for 
bismuth from BSN (as part of triple therapy), for four 
weeks on H. pylori-positive patients with no toxic 
effects;14 300mg/900mg for bismuth from BSS in 
(liquid) 'Pepto-Bismol', used once on healthy 
volunteers with no toxic effects.23 For bismuth 
(neuro)toxicity to occur from BSC and BSN there 
must be extended over-usage - that is over ten times 
the above daily doses for months , if not years ;6, 9, 19 for 
BSS usage at such high oral doses there is the high 
probability of salicylate poisoning occurring before 
that from bismuth .24 
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All the bismuth compounds used in these three 
medicines are weakly soluble in aqueous 
solution/human gastric juices and are also weakly 
absorbed into the human blood stream. This gives 
them all a low toxicity, and only excessive over-dosing 
(i.e. 10g or more a day) for an extended period of time 
(months, even years) leads to bismuth poisoning. All 
were used in the past for treating a variety of 
gastrointestinal disorders, such as flatulence , nausea 
and dyspepsia. After WWII , with the advent of 
antibiotics, their use drastically declined. However, 
they do survive, for example: Pepto-Bismol (BSS) for 
travellers ' diarrhoea being the most extensively used, 
mostly in the USA; then, in limited usage as Roter 
(BSN) for diarrhoea and as an astringent in skin 
dusting powders, mostly in Europe; and, in a more 
limited present-day usage, for BSC , in Dignodenum 
(Germany) for treating gastritis and, as a veterinary 
product (in the UK) for cats and dogs , in Johnson's 
Diarrhoea Tablets. From the 1980s there has been a 
resurgence of interest in the therapeutic use of bismuth 
compounds for the treatment of ulcers and their often 
associated H. pylori (discovered 1982), often in 
combination with antibiotics (i.e. triple therapy). 
Though the exact mechanism by which bismuth works 
here is unknown,6 the fact that its absorption is 
apparently not required for its efficacy means a new 
interest in the use of weakly soluble/absorbed bismuth 
compounds (such as BSS, BSC and BSN) is now 
underway. 
Conclusions 
In this article we have given a brief overview of 
bismuth compounds usage in medicine and of its 
associated toxicity. Chemical analyses of three 
bismuth-containing medicines covering the time 
period 1899 to the present-day have been considered. 
The weight per tablet has increased from 325mg in 
1899 to 729mg in the 1940s to 993mg in 2005, and this 
reflects the increasing amount of inactive ingredients 
added to medications in general over this time period. 
The approximate amount of bismuth/tablet has varied 
from 140mg (1899, USA, BSN) to 50mg (1940s , UK, 
BSC) to 150mg (2005, USA, BSS). However, even 
when exceeding the maximum prescribed dosage for 
each of these three medicines, bismuth toxicity is 
unlikely or will be of a transient nature. The worst that 
could be expected from the normal dosage usage of 
these and other present-day bismuth-containing 
medicines is the formation of black stools or black 
tongue, which may lead to some patient alarm, but 
little else. 
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1. Introduction 
During the fourteenth and fifteenth centuries, at the 
time of the spicers and pepperers, a small but 
significant proportion of the medicines used in 
England were being imported from abroad. Drugs of 
eastern origin found their way here as a result of the 
increased continental traffic that followed the 
Crusaders ' journeys, and the growing activities of the 
Lombard and Hanseatic merchants. 1The former were 
settling in London and elsewhere and were 
establishing substantial businesses in drugs and spices 
through their contacts in Italy and beyond. Drugs 
were also being imported through Montpelier in France, 
a major centre of medical and pharmaceutical 
teaching. This was on the main spice route of the 
Mediterranean as well as being on the pilgrimage route 
to the Holy Land. 
By the sixteenth century a wide range of natural 
products were being imported from the East, 
particularly India, and being used for medicinal 
purposes.2 But in the early seventeenth century, with 
the founding of the English East India Company ('the 
Company') on the last day of 1600, there was a rapid 
change in both the nature and type of trade in drugs 
and medicines, particularly between the East Indies 
and England. There was in fact a dramatic increase in 
the quantities of drugs imported into England; in 1588 
only 14 per cent of the drugs used were imported from 
outside Europe; by 1669 this figure had increased to 
70 per cent, with most coming from the East Indies 
and India.3 
The imports were sold to wholesale druggists, who 
repackaged them into smaller quantities for use by 
apothecaries in towns and rural areas.4 Most of these 
imports came into Mincing Lane, London, which was 
later to become famous as the world's leading centre 
for tea and spice trading after the English East India 
Company took over the trading ports of the Dutch East 
India Company (V.O.C.) in 1799.5 
But the flow of medicines was not just in one 
direction. The expansion of trade with the East Indies 
brought with it opportunities for potentially huge 
exports of many commodities, including medicines. 
Increased trade also meant more trading ships and 
naval ships to protect them, increasing ex-patriate 
communities to administer the trade and the growing 
colonies, and increasing armies to defend the 
territories annexed; all of these had need of medicines. 
But the fortunes of the Company fluctuated wildly 
during its two hundred and fifty year history. In her 
biography of the East India Company Jean Sutton 
suggests that its trading life falls into four main 
periods.6 These are shown in Table 1. The early 
successes were followed by the near collapse of 
trading activity, but successive wars and events in 
India led to renewed trading opportunities. 
2. Supplying Medicine Chests to the 
Company's ships 
Initially the East India Company based its 
arrangements for the supply of medicines to its ships 
on the well established ones operating in the Navy. 
All naval vessels carried surgeons, and an essential 
part of the surgeon's kit was the medicine chest. 
Initially both the Navy and the East India Company 
obtained their medicine chests from private 
apothecaries. We know, for example, that the 
apothecary George Haughton was supplying 
medicine chests to the East India Company as early 
as 1634.7 The Society of Apothecaries, which was 
founded seventeen years after the Company in 1617, 
only began manufacturing medicines in the early 
1670s with the opening of its laboratory, but not until 
1702 did it obtain the privilege of supplying the Fleet 
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with medicines from Queen Anne. A special 
company called the 'Navy Stock' was set up by the 
apothecaries to fund this venture.8 
Table 1: Periods in Company's trading history and 
sources of demand for medicines 
Period Overall state of Sources of 
the Company 's demand for 
trade including medicines from 
drugs and England 
1600 to 1657 Early successes Supplies to the 
followed by Navy 
decline, 
followed by 
near cessation 
1658 to 1703 Period of Supplies to East 
growth India Company 
following Ships 
introduction of 
new charter 
and 
advantageous 
1704 to 1773 Period of Supplies to the 
regulation and Company's 
consolidation outposts 
1773 to 1834 Return to Supplies to the 
diversification Indian Army and 
in response to local communities 
changes in 
Initially the 'Navy side' of the business at 
Apothecaries Hall consisted largely of supplying 
medicine chests for surgeons. It expanded only slowly, 
sales averaging about £200 a year during the first two 
years. But in 1704 the British Fleet in the 
Mediterranean was desperately short of medicines. As 
a matter of urgency the Society's Navy Stock was 
instructed to supply internal and external medicines, 
which were to be transported by the next convoy 
leaving for Lisbon. From there, Vice-Admiral Sir John 
Leake was to distribute the chests to thirteen of Her 
Majesty's ships in the Mediterranean.9 
As bases were established overseas an additional 
demand arose to supply the garrisons with medicines . 
The Society obtained contracts to fit out surgeons ' 
chests for both hospital ships and the garrisons at 
Gibraltar and Lisbon. Sales increased to about £800 by 
17 40, rising to a peak of £1 ,700 a year in 17 68. After 
this they settled at around £700 a year. By the end of 
the eighteenth century naval surgeons' chests from 
Apothecaries Hall were being sent to Newfoundland, 
Minorca, Jamaica, Gibraltar and Lisbon, as well as to 
the ports of the East Indies and Australia. 10 This 
24 
monopoly of supply to the Navy was only 
discontinued in 1805, after over 100 years.II 
To conduct its trade with the east the East India 
Company hired ships in London . From the beginning 
every ship carried a surgeon, and the larger ones 
carried up to four: all required an extei:isive me~ici~e 
chest, and this represented a substantial trade m its 
own right. The demand for medicines for the 
Company grew steadily as British activity in India 
expanded. The fleet of the East India Company 
provide.d the means by which trade in drugs and 
medicines might be developed. 
Table 2: Ships of the East India Company 1600 to 
1834 
Period in Years Number of 
Company's ships Owned or 
history hired 
Period 1: 1600-1657 130 ships 
Initial (57 years) 
Period 2: 1658-1703 290 ships 
Consolidation (45 years) 
Period 3: 1704-1773 391 ships 
Expansion (69 years) 
Period 4: 1774-1834 427 ships 
Final stages (60 years) 
Total: 1,238 ships 
With each period in the Company's history the 
number of ships involved, known as 'Indiamen', 
increased. Over the 250 years of its life the Company 
used a vast number of ships; some 1,200 ships were 
either hired or owned by it, and nearly 10,000 voyages 
were completed.I 2 At various points in its history the 
Company also had its own shipyards, its own dry 
docks for repairs, and its own docks to load and unload 
them. The total number of ships involved is listed in 
Table 2. 
3. Supplying the army in India 
The years of peace, between 1713 and 1739, brought 
an initial lull in demand for medicines by the 
Company. But war broke out again in 1739, 
continuing until 1748, which generated increased 
demand for the restocking of surgeons' medicine 
chests. The year 1747 saw a new development: in that 
year a squadron of East India Company ships set sail 
from Spithead, the departure point for its ships in times 
of war. Each ship carried a detachment of royal troops, 
sent to relieve Fort St David at Cuddalore in India, 
where the Company 's staff had retreated following the 
fall of Madras in the same year. These were the first 
ever troops to be sent to India.I 3 Thus arose another 
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source of demand for medicines· lf--~--=====::;:=========::::=::;::::::::;:::;=;=======;;;;;n 
that of supplying medicines i~ 
medicine chests for the use of 
army surgeons employed by the 
Company. 
The return to peace following 
the end of the war against the 
French in India in 1748 again 
resulted in reduced demand for 
medicines from the Company, 
both for its ships and the army. 
But the Society of Apothecaries' 
lucrative contracts with both the 
Company and the Navy were the 
source of substantial envy in 
some quarters. A pamphlet in 
1748 drew attention the previous 
dealings that the East India L-.;:.=c.;==:::.:.:..:=::..:;;;.__ ___ ~~=..:::.:...:_:.=_;_...:..._:~.:..::,:=======z:~'11! 
Company had had with the Society, stating that the 
Comp~y had dealt 'for several thousand pounds a 
year ~1th t~ese emulsioneers, this bunch of pulp-pated 
pill gilders of Blackfriars. 14 However, the Company 
also appears to have placed some of its business 
elsewhere from time to time, to ' the Bevans of 
Lombard Street and to Johnson of Fenchurch Street 
since they were cheaper' .1s ' 
The scale of the Company's operations in India 
escalated with the taking and development of Madras , 
and Clive's later adventures in Bengal. During the 
Seven Years ' War, between 1756 and 1763, there were 
some 20,000 troops in India. The pacification of 
Bengal in 1766 brought generous dividends to 
shareholders in the East India Company, and improved 
business opportunities. In October 1766 the directors 
of the Company again looked to the Society of 
Apothecaries for the supply of the medicines it needed, 
and awarded a new and bigger contract to the Society, 
or the 'Best-side Banditti of Black Friars ' as the 
anonymous pamphleteer described them. The 
directors of the Society took the opportunity to 
produce 'an enticing catalogue of the chemical 
preparations available from the Hall' _1 6 
However, the Company suffered another reversal of 
fortune at the end of the eighteenth century, as a result 
of armed conflict in central India and mismanagement 
back in London. As a result the Company was stripped 
of its trading privileges. Yet medical supplies were still 
needed for an Indian Army which was to grow to 
arou~d 300 ,000 men by 1820 .17 In 1810 the Army 
Medical Board approached the Society with an urgent 
request: the Society quickly confirmed that it could 
supply medicines for an army of 30 ,OOO men from 
Apothecaries Hall within ten days .18 The Society was 
proud to boast that ' the whole army of India (we 
believe exclusively) is served under the direction of 
the Honourable United India Company [as the East 
India Company had now become] from our 
establishment' .19 This privilege yielded the Navy 
Stock an average of £20,160 a year for the first decade 
of the nineteenth century. 
View of East India Docks, London, 1808 
4. Supplying civilian communities 
As the activities of the East India Company expanded 
the directors decided that, in future , not only the ships 
and army but also all the outposts of the Company 
should be supplied from Apothecaries Hall 'with the 
drugs and medicines that may be wanted for the 
several Presidencies, notwithstanding their prices 
ex~eed thos~ of other persons, as there is a certainty of 
bemg supplied by them with the best of medicines and 
drugs, every article corning under the inspection of a 
deputation from the College of Physicians and the 
Surgeons Company' _20 
The influence of the surgeons employed by the East 
lnd~a Company extended far beyond that of the ships on 
which they worked. Many stayed on in the Company's 
outposts, in both India and elsewhere. Medical 
pe~s.onnel employed by the Company, and later by the 
Bnt1sh Crown , were instrumental in introducino the e, 
western medical system in India and turning it into the 
official system of health care in that country, as well as 
others.21 The Indian Medical Service traces its origins to 
the beginning of the seventeenth century as a 
component of the empire-building exercise.22 The 
impact of colonialism was also seen in medical 
education. In 1827 a series of lectures was started in 
Indian colleges based on European teaching.23 The 
medical acumen of two legendary figures, Gabriel 
Boughton and William Hamilton, has been stated to 
have aided the East India Company in establishing a 
foothold in the sub-continent.24 
. India itself ':as a staging post for the much longer 
Journey to the islands of the East Indies , to Indonesia 
and later Singapore, which took many months . Often, 
the ships would be away from home ports for several 
years . On their return journey from India the 
Company's ships stopped off at St Helena, and a 
thriving_ British community sprang up there to supply 
them with fresh meat and water, fruit and vegetables , 
and the many other commodities needed by ocean 
going ships. The actions of medical personnel and 
25 
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others in all these places further increased the demand 
for medicines from England, which would be brought 
out on the ships of the East India Company. 
Detailed records remain of some of the cargoes 
carried by the Company's ships . In one year alone the 
consignment included 10,000 pounds of Glauber's 
Salts and 28,000 pounds of Epsom Salts.2s These 
were part of the Indian order made up and packed at 
Apothecaries Hall for shipment to Bengal, Bombay, 
Madras, Fort Marlborough, Prince of Wales Island 
and St Helena. Details of the consignment are given 
in Table 3. 
Table 3: Consignment of medicines to India 1821 
Medicinal substance Quantity 
Glauber 's Salts 10,000 pounds 
Epsom Salts 28 ,OOO pounds 
Citric acid large quantities 
Terebinth large quantities 
Arsenic large quantities 
Ointments Many casks 
As trade expanded, further trading stations were 
established around the Indian coastline, and an 
additional need arose to supply these with medicines. 
But the British presence was concentrated in the main 
cities, which in the early nineteenth century were 
Calcutta , Bombay and Madras . In due course British 
pharmacists began to set up businesses across India, 
and substantial quantities of medicines were 
imported to meet local demand.26 These imports 
arrived in the Company 's ships. Eventually however, 
pharmaceutical manufacturing was established in 
India itself, and the need to import vast quantities of 
medicines diminished rapidly.27 
5. Supplying the drugs and medicines 
needed by the Company 
Growing demand for medicines from both the Navy 
and the East India Company created increasing 
challenges for supply to the Society of Apothecaries in 
the early years . Initially, the Society acted only as a 
retailer, buying its medicines from other local 
suppliers. As the trade grew it first set up its own 
laboratory to manufacture what it could on a much 
larger scale. As time went by it recognised the need to 
grow its own herbs and medicinal plants , setting up the 
Chelsea Physick Garden. It even acquired its own mill 
to powder its dried medicinal plants. 
The Society had established a laboratory for the 
compounding of vegetable medicines as early as 1623 , 
but this was only for the instruction of apprentices. The 
College of Physicians had previously set up a 
manufacturing facility, but this was destroyed in the 
great fire of London in 1666.28 Following the fire , in 
26 
1672 seventy apothecaries subscribed a total of £1,205 
to set up a company, then known as a ' stock', to 
establish their own manufacturing facility. This 
became known as the 'Laboratory Stock' . This 
allowed the Society to manufacture a range of 
medicines on a large scale , with the benefits of reduced 
costs resulting from mass production . It also gave it 
the capacity to guarantee the purity of commercially 
produced drugs for the first time. 
When the contract was granted to supply the Navy 
with medicines in 1702 an additional joint stock 
company, the 'Navy Stock' , was established. This 
supplied medicine chests to the Navy, but these were 
actually prepared in the laboratory. By the early 
nineteenth century the laboratory was supplying not 
only the East India Company but also the army, the 
prison service, the crown agents , convict ships to 
Australia, chemists, druggists and infirmaries. The two 
stocks were merged in 1822, forming the 'United 
Stock,' and manufacturing continued on the premises 
of the Society until 1921.29 
In due course the Society found it necessary to 
develop the capacity to grow it owns herbs and plant 
medicines . With this in mind it set up the Chelsea 
Physick Garden shortly after the establishment of its 
laboratory, in 1673 .30 The Society rented four acres on 
the Chelsea riverside from Lord Cheyne. Three years 
later a wall was built around it. The garden 's original 
purpose was to grow plants that were no longer easily 
found in fields and woods, along with the exotic plants 
being imported from the East in ever greater 
numbers.31 It also had an important educational 
function, but increasingly it became a source of raw 
materials needed by the laboratories. 
As trade increased still further the volume of plant 
material that needed to be transpmted by horse and 
cart across London from Chelsea to the laboratory in 
Blackfriars was substantial. Late in the eighteenth 
century the Society acquired an old ' horse-mill ', 
across the river from the gardens in Battersea.32 The 
mill had previously been used by John Field , who was 
Master of the Society between 1785 and 1786, and his 
son Henry, who was Apothecary to Christ's Hospital 
and was Treasurer to the United Stock. Here the drugs 
were ground before being sent to the Hall for final 
preparation.33 
It appears that the windmill in Battersea was only 
used for a relatively short time. Plant material and 
other crude drugs also arrived at the docks in London 
from India and elsewhere, and there was a need to 
process drugs nearer the laboratory site. The 
proportion of raw material provided by the Physick 
Garden became ever smaller. An opportunity to extend 
the trade premises at the Blackfriars site came in 1801, 
with the purchase of land to the north of the laboratory. 
This was used to erect a Mill House and a separate 
engine house to drive the mill.34 The new Mill House 
accommodated three pony-powered stone mills , and 
was only demolished in 1915.35 
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6. The Company's commitment to quality 
One of the main reasons why the Society was able to 
retain its contract with both the Navy and the East 
India Company over such an extended period was that 
it placed great emphasis on the quality of its products. 
Clear arrangements were in place to ensure that this 
happened , with regular monitoring of production 
processes and final products. Its operations were 
headed by a Court of Proprietors, with a committee of 
managers , a purchasing committee, an inspection 
committee and another to regulate prices . These 
measures enhanced the Apothecaries ' reputation for 
good quality medicines and drugs , but made them 
expensive. 
The quality of the Apothecaries Hall medicines and 
drugs was widely recognised at a time when the 
quality of what was offered by many suppliers was 
highly questionable. For example, the apothecary John 
Quincy noted approvingly ' the care of the 
Apothecaries Company, who with a joint stock have 
these medicines made at their Hall under such careful 
management and inspection as cannot give any 
possible opportunities for impositions .'36 
Like its contract with the Company, the contract that 
the Society had with the Navy was not without its 
detractors. The naval surgeons resented the high prices 
charged for medicines and drugs , which they were 
obliged to obtain from Apothecaries Hall , as a result of 
the Order signed by Queen Anne in 1702. It could cost 
between £80 and £90 to fit out one chest. There were 
also complaints about ' the system of certificates, 
delays, burnt hartshorn [ ammonium bicarbonate], and 
insufficient supplies' .37 
Despite the initial difficulties and complaints from 
the Navy, in the early eighteenth century the focus on 
the quality of its medicines by the Society and its 
resulting reputation resulted in the approach from the 
Company to supply the medicine chests for the 
surgeons on its ships. The Company put quality before 
price when it came to medicines . Representatives from 
the Company fust inspected the surgeons' chests at 
Apothecaries Hall in 1706, and it seems likely that a 
contract to supply them over the following years 
resulted from that visit, although evidence of a formal 
contract is lacking.38 
As a further safeguard against the quality of the 
medicines supplied by the Society, the East India 
Company employed its own Inspector of Medicines, 
indicating the scale of its purchase of these items . The 
inspector, along with the officers of the Royal College 
of Physicians , the Physician to Greenwich Hospital 
and the First Commissioner for the Sick and Wounded, 
were given places of honour at the Apothecaries dining 
table , held in the Great Hall, for what has been 
described as 'the eighteenth century equivalent of 
corporate hospitality' .39 Thus was the relationship 
between the Company and the Society sealed. 
If there was trust between the Society and the 
Company the same could not be said of the different 
groups of the Society's stockholders. The award of the 
new East India Company contract in December 1766 
necessitated the est;iblishment by the Society of new 
Articles of Agreement, allowing for an increase in the 
capital of the Navy Stock to £12,000. As on previous 
occasions there were serious disputes amongst the 
members of the Society about who should benefit. 
There were two main classes of membership of the 
Society; the Liverymen and the Yeomanry. Only 
Liverymen who were Proprietors (or stockholders) of 
the so-called 'Laboratory Stock' were permitted to 
take up the new shares in the Navy Stock, a condition 
that elicited an angry response from the disgruntled 
Yeomanry. 'The great increase and extension of the 
trade' continued during the Napoleonic wars, 
extending from the end cif the eighteenth century up to 
1815. This was to be of greatest benefit to the 
Liverymen, the sole Proprietors of the Navy Stock. 
The anger of the Yeomanry appears to have been 
more than justified. In the 1730s profits from the Navy 
Stock were modest, estimated at around £175 per year. 
The year 1739 to 1740 was exceptional, with profits 
surging to £843. It was followed by an increase in the 
capital of the Company the next year. As a result of the 
East India Company's new contract profits reached 
£1 ,677 for the year 1766-67, and shareholders 
received good dividends.40 But only the Liverymen 
benefited. 
7. The Relationship between the Company 
and the Society 
The Society and the Company maintained a close 
relationship for over one hundred and fifty years. 
There were many alternative sources of supply 
available to the Company. But the significance of the 
medicine business was rather different for the Society 
than it was for the Company. Despite the sums 
involved the trade in medicines was always only a 
small part of the business of the Company, which was 
vast. By the 1720s the paid-up share capital of the 
Company was almost £3 .2 million, with an annual 
turnover of many hundreds of thousands of pounds.41 
But for the Society the trade with the Company and the 
Navy represented the core of its business for many 
years. 
The two institutions had much else in common. The 
Worshipful Society of Apothecaries was founded in 
1617, just 17 years after the founding of the East India 
Company. The headquarters of these two great 
institutions were located about a mile from each other 
in the city of London; the Society was located in 
Blackfriars Lane, close to the River Thames , where it 
is still located. The headquarters of the East India 
Company were in the City of London, initially at 
Cosby Hall, and then in Lime Street, before moving 
the short distance to Leadenhall Street in 1817 .42 This 
building was eventually demolished in 1929. Thus 
throughout their history the headquarters of the two 
institutions were no more than a short distance from 
each other. 
We can only speculate about some of the other links 
between the two institutions. At least some of the 
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East India Company Headquarters, Leadenhall Street, 
London, 1820 
investors in the Society were likely also to have been 
investors in the Company. During its lifetime many 
thousands of well-to-do individuals chose to invest in 
Company stocks and bonds.43 Some of these could 
well have been apothecaries. It seems probable that 
at least some of the Liverymen who held shares in 
either the Laboratory or Navy Stocks also held shares 
in the East India Company. Both institutions, but 
particularly the East India Company, were significant 
employers in the area. It also seems quite possible 
that there was at least some movement of staff 
between the two institutions. 
8. Epilogue 
The period covered in this paper was one during which 
the British Navy was busy fighting wars around the 
world. The East India Company itself was actively 
involved in wars over an extended period, and was in 
fact directly involved in controlling large areas of 
India through its army. For the Society of Apothecaries 
war was good for business, but for the East India 
Company war was to be its downfall. 
For the East India Company the beginning of the 
end came in the form of the Charter Act of 1833. 
Through this the British government divested the 
Company of its commercial functions, but renewed its 
political and administrative authority for another 
twenty years. The end of the Company came as a result 
of the Indian Mutiny in 1857, although in truth it 
slowly faded away rather than suffering a sudden 
death. It was formally dissolved in 1858, although core 
staff continued to be employed for a number of years 
afterwards. Its headquarters at India House were 
demolished in 1862, after which staff moved to a 
succession of rented addresses. The Company was 
finally wound up in 1873, but even then a number of 
transactions were still being followed up, and the last 
cheque was finally honoured by the Bank of England 
only in 1884.44 · 
The nineteenth century treated the Society of 
Apothecaries more kindly. It continued to receive 
substantial orders from the Navy even after the ending 
of its monopoly position in 1805. Indeed, between 
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1806 and 1811 the cost of drugs, medicines, pill tiles, 
bottles, corks, galley pots, mortars and pestles , 
needles, funnels, sponges, and many others, supplied 
to the Navy by the Society averaged £24,917 per 
year.45 This was in fact the Society's largest account, 
being even bigger than that of the East India Company. 
During the same five year period the average annual 
bill for drugs and medicines supplied to the Company 
was £21,582, some £3 ,OOO less than that for the Navy. 
The Indian Mutiny of 1857 also produced a very 
different outcome for the Society of Apothecaries. The 
Council of India, which effectively replaced the East 
India Company as the governing authority in India, 
renewed the contract for drugs and medicines the 
Society had had with the Company, providing the 
United Stock with a regular income, until the final 
payment of just £19 in 1881 concluded the business. 
In that year the United Stock was dissolved, and 
thereafter the Society's trade relied on contracts with 
the Crown Agents, the Army Medical and Veterinary 
Departments, merchants, hospitals and retail 
customers, until it, too, ended in 1921.46 
For the Society of Apothecaries the emergence of 
the British Raj provided additional opportunities for 
trade, with the growth of business within India itself. 
Although the medicines originally supplied were for 
the use of the Navy and the Company's staff, 
increasingly they were traded on. The history of the 
development of western pharmacy in India starts with 
a young Scot by the name of Bathgate.47 He came to 
India as an employee of the East India Company, and 
opened his first chemist's shop in Calcutta in 1811. At 
that time Bathgate's shop was the most familiar centre 
for the supply of medicines for the citizen's of the 
town. The firm that he founded eventually took up 
drug manufacturing for the Indian market, especially 
of tinctures and spirits, in 1910 _4s 
For India, the end of the East India Company and its 
ships made little difference to its export trade in -raw 
drugs to Great Britain. There were many private 
shippers and merchants only too eager to take its place. 
Four key products came to dominate the market; 
opium, cinchona, nux vomica and senna.49 In 1863 
British India exported opium to the value of £12.5 
million; by 1872 it had increased to £13.4 million. In 
1875 India exported 72,452 pounds of cinchona to 
Britain, mainly from Madras; seven years later, in 
1882, this had shot up to 641,608 pounds. 
European drugs continued to be imported into India, 
but the quantities were small in comparison with the 
volume of raw drugs exported to Great Britain. The 
very first edition of the Indian Medical Gazette in 
1866 noted that '£20,000 are annually expended in the 
importation of European drugs to India' .50 It was 
hoped that many of these could be replaced by 
indigenous drugs. Both imports and exports were 
transported by ship, andthis paper has shown that the 
activities of the East India Company prepared the 
way for the extensive trade in drugs and medicines 
between the two countries that followed its demise. 
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Note: An earlier version of this paper was presented at the 
38th Congress of the International Society for the History 
of Pharmacy in Seville , Spain in September 2007. 
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A Beginner's Brief Encounter with 
Early 19th Century Pharmacology 
Trevor E Whaley MRPharmS, MCPP(Emeritus) 
Doncaster 
Why would a beginner choose a subject that deserves 
dedicated research, informed argument and learned 
opinion? It all started when I became interested in a 
small hospital, called St James's, and its founder, Dr 
George Dunn. Local Mid-19th Century and, since 
neither had been specifically studied before, a perfect 
opportunity for a beginner.' 
From Roman times, when the military station there 
was called Danum, Doncaster has had the 
geographical good fortune to be situated on the direct 
route to the North from London, resulting in it being, 
by the middle of the 19th Century, an important 
staging post for coaches on the main London to 
Edinburgh highway. At the peak of the coaching era, 
with its links particularly to Leeds, the West, the East, 
and providing services to its own surrounding area, 70 
to 80 coaches a day would probably pass through the 
town, requiring hostelries for travellers and the 
maintenance of well in excess of 1,000 horses .2 
Then came the railways.3 The first passenger link, 
corning from the West, was made in time for the St. 
Leger horse race of 1848 (racing being one of our 
other claims to fame) . Then came the important link 
with London and the South, just in time for the 1849 
St. Leger. At this time Doncaster already had a railway 
repair works , and it also had a totally justified 
expectancy of more to come, since in 1853 the Great 
Northern Railway moved · its Locomotive Head-
quarters from Boston to Doncaster, which meant that 
locomotives and carriages would then be built in the 
town. The resulting influx of mechanics, their families 
and supporting traders resulted in an increase of 2,500 
in the one year on a population which was stated, in the 
1851 Census, as just over 12,000. 
But how did Doncaster compare to known dates in 
medical history? The Dispensary Movement started in 
London around 17 69. Considering that Doncaster was 
apparently, at that time, a very attractive little country 
town, it is not too surprising that its Dispensary did not 
open until 1792, when the population was still only 
around 5 ,600 .4 
The idea was that a patient (or 'proper object' as they 
would be known) who could not afford medical 
treatment could seek a letter of recommendation from a 
governor of the Dispensary to receive free advice and 
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medicine, which could include a home v1s1t if 
necessary. The governor in tum could have one patient 
on the books at any one time for the payment of one 
guinea annually. The more he paid, the more patients 
he could recommend. 
An important rule was that there would be 'a general 
inoculation in the town as often as was thought 
necessary'. As we know, it was Lady Mary Wortley 
Montagu who brought this procedure back from the 
Middle East around 1720. The fluid from the blister of 
a mild case of smallpox being injected into the arm of 
a hyalthy individual to produce a mild attack, and 
confer future immunity. Fortunately, the situation was 
greatly improved when Dr Edward Jenner introduced 
vaccination using cowpox material in 1796, publishing 
details of his work in 1798. The Royal Jennerian 
Society came into being, and in a Dispensary minute 
in 1803 it was agreed that the Apothecary at the 
Dispensary might accept the office of Secretary to the 
Doncaster Jennerian Society for promoting the 
'vaccine inoculation' .5 The only further reference I 
could find to this was a mention in the minutes of Oct 
1807 which read 'Any person wishing to have their 
children inoculated may apply at the Dispensary every 
Tuesday morning at Nine o'clock' . 
Throughout most of its existence the Dispensary 
seems to have had the facility to provide overnight 
accommodation, if required, for one patient and a 
nurse. But, although an attempt had been made in 1845 
to open one, we still did not have a hospital. 
So, back to Dr Dunn, who in April 1852 wrote a 
circular letter to the wealthy residents of the area 
stating that he had purchased a small plot of land on 
which he intended to build a small hospital and asked 
them if they would care to become subscribers.6 The 
local newspapers took this up about three weeks later 
with an article headed 'Is an Hospital Wanted in 
Doncaster?' .7 From these two sources a clear picture 
emerged of how a serious accident would be dealt 
with . The surgeon would be called, but could be on his 
rounds which would cause delay. He would examine 
the patient and direct him to be taken home, or, if a 
stranger, to the nearest inn. The surgeon would 
probably have to return home to collect any necessary 
instruments . Meanwhile, the patient who might , for 
example, be a railw.ay worker could be taken back to 
already overcrowded and totally unsuitable lodgings, 
where his room-mates could be asked to move out, or 
it might not even be possible to continue to 
accommodate him in the new circumstances. 
Assuming that was sorted out, the surgeon returns to 
treat his patient, but, as the article points out, although 
clean linen would probably be available for immediate 
and subsequent care, such things as poultices , baths, 
regulated temperature and the services of a trained 
nurse might not be so readily available. 
So, opinion seemed to be on the side of a hospital. 
However, reading the ne~spaper coverage of meetings 
of the Dispensary Governors it appeared that the 
Medical Officers wanted a hospital of their own, and 
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the lay-governors were looking for a way to 
amalgamate with Dr Dunn. The next meeting, which 
had to be adjourned because of its length, showed a 
definite animosity within the medical camp, with the 
majority of it being directed at Dr Dunn. Finally, all 
became clear at the resumed meeting when Dr 
Schofield, the Senior Dispensary Physician, called Dr 
Dunn a 'medical heretic ', suggesting he 'followed a 
system which sprang from the disordered brain of a 
monomaniac' . Yes, Dr Dunn was a homoeopathic 
practitioner and his hospital would follow those 
principles. 
Needless to say, no amalgamation was possible, the 
Dispensary did not get their hospital at that particular 
time, and Dr Dunn went ahead with his. I cannot leave 
Dr Dunn without mentioning his involvement in 
obtaining a clean water supply for the town, his election, 
by the workmen themselves as Surgeon to the 
Locomotive Sick Fund, and his later service as Mayor, 
Alderman and Justice of the Peace. One final point, on 
the morning of the inauguration of his hospital in 
January 1853 he had his son christened at the local 
Parish Church Walter Hahnemann Dunn. 
Homoeopathy 
But how could either side justify its position based on 
the pharmacology of the day? Although having had no 
interest in homoeopathy in my own career, I had no 
intention of 'taking sides ' . I simply wanted to take the 
place of a mid-19th Century observer looking at 
available information. 
It would have been so convenient if the newspaper 
reports had given details of the medical arguments at 
the meetings mentioned. They were obviously lengthy. 
Towards the end of the three hours of the second half 
of the adjourned meeting one lay-member suggested 
that the medical men had had all of the discussion to 
themselves so far, and that it might be a good idea to 
put them out of the room so that they could get on with 
the business. A second made the point that he didn't 
know who Hahnemann was on the one hand or Galen 
and Aesculapius on the other - he simply wanted a 
hospital. Interesting that after over 1600 years of 
possible medical advancement , practitioners were still 
making reference to Galen and the Roman god of 
medicine. The only specific reference to any medical 
practice was in Dr Dunn 's denunciation of ' bleeding 
and blistering '. 
So, where else could I look? Fortunately, Dr Jonathan 
Pereira, later of Pharmaceutical Society fame, had 
published the two parts of his Elements of Materia 
Medica in 1839 and 1840, a mere blink of an eye, at 12 
to 13 years previous, when compared to Galen.8 The 
first problem came on only the second page of the 
preface, where he stated that although he was well 
aware of the vast superiority of a physiological or 
therapeutical arrangement of medicines as a form of 
classification, he was of the opllllon that 
pharmacologists were too imperfectly acquainted with 
the operation of therapeutical agents to make this a 
success, and that any such classifications were in reality 
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based on prevailing medical doctrines of the day, or on 
the peculiar notions of the writer. 
In defining pharmacology he divided it into three parts: 
Pharmacognosy; Pharmacy (collection, preserving and 
preparation); and Pharmaco-dynamics (today 's 
pharmacology), and -it did not take long to realise why all 
of the problems arose in this third sub-division. In 
discussing the 'mode of action of medicines' , Pereira 
again divided them into three parts: Mechanical; 
Chemical; and Dynamical. Since the majority of items in 
the Materia Medica could not be placed solely in 
Mechanical or Chemical a third division Dynamical had 
to be admitted. Similarly, in discussing the nature of 
actions induced by medicines, we again find three 
classes: Stimulants; Contra-stimulants or sedatives; and 
Alteratives. This last group was neither stimulant nor 
contra-stimulant and again included 'nearly the whole of 
the articles comprising the Materia Medica'. Pharmaco-
dynamics appears to have been a subject of theories and 
ideas , effectively a series of arguments within itself. 
It was interesting that Pereira actually quoted 
Hahnemann's Organon in support of his own opinion 
that the pure effect of a medicine could only be 
ascertained on the healthy human body, because 
symptoms of disease mingling with the effect of the drug 
would make it much more difficult to ascertain the pure 
effect of the drug alone. Only with an understanding of 
the pure effect of the drug could come an understanding 
of how the drug's action was modified by the disease . 
Fortunately Pereira devoted a complete section to his 
interpretation of homoeopathy. In it he separated the use 
of medicines into the homoeopaths' three divisions of 
Antipathic, Homoeopathic and Allopathic, and covered 
almost six pages with his observations. Under Antipathic 
(use of medicines that produce an effect opposite to that 
of the disease), the important point appears to be the 
differentiation between primary and secondary effects . 
For example the use of a purgative to produce an 
evacuation (primary effect) is followed by a period of 
constipation (secondary effect) . Since the secondary 
effects, according to Hahnemann, were always injurious 
one should use no larger dose than was absolutely 
necessary. Thus, part of the explanation for very small 
doses in his section on homoeopathy ( effect of medicine 
being similar to the disease). His section on Allopathy 
(effect of medicine being neither opposite nor similar to 
the disease) centres around cure by 'counter irritation' 
and provides no conclusive argument. 
However, in the homoeopathy section he does 
attempt to provide some detail in summarising his own 
opposition to it. In the first of four paragraphs he quotes 
specific drugs with known, repeatable effects. He cites 
sulphur, a treatment for scabies, as being incapable of 
producing scabies, although Hahnemann asserts that it 
is capable of producing an eruption analogous to it. He 
quotes the researcher who took the ' requisite quantity' 
(presumably the standard dose) of quinia without 
acquiring intermittent fever (i.e. the drug did not 
produce an effect similar to that to be cured) and 
stressed the benefits of the drug in cases of the ague. 
Hahnemann apparently asked 'are the patients really 
cured in these cases?' , but Pereira gives no explanation 
of the question, simply countering with the fact that the 
patient surely knows if he is well or not. Finally, in this 
paragraph, is a simple fact: 'Acids and vegetable diet 
cure scurvy, but I never heard of these means causing 
a disease analogous to it'. 
Let's for the moment be a little nai:ve: pre-1754 
scurvy was the $COurge of the navy, merchant shipping 
and even armed forces in foreign fields; in 1754 James 
Lind showed that lemon juice cured scurvy; post-1754 
- no scurvy. Maybe unrealistic, but the point is that he 
was quoting a known, repeatable effect and no one 
could say that one's regular ' five a day' would produce 
or simulate scurvy. The problem is what did 'Acids 
and vegetable diet' mean? Fortunately, in Vol. II the 
section on Lemon Juice has under 'uses ' the heading 
' as an Antiscorbutic ': 'Lemon Juice has long been 
regarded as an invaluable antiscorbutic; but on account 
of the difficulty of preserviRg it, crystallized citric acid 
is usually substituted'. Another 92 years would elapse 
before the isolation of ascorbic acid , but if we could 
persuade him to drop any reference to acids we might 
be able to allow the point. 
Pereira's opinion in the second paragraph was that in 
many instances homoeopathic remedies (like added to 
like) could only increase the original condition, 
apparently forgetting his own conviction that the doses 
were too small to have any effect whatsoever. His third 
paragraph is again purely personal opinion, in which 
he was totally dismissive of minute doses or of any 
power being transferred by rubbing or shaking during 
preparation of homoeopathic medicines. He 
attempted, finally, to give examples of experimental 
evidence, but only in so far as quoting examples of 
tests using homoeopathic medicines, all of which he 
quotes as failing . He gave no indication of the 
effectiveness of traditional medicine in similar cases, 
nor was there any counter-evidence from the 
homoeopaths . 
Back to the original question, re-worded with 
hindsight. Could either party justify its position based 
on pharmaco-dynarnics? I think that even Dr Pereira 
would say 'Not a chance' . It would appear that 
arguments could only be based on observable facts and 
outcomes , but the real argument would come in the 
interpretation of those facts against the background of 
very strongly held opinions. 
This was my very brief encounter with early 19th C 
pharmacology, probably with questionable concl-
usions , but an extremely enjoyable exercise. 
This paper was presented at the BSHP Annual Spring 
Conference, 5th April 2008 . 
Author's address: TandCWhaley@trol4.fsnet.co.uk 
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Book review: Nature's Alchemist 
herbal. Far greater in scope and accuracy than his fellow 
apothecary Thomas Johnson's update of Gerard's 
Herbal (1633), Parkinson eventually published his 
monumental study, Theatrum Botanicum. The Theater 
of Plantes, in 1640 at the incredible age of 73 . Its 
appearance led directly to King Charles conferring on 
him the title of Botanicus Regius, or Royal Herbalist, 'in 
recognition of his significant contribution to the welfare 
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of the people'. A human variant of alchemical 
ennoblement, it was the accolade Parkinson had coveted 
for a quarter of a century; moreover, this weighty tome 
was to prove essential reading for doctors and 
apothecaries for more than a hundred years. 
However, when John Parkinson died in 1650 his life 
was in ruins, destroyed by the Civil War. He had lost 
everything: 'his home, his garden, his family, his king 
and his country.' He bequeathed nothing to posterity 
except his two books and a small bundle of personal 
papers which is in a collection left to Magdalen College, 
Oxford, by John Goodyer, one of Parkinson's earliest 
and closest friends. Intrigued, and appalled by the speed 
with which he had sunk into obscurity,Anna Parkinson 
embarked on a personal quest to find out about this man 
to whom, family myth maintained, she was distantly 
related. Meticulously researched, her very readable and 
evocative biography succeeds in re-creating, if 
somewhat fancifully in parts, the life and times of this 
very English apothecary who achieved so much but 
about whom so little is known. 
An unusually well-educated Lancashire lad from a 
humble farming background, John Parkinson travelled 
to London to find fame and fortune and never ventured 
beyond its boundaries. On completing his appr -
enticeship to apothecary Francis Slater in 1592 he 
became a freeman of the Grocers' Company; he married 
a widow (going on to have a family of his own), took on 
an apprentice in 1594 and opened a shop the same year 
on the south side of Ludgate Hill, just outside the city 
gate. Parkinson then quickly established what became 
an internationally-renowned garden and plant research 
centre within easy walking distance of his business 
premises. He was later to experience the major trauma 
of defecting from his mother company to become a 
founding member of the Society of Apothecaries in 
1617 and its Renter Warden in 1620/1. Parkinson's 
ever-increasing knowledge and expertise enabled him 
to move in very elevated medical , botanical and Court 
circles and facilitated the networking opportunities he 
valued so highly with both English and continental 
apothecaries, botanists , physicians and merchants . And 
like many others (including his contemporary, the poet 
John Donne) , he suffered great personal, professional, 
family and economic disappointments and hardship 
during the long and turbulent decades of anti-Catholic 
fervour, and the consequent social and political 
upheavals, of this period in England's history. 
Anna Parkinson, a journalist and former BBC 
producer, has written an attractively illustrated, sensitive 
and sympathetic biography of her ancestor which both 
glows with obvious pride in his accomplishments and 
achievements as well as demonstrating her strong sense 
of affinity with him and his life 's work. 
Dee Cook,Archivist, Society of Apothecaries 
1. Gareth Roberts . The Languages of Alchemy . The Centre 
for the Book Fellowship Lectures: The British Library Cen-
tre for the Book, 1997. 
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The Extra Pharmacopoeia 
Martindale and Westcott 
FIRST EDITION REPRODUCTION 
The year 2008 marks the 125th anniversary of the publication of the first edition of the book 
that was to become the present day, world-renowned, Martindale: The Complete Drug 
Reference. In celebration, Pharmaceutical Press has produced a reproduction of The Extra 
Pharmacopoeia by William Martindale and Wynn Westcott. Available in hardback, maintain-
ing the original content and text design, it provides insight into the latest developments in 
therapeutics in the late 19th century and will delight fans of the modern day Martindale: The 
Complete Drug Reference. 
Pharmaceutical Historian Back Issues 
ISBN: 978 0 85369 826 5 • May 2008 • Hardback 
144 X 82mm O 328 pp O £19 .95 
Available from Pharmaceutical Press, c/o Turpin 
Distribution, Stratton Business Park, Pegasus 
Drive , Biggleswade,Bedfordshire SG18 8TQ, UK 
or Pharmaceutical Press, 1573 St Paul Avenue, 
Gurnee, Illinois, 60031 USA. 
Historical note 
The idea for the Extra Pharmacopoeia came from 
William Martindale 's work answering scientific and 
dispensing questions for the Pharmaceutical Journal. 
He had a flourishing business in the West End of 
London . On publication in 1883 the 'EP' was rapidly 
successful and by 1885 four editions had been 
published. At first it included drugs and medicines that 
were extra or outside the current British 
Pharmacopoeia . 
Dr Wynn Westcott collaborated with Martindale 
from the start and continued until his death in 1925. 
William Martindale died in 1902 and the book passed 
to his son , Dr William Harrison Martindale, who 
continued publishing until 1933. On his death the 
copyright was bought by the Pharmaceutical Society 
of Great Britain . To cover the vast increase in 
pharmaceutical knowledge the book is now published 
in two volumes as Martindale : The Complete Drug 
Reference, 35th Edn , 2007 and in electronic form . 
Complete volumes of four issues: Volume 35 (2005); Volume 36 (2006); Volume 37 (2007) . Each volume 
available for £8 UK or £10 Overseas (including post and packing) 
The Indexes for 1967 to 1995, 1996 to 2000 and 2001 to 2005 can now be viewed free of charge on the 
website: www.bshp.org under Publications . 
Orders to: Peter Homan, 3 The Ridings, Epsom, Surrey, KT18 5JQ Tel: ( +44) (0)1372-723001 
Email: peter.homan@lineone.net Cheques , Banker's Orders, etc. to be made payable to the British Society 
for the History of Pharmacy. Payment can.only be accepted in Pounds Sterling. 
ISSN: 0079-1393 Indexed in Medline as Pharm. Hist. (Lond.) 
© British Society for the History of Pharmacy 2008 
Typeset and Produced by Ralph Allen Press Ltd , Bath BAI 3EN 
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Wednesday 24 September 2008 
'The History of Aspirin' by Mr Diarmuid Jeffreys. 
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Wednesday 19 November 2008 
'Thomas Mott Caton: the life and times of an early 19th 
century local London apothecary' by Dr G Clein. Lambeth 
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History' by Dr John Crellin. Lambeth 6.30 p.m. 
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Wednesday 4 November. 
BSHP Conference, 27-291h March 2009, Bassenthwaite, 
Cumbria 
Call for contributions from members. 
As this area of the Lake District is famous for its literary 
connections I thought it would be a good idea to make 
the main theme for the conference 'pharmacists or 
pharmacy in literature, ancient or modem'. If you would 
like to give a short presentation (15 minutes plus 
questions) on this or on a pharmacy or pharmacist from 
the locality please let me know. 
Papers are also welcome on any pharmacist, or pharmacy, 
whose contribution to the profession in the past you think 
members should know about. If you would like to 
contribute a paper at the conference please contact 
Shirley Ellis at l Willow Way, Bottisham, Cambridge 
CB25 9BS or by e-mail to ellisbottisham@ 
compuserve.com giving your details and a title for 
your contribution. Closing date 30 November 2008. 
Shirley Ellis has also been considering alternatives to 
the quiz for Saturday evenings and wondered 
whether a poetry reading by a professional would be 
of interest. Please let her know and if your answer is 
in the affirmative perhaps you could identify a poem, 
or poems, you would like to see included. Also would 
you prefer members to read the poems rather than an 
actor? 
RPSGB Museum Takes the Public Behind the Scenes 
The Museum of the Royal Pharmaceutical Society of 
Great Britain (RPSGB) is inviting people to get a dose 
of history with its new 'Behind the Scenes' initiative. 
These brand new sessions have been designed to 
encourage people from the local community to get up 
close to the Museum's collection. Ten sessions will be 
hosted from August through to December, with the 
Museum exploring a new theme each month. The 
following sessions will take place: 
Lambeth s Links with Pharmacy, 6 August, 2-3pm 
& 21 August, 6-7pm 
Making Medicines, 3 September, 2-3pm & 18 
September, 6-7pm 
Medicine Chest, l October, 2-3pm & 16 October, 
6-7pm 
Old Photographs, 5 November, 2-3pm & 20 
November, 6-7pm 
Christmas Cold Cures, 3 December, 2-3pm & 18 
December, 6-7pm 
The initiative forms part of an 18-month Audience 
Development Programme, funded by the Heritage 
Lottery Fund. The project targets three key audiences: 
pharmacy students and lecturers; primary and 
secondary school students, and London-based 
adults.To find out more about the Behind the Scenes 
sessions, or to book your place, please contact the 
RPSGB's Museum on 0207 572 2210 or email 
museum@rpsgb.org 
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'Traditional Use' Claims for Herbs: 
The Need for Competent Historical 
Research 
Dr John K Crellin 
Newfoundland, Canada 
The intention of this article is: (i) to make clear that 
'traditional use' claims for herbal medicines, sanctioned 
today by various regulatory bodies, demand critical 
appraisal; (ii) to emphasise that historians of pharmacy, 
with a special interest in drugs, have an important role 
in such appraisals, and (iii) to outline key considerations 
for evaluating claims. 
Traditional use claims are often made for herbs in 
authoritative monographs and texts without adequate 
documentation. 1 Ready appraisal of such claims - which 
can be based on usage varying from 'three generations' 
(interpreted as 75-100 years) to 'thirty years ' - can be 
problematic even to deciding whether any hidden health 
issues are involved.2 Such matters are spotlighted in 
recent Natural Health Product (NHP) monographs 
published, with documentation, by the Natural Health 
Products Directorate (NHPD) of Health Canada.3 I use 
questionable quarrying of'traditional' herbal information 
in monographs to promote discussion on the general 
quality of traditional use claims in all jurisdictions where 
the evidence is not transparent. 
The Canadian monographs, arising from Natural 
Health Product Regulations that came into effect on 1 
January 2004, are designed to improve the quality and 
efficacy of marketed natural health products (herbal 
~emedies, homeopathic medicines, vitamins, minerals, 
traditional medicines, probiotics, amino acids and 
essential fatty acids).4 A manufacturing company that 
follows monograph specifications in its pre-marketing 
application for a mandatory natural health product 
number will have a speedier evaluation. However, in 
failing to provide adequate evidence to support the level 
of 'reasonable certainty' of evidence - often used to 
justify claims of traditional usage - the NHPD 
statement that the monographs 'serve as reliable 
[ emphasis added] sources of product information for 
consumers' can be challenged. 5 
Some may see questions about errors and debatable 
interpretations as nit-picking because the NHP 
regulations do provide a new level of quality control for 
self-care products considered inherently safer than 
pharmaceuticals. However, this not only sidesteps the 
potential to mislead public expectations and unresolved 
concerns over effectiveness and safety of herbs in 
everyday usage, but also lessens confidence that 
government authorities are providing the best possible 
information. 
Part 1: Illustrations of Problems and Issues 
This part, in documenting issues, examines: (i) a 
representative monograph, and (ii) the NHPD guidance 
document as it relates to traditional use claims. The data 
behind the summary statements plus other examples can 
be found in an Appendix (see note 1). 
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An overarching issue raised by the monographs is the 
inconsistent use of what historians call 'primary' 
references compared with recent 'secondary' sources. 
'Primary' covers printed books, journal articles or other 
material (published or in manuscript) written by 
knowledgeable authors who provide, at least in part, 
authoritative comment, originality (information not 
available elsewhere that may correct or add to work of 
others), first-hand witness of trends or events, or even a 
reflection of the history of the times. 'Secondary' sources, 
commonly recent compilations, are less useful for such 
features; certainly those generally used by NHPD and the 
herbal literature do not critically appraise historical 
resources in the way they often do with modem studies. 
Aside from a limited selection of primary references 
(none in some monographs) and inconsistent and 
questionable use of secondary sources, particularly 
troublesome are the erroneous citations and the partial 
or misleading quotes.6 One widespread issue is failure 
to check references (where provided) in secondary 
sources. For example, D. E. Moerman's Native 
American Ethnobotany (1988) is an invaluable 
compilation from innumerable publications.7 However, 
citing the work for specific usage needs a critical 
approach to the references used by Moerman, which are 
variable in authority and quality, and thus raise 
questions of interpretation over, for example, correct 
plant identification. 
A need also exists to appreciate that secondary source 
misinterpretations of primary sources can extend to 
temptations (i) to dismiss information in primary 
sources that does not ' fit' current herbal interests or (ii) 
to 'read into' older texts support for current views. 
Black cohosh is noted below as an example where 
NHPD finds questionable traditional support for the 
current interest in using the herb for menopausal and 
premenstrual symptoms. 
A NHP monograph: Black Cohosh8 
Excerpts from monograph ( quotes from ·the 
monograph are boxed; the bold numbers correspond 
to those used in the comments.) 
Comments 
NHP traditional claims 
[1) 'Traditionally used (in Western herbalism) to help 
relieve menopausal symptoms (Ellingwood 1983 [reprint 
of 1919); BPC [British Pharmaceutical Codex] 1934; 
Lloyd 1921).' 
[2) 'Traditionally used (in Western herbalism) to help 
relieve premenstrual symptoms (Ellingwood 1983 
[1919); Felter and Lloyd 1983 [1898); Lloyd 1921). ' 
[3) ' Traditionally used (in Western herbalism) to relax 
skeletal muscle and ease nervous tension (Ellingwood 
1983; Felter and Lloyd 1983; Lloyd 1921).' 
'Traditional uses: 
Dose(s) [Traditional] 
[4) 300-3000 mg dried root or rhizome per day 
(Williamson et al. 1988; Ellingwood 1983; BPC 
1934) ' 
rF or references see note9 l 
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Erroneous citations 
[1] Lloyd makes no specific mention of menopause. He 
notes use for 'diseases of women,' but as did other 
authoritative writers, he probably referred to ameno-
rrhoea and dysmenorrhoea. 
[2] Lloyd provides ao specific reference to premenstrual 
symptoms. 
Partial or misleading quote 
[4] The dosage is not supported directly by the citations. 
The monograph weaves together information and adds 
'per day'. In fact, Ellingwood gives no dosage for dried 
root, noting only extracts, tincture and a specific 
Eclectic remedy (Macrotys), while recommending 
different preparations for different conditions. 
Particularly problematic is the high dose of3000 mg 
(not supported by references) when read in the context 
of (i) the non-traditional dose given in the monograph 
of 40-200 mg and (ii) such properties noted in the 
nineteenth-century literature as slowing pulse rate, and, 
as one author wrote in 1884, that it was employed 'in 
cardiac disease, where it acts like, but less efficiently 
than, digitalis'_ to 
Debatable interpretations 
[l] Ellingwood refers to ' hysterical conditions of the 
menstrual epoch in hypochondriasis or melancholia at 
these times, with congestive dysmenorrhoea'. This quote 
is excerpted from a wide range of recommendations -
from the premonitory stage of acute fevers, to chorea, to 
acute rheumatism and rheumatic fevers. It is unclear 
whether Ellingwood's 'epoch' refers to menopause. 
Elsewhere in his book, the tenn more clearly refers to 
menstrual cycles, whereas in places he specifically notes 
'menopause', e.g. , for valerian: 'nervous disturbances 
incident to the menopause'. 
[1] The BPC (British Pharmaceutical Codex) refers to 
'supposed action in various uterine disorders' ( emphasis 
added) with no specific indication for menopause. In 
fact, the reference to 'supposed action' suggests 
scepticism or declining interest even for the more 
widely accepted recommendations for 'amenorrhoea 
and dysmenorrhoea, and neuralgic pain of the uterus 
and ovaries', conditions specified in the BPC 1923 but 
omitted from the 1934 edition. 
[2] Although some historians might interpret 
Ellingwood's 'hysterical conditions of the menstrual 
epoch' (see [l] above) as premenstrual symptoms, that 
interpretation is unclear in many other contemporary 
accounts of black cohosh. Felter and Lloyd note 'painful 
conditions' incident to imperfect menstruation, i.e., 
' restoration of suppressed menses ' (amenorrhoea), 
rather than premenstrual symptoms. 
In reading modem terminology into the older texts, it 
has to be appreciated that current concepts of 
premenstrual tension only emerged in the 1930s (in part 
due to new knowledge of hormones), while the sense of 
it being a medical/social problem became even more 
firmly established with (a) the later terms of premen-
strual syndrome ('PMS') and 'late luteal dysphoric 
mood disorder' , and (b) its use as a criminal defence 
(including for murder) in the early 1980s. As a medical 
problem PMS attrac;ted new treatments, including herbs 
with no clear traditional evidence of effectiveness. 11 It is 
relevant to note that, despite monograph claims, 
efficacy remains debatable.12 
[3] While Ellingwood's reference to 'muscular aching' 
can be read in the context of a concept he proclaimed -
'an efficient nerve sedative, although its most pro-
nounced action is on the unstriped muscles' - this is a 
conceptual rationalisation. The plant's reputation on 
rheumatism was accounted for in a number of ways that 
do not support the comment on muscle relaxant activity, 
nor does the citation to Felter and Lloyd who note use for 
'muscular pain ofa rheumatoid character'. Lloyd (1921) 
does refer to a report of a sedative action, though this is in 
the context of lessening the 'frequency and force of the 
pulse', and for soothing pain and allaying irritability. 13 
Another author around the same time (1884) also 
indicates sedative action, but in 'very large doses . . . 
causing vertigo, dilatation ·of pupil, and a tendency to 
somnolence' .14 Without clear reference to preparation 
and dosage, the monograph recommendation is 
problematic. 
Summary comments. Besides the issue of heavy reliance 
on the Eclectic medical textbooks (see comments below 
on primary sources) and the possibility of the current 
promotion of black cohosh biasing interpretation, a 
further feature of the monograph is that it allows both 
traditional and non-traditional claims that black cohosh 
relieves premenstrual and menopausal symptoms. The 
resulting uncertainty is surely signalled by the different 
non-traditional and traditional dosages for the same 
conditions. 
The NHP guidance document15 
Intent of document 
Given the issues just outlined, the published guidelines 
that presumably shape the monographs are of general 
interest if only because they lead to the question: Can 
regulatory authorities serve two constituencies, the 
public and industry? The guidelines state: 16 
The intent of this document is to ensure that the 
[monograph] requirements . are rigorous enough to 
protect public health and increase consumer confidence, 
yet flexible enough for industry to develop useful NHPs 
while accommodating changing scientific developments. 
What level of information, then, is considered 
appropriate for the public: minimal, overly simplified, 
or comprehensive with public education in mind? 
Moreover what definitions of traditional medicine are 
followed? NHPD follows the lead of the World Health 
Organization Traditional Medicine Program: 
the sum total of knowledge, skills and practices based on the 
theories, beliefs and experiences indigenous to different 
cultures, used in the maintenance of health, as well as in the 
prevention, diagnosis, improvement or treatment of 
physical and mental illness. 
However, NHPD sets limits on the 'sum total of 
knowledge' through effectively circumscribing the 
meaning of ' traditionally used ' by accepting a short 
history of 'at least 50 consecutive years of traditional 
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use' (albeit longer than EU regulations). Perhaps 
NHPD, like other authorities, feels some latitude in 
interpretation is justified, since the term ' traditional' 
often tends to be used loosely. Sometimes, it is 
synonymous with folklore: the beliefs, legends, and 
myths associated with the ' common people' . On the 
other hand, while the transmission of beliefs through 
time is a recognised feature of folklore, continuity is 
more commonly viewed as a key part of being 
'traditional', that is knowledge built up, handed down, 
and 'evaluated' through generations of experience. 
Scientists study traditional medicine nowadays for new 
drugs on the assumption that empirical knowledge of 
usages survives from one generation to the next, such 
that a reasonably good chance of effectiveness exists. 
NHPD's rationalisation for a history of 'at least 50 
consecutive years' within 'a cultural belief system or 
healing paradigm' is that two generations allow 'possible 
reproductive side effects to be identified'. Yet the ability 
to recognise ' reproductive side-effects' - or for that 
matter other adverse reactions - is related to the type and 
dosages of a preparation employed. Important, too, is an 
extended period of time, since, when herbs had their 
widest usage within Western health care, side-reactions 
( apart from known toxicities) were not systematically 
recorded as distinct from general effects; indeed, a 
general consciousness over unanticipated adverse effects 
did not emerge into general use until the close of the 
nineteenth century. 
Sources of information 
Another issue with the Guidance Document is the 
limited sources of information that NHPD accepts in an 
application for a product licence. This may only be a 
single supporting reference if it demonstrates 
'pharmacopoeia! evidence for traditional use claims' . 
Although pharmacopoeias generally include products in 
current usage (albeit not always widespread), they are 
not therapeutic texts with clinical detail; they are more 
compendia of drug standards that have national or 
official legal authority, though that is not the case with 
the British Herbal Pharmacopoeia (1983). 
If pharmacopoeia! requirements are not met, NHPD 
stipulates that 'at least two independent references ' are 
to be used, 'i.e. references that do not cite the same 
source, or each other, as the main source of information 
regarding the traditional use '. Despite various criticisms 
(predating the new natural product regulations) over 
allowing only two references, Health Canada has 
persisted with this guideline despite its violation of 
minimal standards of historical scholarship. 
NHPD also limits, at least indirectly, sources of 
traditional medicine information likely to be used 
through its list of 'authoritative' and ' reputable' sources 
for manufacturers to consult. However, apart from two, 
they are all from the 1990s and 2000s. 17 Most are 
valuable compilations, but they are not primary sources 
as defined earlier, nor do any systematically use or 
document primary sources for historical information. 
They generally take traditional uses from writings peer 
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reviewed for scientific, not historical, content. The 
guidance document, by allowing questionable assump-
tions, also makes it easy for manufacturers to sidestep 
its own stipulation of fifty years to uncover adverse 
reproductive effects. For instance, 'traditional use' is 
accepted if a reference describes (i) usage in the context 
of a particular 'cultural belief system or healing 
paradigm' that has been in existence for at least 50 
years, or (ii) includes 'statements that imply a traditional 
use' (e.g., 'In folklore used as .. .'). 18 A flavour of the 
issues comes from an example provided by NHPD of a 
herb 'used in the time of King Edward II to alleviate 
coughs ' . Even though, NHPD continues, 'neither a 
concrete date nor time frame is given (e.g. 1284-1330 
AD), if the time being referred to is more than 50 years 
ago, the NHPD will assume that the reference supports 
a traditional use claim and that the ingredient has been 
used for at least 50 years ' . 
This example, with all its assumptions, suggests that, 
in accepting information from any secondary reference 
in good standing that cites (maybe from another 
secondary source) a medieval manuscript, many issues 
will be overlooked. For instance, difficulties in 
botanical identification, that the original reputation of a 
herb or preparation was supported by magico-religious 
beliefs, by the enthusiasm of one or a few practitioners 
(including the original author who may have been a lay 
person with limited medical experience), or by concepts 
that faded so that the herb had little use even if 
remembered by herbal writers. 19 
The Guidance Document also prompts questions 
about NHPD's recommended dosages considered in the 
appendix (see note 1). 
Part 2. Methodology for Uncovering Reliable 
Information 
Criticism of traditional use claims must be constructive 
so this part offers considerations for those interested in 
researching the validity of traditional claims. 
What exactly is meant by 'traditionally used' 
in herbal medicine? 
Any methodology must be underpinned by a clear sense 
of what it is trying to accomplish; indeed this is 
generally necessary before deciding on and examining 
appropriate literature and other sources of information. 
A consensus is needed on the meaning of 'traditional 
herbal knowledge' and on what can be said to have been 
'used for centuries'. Although, as said, empirical 
knowledge is generally understood as being built up and 
evaluated as it is handed down through generations, it 
must be appreciated that herbalism in the past was 
diverse and complex (as nowadays). Despite a 
definition of traditional medicine as the 'sum total of 
knowledge skills and practices' , regulatory bodies like 
NHPD do not make it clear that the use of herbs has 
accumulated over time by drawing on anecdote, magic, 
myth, religious teachings, symbolism, 'factual' or 
empirical observations, and scientific evidence. The 
selection of information has always varied depending 
on the practitioner (from 'wise women' and sectarian 
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botanic practitioners to licensed physicians), the 
theories of the time, and patients who selectively choose 
ideas and practices according to their own concepts of 
health and disease and their personal situations, and 
experience. 
The reason for noting here the complexity of Western 
herbalism is to emphasise that it does not mean the 
absence of overlapping practices among the different 
schools of thought. Indeed, the same information from 
different arenas may point to relatively robust evidence 
of mainstream usage that may well be indicative of 
being therapeutically useful for many patients. The 
challenge is to uncover this from separate accounts of 
that can include idiosyncratic suggestions, and the 
promotion of quacks who offered a cure for every ill, 
from cancers to strokes. Relevant considerations are 
given in the next section. 
Critical appraisal of primary sources 
Any historical investigation needs to evaluate a range of 
primary sources, the strengths of information in each 
and pitfalls due to biases etc. To focus, I chose NHPD's 
heal-all monograph because of its five primary 
references.20 (For details on heal-all, see Appendix, note 
1 ). Since space only allows detailed illustrative 
comments on one of the primary references, my 
summary includes brief notes on the other four (by 
Culpeper, Meyrick, Wren and Grieve). 
l. Harvey Wickes Felter and John Uri Lloyd: King's 
Dispensatory (1898) 
This primary reference is singled out for detailed 
comment, since it also raises questions about a heavy 
reliance on a particular school of thought (sometimes 
called sectarian) botanical medicine, namely the 
Eclectics. The two authors in their revision of King's 
Dispensatory apparently did not value heal-all 
highly, for the comment 'once used' is found not in a 
specific entry on the herb, but as a brief note in an 
extensive account of Scutellaria.2 1 This is especially 
noteworthy as the Dispensatory was a principal text 
for the sectarian medical practice of Eclecticism that 
had become noticeable in the United States by the 
1850s. It was one of various attempts to reform 
medicine through employing treatments less 
vigorous than extensive blood-letting and strong 
doses of purgatives and emetics that had become 
associated with conventional medicine. Eclectic 
medicine, with its own medical schools, remained a 
factor in the U.S. medical scene until its declining 
years of the 1920s and '30s.22 An appreciation of its 
characteristics is important for evaluating the validity 
of information in the texts. 
In its heyday, Eclectic medical practice was 
characterised by, for instance: 
(i) The use of botanical, especially native North 
American, remedies (with much faith in empirical 
'practice', sometimes taken from other schools of 
medical practice). 
(ii) Concepts that included specific Eclectic medical 
preparations. For instance, (a) 'concentrated' remedies 
e.g. , resins, resinoids, oleoresins, until these were 
generally replaced by (b) single herb .medicines 
marketed under the doctrine of 'specific medications'. 
The latter were based on a concept that certain well-
defined symptoms would be corrected by a particular 
medication. Such preparations, specially manufactured 
for Eclectic practitioners, were intended to contain the 
active principles minus inert constituents. Unfortu-
nately, the formulae and method of preparation were not 
made public. 
(iii) A large body of literature on materia medica. Much 
of this has recently become prominent again (as printed 
and digitised reprints) and selectively drawn on as part 
of current herbalism, which some see as neo-
Eclecticism. 
No one will deny that quality empirical evidence 
exists in the Eclectic materia medica/therapeutic 
literature. However, careful interpretation of therapeutic 
recommendations is needed because of (i) possible 
biases inherent in the Eclectic reform ideology and its 
evangelical promotion of botanicals as alternative 
practice, (ii) some clinical experiences related to the use 
of the specific Eclectic remedies of unknown 
composition, and (iii) lists of uses that went far beyond 
those found in other arenas of herbal medicine. Since 
NHPD does not justify its selection of usages from the 
cumbersome therapeutic lists in Felter and Lloyd (or in 
two other books, one by a further well-known Eclectic 
writer, Finley Ellingwood, and another by Lloyd), it is 
questionable whether these, representative of only one 
thread of herbalism, should be relied on so heavily. 
(Eclectic citations are also heavily used in the black 
cohosh monograph already considered.) 
2. Other primary references 
The dates (1652, 1789, 1898, 1907, and 1932) of the 
five primary sources used in the heal-all monograph 
might suggest evidence of consistent usage over time. 
However, a close examination indicates that, as in other 
monographs, historical sources are unsystematically 
cherry-picked. Why, for example, is Felter and Lloyd 
used to document certain uses and not others on which 
they also comment? In the heal-all monograph, despite 
references to more than two primary sources (NHPD's 
minimum) for at least one claim, no attempt is made to 
ensure a judicious selection of sources or to avoid taking 
information out of context. For instance, although 
Nicholas Culpeper's The English Physitian is probably 
the best known 'herbal' of all time, care is needed in 
evaluating its information for self-care today. NHPD 
ignores, for example, Culpeper's statement that heal-all 
is under the influence of Venus; although this omission 
may be justified, differing opinions over interpreting 
Culpeper have to be evaluated, as should other concepts 
of his time, e.g., the need to ensure a correct balance of 
humors - that can justify usage based on theoretical 
grounds alone. 23 
Maud Grieve's A Modern Herbal (1931) is another 
popular herbal. As an edited compilation of Grieve's 
writings by Hilda Leyel, who also added many entries, 
it contains much general information, sometimes on 
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cultivation details - a reflection of Grieve's promotion 
of herbs as part of the 1914-18 war effort. Although the 
Herbal contains valuable first-hand observations on 
then current usage, especially of herbs grown in 
England, this does not apply to all entries, and 
therapeutics is not the strongest part. Thus careful 
interpretation is needed when evaluating (i) whether 
theoretical considerations such as the doctrine of 
signatures (which Leyel did not reject) underpinned 
some suggested reputations, or at least sustained 
theoretical interest in little-used herbs, and (ii) whether 
historical quotes - ostensibly included for general inter-
est as 'former' usage - are sometimes read uncritically 
into a current recommendation, as when Grieve quotes 
Culpeper on heal-all. 
It is especially difficult to understand why citations to 
William Meyrick's Herbal of 1789 are parachuted into 
the monograph, even though it is a useful volume for the 
historian. It was written for 'families', as were many 
writings on domestic medicine of the same vintage of 
far greater authority and influence than Meyrick's, for 
instance William Buchan's Domestic Medicine and 
Samuel 'Tissot's Advice to People in General, with 
Respect to their Health. Meyrick, a surgeon, claims 
'unquestionable authority, or confirmed by actual 
experiments' for his therapeutic claims, but critical 
interpretation of his remarks does need to consider 
whether concepts such as astrology might be at play.24 
Moreover, while incorporating the works of others, he 
omitted some eighteenth-century writers on materia 
medica, representative of conventional practice, such as 
William Cullen, who must be considered a more critical 
authority of the time. 
IfNHPD's choice of the first edition ofR.C. Wren's 
Potters Cyclopaedia of Botanical Drugs and 
Preparations (published by Potter & Clarke, wholesale 
botanic druggists and manufacturing chemists) is 
intended to capture a non-Eclectic medical tradition 
then it is a surprising choice. Although it was written for 
those engaged in 'medical and pharmaceutical pursuits 
who are so often called upon the give particulars 
regarding the use and employments of Herbs, Roots, 
Barks &c., it had the character of an aide memoire. 
Appearing at the time when many 'pocket-size' texts for 
the medical and pharmaceutical profession were being 
published, readers were expected to have some 
knowledge of herbs in order to interpret the synoptic 
information, perhaps a reason for NHPD's misquotes.25 
While a useful resource for the historian, the work is far 
removed from the detailed and therapeutically useful 
mainstream materia medica/therapeutic texts published 
at the time. 
In bringing together all the information on heal-all, 
leaving aside Culpeper's comment on the influence of 
Venus on the plant, it seems its reputation rested mostly 
on its astringent properties. The latter was linked to the 
strength of the preparation, and a reference by 
Meyrick to the use of juice is noteworthy, albeit 
omitted by NHPD; at the same time he hinted that 
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interest in heal-all had faded since wound herbs were no 
h . C I , . 26 longer held in esteem, as t ey were m u peper s time. 
Undoubtedly, evaluating the strength or weakness of 
the traditional reputation must consider whether, like 
many herbs, uses were postulated from the level of · 
astringency (including styptic action) of tannin 
constituents, and on a lingering coat-tail effect of the 
once general interest in astringent herbs to treat woun~s. 
Certainly the lack of enthusiasm by Felter and Lloyd 1s, 
as noted, telling - all the more so as other writers also 
reflect a weak tradition. As in many cases of traditional 
use claims, this illustrates the type of assessment 
generally omitted in secondary sources and useful for 
public information. 
Summary of methodology 
A key component of an appropriate methodology, as 
already noted, is the need for a consensus on what is 
to be accomplished to meet the definition of the 'sum 
total of knowledge skills and practices based on the 
theories, beliefs and experiences indigenous to 
different cultures'. In approaching this I have 
indicated the importance of careful evaluation of 
primary sources. To this I add other comments. 
To reach a level of 'reasonable certainty' about the 
effectiveness of a herb or herbal product for a significant 
proportion of the population, documentation needs to 
show evidence of positive experiences beyond lone case 
histories, which may rest on idiosyncratic observations 
( often linked to a theory that postulated a particular 
usage, on placebo responses and/or post hoe ergo 
propter hoe arguments). One way of looking at this is 
making clear that it is more than a series of anecdotes by 
reaching a level of what can be called anecdotal 
knowledge; this can be defined as a pattern of 
observations that, by being drawn from different 
practices and schools of thought and evaluated over 
time, minimise biases. 
Finding patterns of information 
In developing an adequate range of sources for 
uncovering patterns, many accounts, like the NHP 
monographs, fail to use adequately the largest body 
of literature on herbs (much appearing under the 
heading 'materia medica') published by conven-
tionally trained medical and surgical practitioners. 
Granted much diversity existed among 
'conventional' practitioners (many incorporated 
homeopathy and Eclectic medicine), but, within the 
medical literature, a history of careful efforts exists to 
evaluate the effectiveness of herbs . Some of this, 
certainly in the seventeenth century, was driven by 
the well-known conflicts between supporters of new 
chemical medicines and those who favoured older 
knowledge of plant remedies/regimens. Biases, 
therefore, from special interests have to be looked 
for, though it is wrong to assume that this particular 
issue continued to influence all physicians in the 
nineteenth century. 
It is too simple, as is so often done, to chastise 
conventional nineteenth-century treatment as being 
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solely heroic blood letting, purging and vomiting. Much 
more critical approaches, including limited clinical 
trials and experimental studies, are clear from numerous 
textbooks from the eighteenth century onward that are 
not slavishly copied from one to the other. While 
empirical evidence was respected, its quality was 
constantly evaluated. Authors writing in English who, 
to a greater or lesser extent, fulfil this over a long period 
of time include William Cullen, William Woodville, 
Robley Dunglison, Jonathan Pereira, George B. Wood, 
Roberts Bartholow, George Butler and many others, 
none mentioned by NHPD. 
Ideally, the search for traditional knowledge should 
also evaluate relevant manuscript sources (e.g., 
physician case books) and sources for documenting the 
oral tradition. Textbook teaching is not necessarily 
reflected in everyday practice. Differences can be found 
in how a herb is used (e.g., powder, infusion (cold or 
warm), decoction, etc.) and whether used singly, or, as 
more generally the case, in multiple ingredient 
prescriptions with other constituents intended to 
enhance activity (e.g., honey for sore throats). 
Sometimes manuscripts illuminate the evaluation of 
empirical knowledge more than published herbals that 
are consciously underpinned by concepts current at the 
time. 
Conclusions 
The evidence I have outlined, and many more 
examples could be given, prompts questions whether 
most current traditional use claims are a guide to high 
probabilities of relieving symptoms and hence 
justifying a patient's time and costs. There is an 
absence of transparent scholarship behind claims. 
Undoubtedly regulatory bodies are under various 
influences and pressures. For example, apart from 
being bounded by existing government regulations, 
difficulties exist in providing accurate and succinct 
labels. Nevertheless that does not absolve any 
authority, when sanctioning traditional uses for self 
care today, from demonstrating sound scholarship. 
Historians of pharmacy are in a good position to be 
watchdogs. 
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Endnotes and References 
I. Still widely referred to are the unreferenced German 
Commission E monographs (an English translation is avail-
able), while most herbal reference books cite secondary sourc-
es for traditional claims. For full details on this see an 
Appendix to this article available from the author 
GcreUin@mun.ca), which tabulates data in the monographs 
noted below (plus additional examples) with direct quotes 
from the cited authorities. It is appropriate to add that the 
frequency of monograph revisions can be confusing for man-
ufacturers. 
2. For use over ' three generations': Australian Regulatory 
Guidelines for Complementary Medicines, Part IV, section 3 
<http://www.tga.gov.au/docs/htrnl/argcm.htrn> accessed 
April 2008; for 30 years. U.K.: Statutory Instrument 2005 
No. 2750, The Medicines (Traditional Herbal Medicinal 
Products for Human Use) Regulations 2005. 
<http://www.opsi.gov.uk/SVsi2005/20052750.htrn> ac-
cessed April 2008 (see also key requirements for registration 
<http://www.mhra.gov. uk/home/idcplg?IdcService=SS _ GE 
T_PAGE&nodeld=595 >. The U.K. registration is based on 
European Directive 2004/24/EC of the European Parliament 
and of the Council of 31 March 2004 amending, as regards 
traditional herbal medicinal products, Directive 2001/83/EC 
on the Community code relating to medicinal products for 
human use. 
3. All monographs can be found through Health Canada. 
Single Ingredient Monographs (introductory remarks). <http:// 
www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/ 
monograph/mono_ list_ e.html::O: accessed April· 2008. 
4 . Relevant information: Health Canada. At a Glance: A 
Regulatory Framework for Natural Health Products .< http:// 
www.hc-sc.gc.ca/dhp-mps/prodnatur/about-apropos/glance-
apercu _ e.html> accessed April 2008. 
5. The term 'reasonable certainty' is often found in the 
literature (sometimes as a 'doctrine') to describe evidence 
from the historical record in lieu of clinical trial data. I 
suggest this can only be justified if appropriate methodology 
is followed. For quote on reliability, see Health Canada. 
Single Ingredient Monographs introductory remarks (note 3). 
6. Representative examples appear in Appendix (see note!). 
7. Portland: Timber Press; available and updated on the 
Internet: <http://herb.umd.umich.edu/ > accessed April 2008. 
8. <http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/ 
licen-prod/monograph/mono _ cohosh-grappes _ e.html> dated 
28 March 2007, accessed April 2008. 
9. For citations: Ellingwood F. New American Materia 
Medica, Therapeutics and Pharmacognosy. Evanston, 1919 
reprint 1983), also available: < http://www. henriettesherbal. 
corn/eclectic/ellingwood > accessed April 2008. Felter HW 
and Lloyd JU. King's American Dispensatory. Cincinnati, 
1898 reprint 1983), also available: <http://www. 
henriettesherbal.corn/eclectic/kings/cnicus.htrnl> accessed 
April 2008 ; Lloyd JU. Origin and History of all the Pharma-
copeial Drugs, Chemicals and Preparations with Bibliogra-
phy. Volume I. Vegetable Drugs. Cincinnati, 1921. This is a 
poor choice of reference given that, as hinted in the title, it is 
not intended as a work on therapeutics. 
10. Johnson L. Manual of Medical Botany of North America. 
New York: Wood, 1884, p. 69. Granted it is unclear whether 
NHPD would accept 3000 mg as a single rather than divided 
dose (see Appendix, note 1). 
11. For some discussion, Rittenhouse CA. The Emergence of 
Premenstrual Syndrome: The Social History of a Women's 
Health Problem. PhD University of California, San Francisco, 
1989; Rodin M. The Social Construction of Premenstrual 
Syndrome. Social Science and Medicine 1992; 35: 49-56. 
12. For recent comment on this: Reed S, Newton M, LaCroix 
A. Vaginal, endometrial, and reproductive hormone findings: 
randomized, placebo-controlled trial of black cohosh, multi-
botanical herbs, and dietary soy for vasomotor symptoms: 
the Herbal Alternatives for Menopause (HALT) Study. 
Menopause 2008; 15: 51-58. 
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13. Lloyd (note 9), p . 62. 
14. Johnson (note 10), p. 69. 
15. Health Canada, Evidence for Safety and Efficacy of Fin-
ished Natural Health Products. Natural Health Products Di-
rectorate Guidance Document, dated December 2006, section 
1.2, <http://www.hc-sc.gc.ca/dhp-mps/prodnatur/legislation/ 
docs/efe-paie _ e.html> accessed April 2008. Henceforth quot-
ed as Guidance Document. Unless otherwise stated other ref-
erences to the document in this paper are to section 2.2.1, titled 
'Traditional Use Claims' . Omitted for comment here because 
of lack of space are points in the Guidance Document such as 
the role for expert opinion and of oral reports. 
16. Ibid. Introductory section. 
17. Ibid. Appendix on ' Examples ofUseful References. The 
following resources may be useful in the literature search for 
safety and efficacy evidence. 'References to Traditional Use.' 
18. This presumably justifies NHPD 's reliance on recent 
secondary sources that, for example, state, without documen-
tation: ' in folk medicine, the drug is used .. .' For example, 
such a phrase is used in Bisset and Wichtl. Herbal Drugs and 
Phy topharmaceuticals. Stuttgart: MedPharm, 1994, p. 284. 
19. For discussions on issues and aspects of methodology, 
see: Riddle JM. Research Procedures in Evaluating Medi-
eval Medicine. In Bowers B ( ed.) The Medieval Hospital and 
Medical Practice. Aldershot: Ashgate, 2007. In a private 
communication Riddle has pointed out that in King 
Edward ' s time sources were unlikely to have come from 'a 
medical writer or even one with medical knowledge'. 
20. The references are: Culpeper N. The English Physitian or 
Astrologo-Physical Discourse of the Vulgar Herbs of the Na-
tion. London, 1652; Meyrick W. The New Family Herbal; or 
Domestic Physician. Birmingham: Pearson and Rollason, 
1789. Albeit an interesting work that was 'intended for the 
common use of families of every description' ; perhaps 
NHPD's reason for using it is because of its ready availabil ity 
on the Internet; Felter and Lloyd (note 9); Wren RC. Potter 's 
Cyclopaedia of Botanical Drugs and Preparations. London: 
Potter & Clarke, 1932, p. 167. (Therapeutic information un-
changed from 1907 edition quoted used by NHPD ); Grieve M. 
A Modern Herbal (ed., Leyel CF). New York: Dover, 1971 
(facsimile reprint of 1931 ), 2 vols. 
21. Heal-all is listed as a 'related species '. 
22. For historical perspectives on the Eclectic medicine in 
the context of the nineteenth-century sectarian botanical 
movements, at least in America: Berman A and Flannery M. 
America 's Botanico-Medical Movements: Vax Populi. New 
York: Haworth Press, 2000, pp. 111-144. 
23. Differing opinions include whether astrology has a critical 
role in Culpeper's recommendations. For some sense of this: 
Woolley B. The Herbalist Nicholas Culpeper and the Fight for 
Medical Freedom. London: Harper Perennial, 2004, p. 175. 
24. Meyrick (note 23) preface, pp. vi-vii, hints at a possible 
interest in astrology. 
25. The point of ' reference books for those with knowledge ' 
is made in Buenz EJ, Schnepple DJ, Bauer BA, et al. Bio-
prospecting Historical Herbal Texts by Hunting for New 
Leads in Old Tomes. Trends Pharmacol Sci 2004; 25: 494-498. 
26. I might add that Meyrick did not mention it as treatment 
for wounds, while one dominant medical authority on mate-
ria medica at the time noted it was merely a 'weak astrin-
gent'. (Cullen W. Lectures on the Materia Medzca. Dublin: 
Whitestone, 1781 , p. 173.) 
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Christoph Glaser: 
A distinguished, controversial and 
mysterious Swiss Pharmacist in 
Paris under Louis XIV 
Patrizia Catellani and Renzo Console 
Introduction 
Christoph Glaser1 was one of the few distinguished 
pharmacists to make significant contribution to the 
development and teaching of chemistry in Europe in 
the 17th century. We are driven to write this article by 
the many inconsistent things that have been written 
about him, by the certainties claimed where 
uncertainty remains and by the intriguing, unsolved 
problem as to whether or not he conspired in murder. 
In particular we will suggest that there is credit given 
to Charas and Lemery that rightfully belongs to 
Glaser. We hope to provoke others to join us in the 
task of setting the record straight - or at least making 
clear what remains as uncertain. 
He made chemical theory appear accessible2 by 
avoiding all metaphysical considerations and 
explaining chemical operations in simple and 
understandable terms. He consolidated the 
systematic subdivision of such operations according 
to the nature of the substances involved, i.e. mineral , 
vegetable and animal. Later the more famous Nicolas 
Lemery was wrongly given credit for this. Glaser's 
contribution was overlooked for a long time and in 
some cases was misrepresented, as we are going to 
see later in this article. 
We are trying to help future research about him by 
mentioning sources, reorganising what has been 
written so far, highlighting doubts and exposing clear 
mistakes. Interested readers might be able to 
distinguish between so much hearsay and the little 
reality that has appeared so far about our Swiss 
pharmaceutical chemist. 3 
Information on his life, education, residence, 
family, religion, the dates of his birth and death, and 
also the place and causes of his death, are all 
contradictory, inaccurate or non-existent. Although 
he was a German-speaking Swiss coming from 
Basel, he pursued nearly all his career in France and 
published the early editions of his only book, the 
Traite de la Chymie, in French. Glaser was protected 
and favoured by high ranking individuals. However 
it has been written that he was reserved and 
unsociable. He is not known to have been a member 
of academies or other organisations. There are no 
known portraits showing him with certainty.4 
Glaser 's name appeared in connection with a 
famous and controversial scandal when the Marquise 
de Brinvilliers underwent a trial for murder (in 
absentia) and Glaser was suspected of having 
provided her with poisons. It was at this very time 
that his career ended as suddenly as it had begun, 
leaving behind a large number of unresolved 
https://doi.org/10.24355/dbbs.084-201803131618
questions . Glaser's relationships with his famous 
colleagues, Moyse Charas and Nicolas Lemery, are 
unclear, although we know that they worked with 
him at some stage. The impression is that they did not 
particularly like him and vice-versa. 
Like other researchers we still need to study the 
original sources in greater depth . Ideally we would 
like to find new documents in the hope of giving 
confident answers to the questions that are still open. 
For example, questions like these: When was 
Glaser born and what was his origin? How and where 
did he learn chemistry? Why and when did he move 
to Paris, and where was his phannacy located? Why 
was he favoured by the French royals and their 
entourage? Was Nicolas Lemery his apprentice for 
only a few months? What was Glaser's contribution 
to the development of chemistry? Was Moyse Charas 
right to claim the authorship of Glaser 's Traite? How 
bad was Glaser 's role in the de Brinvilliers poisons 
affair? Was he ever imprisoned, either briefly or for a 
long time? What is known about his wife (or wives)? 
Why did he vanish in 1672? Did he return to 
Switzerland to continue his work there? When and 
where did he really die? 
Glaser's Origin and Early Career 
One of the very few things that are sure about 
Glaser 's life is that be grew up, studied and started 
his profession in Basel (see Fig. 1). We also know 
from Glaser himself that he travelled to Slovenia 
looking for minerals before he moved to Paris. 
We do not know with certainty when Glaser was 
born. For many years since 1890 historians have 
followed a suggestion made by Henri Lagarde5 that 
Glaser was born in about 1615. We tend to agree with 
him. However the historian Paul Dorveaux, without 
mentioning the source of his information, wrote in 
1929 that Glaser had been born on 27th January 1628 
in Basel.6 Many historians have later accepted this 
date. · 
We know from editions of his only book that 
Glaser established and maintained his Parisian 
domicile and pharmacy in the Foubourg Saint-
Germain. However in his books we have seen two 
different names for the place where he actually lived 
and a third one in the archives of the Bastille. 
Possible places are: 
The petit marche, shown in the title-page of the 1663 
edition of Glaser's Traite de la Chymie. 
The rue Neufve des Fossez, in the title-page of the 1668 
edition of the same Traite. 
The rue du Petit-Lion, mentioned in a 1676 unofficial 
transcript of the Marquise de Brinvilliers's trial. 
This may mean that Glaser moved his practice at 
some point, or that some of the addresses were 
different ways of indicating the same place. Some 
authors have written that he moved once; others have 
simply chosen to mention one of the three addresses. 
We have seen a modern thesis on Glaser7 where the 
author has, in his view, been able to identify the 
present names of the streets and has concluded that 
Glaser only moved once, without leaving Saint-
Germain. 
Glaser 's first major appointment in Paris was as 
demonstrator of pharmaceutical chemistry at the 
Jardin des Plantes, also located in Saint-Germain and 
so he would not have had to travel too far to deliver 
his lessons. See Fig. 2. 
We can ask ourselves why Glaser decided to move 
to Paris. There is no easy answer to this question. It 
is possible that the King's physician Antoine Vallot 
had heard about Glaser's reputation and had called 
him to Paris. It has been suggested that the finance 
Figure 1. Map of Basel (1493), the town where Glaser grew up, studied and started his profession. 
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for themselves. Some elements of 
her book seem to indicate that she 
used Glaser's advice or used his 
Traite while compiling her book. 
Glaser's Skill in · 
Pharmaceutical Chemistry 
Glaser must have already been 
known as an accomplished 
pharmaceutical chemist when he 
arrived in Paris, because his 
prestigious appointment as 
demonstrator at the Jardin Royal 
took place in 1660, just three 
years after arriving in Paris. He 
replaced the well known Nicolas 
Lefevre, author of a Course de 
Chymie, who had decided to 
move to England. Glaser wrote 
his own Traite de la Chymie for 
the benefit of the students 
attending his courses at the Jardin 
Royal. Towards the end of the 
Figure 2. The Jardin des Plantes, Paris, where Glaser was demonstrator 19th century the French doctor 
of pharmaceutical chemistry. and historian Gabriel Legue, 
Wikimedia Commons, http://commons.wikimedia.org/. wanting to highlight Glaser's skills, 
included a speculative description of 
superintendent, Fouquet, might also have influenced how Glaser's pharmacy and laboratory might have 
Glaser 's decision. This is likely but cannot be proved. looked in his book Medecins et Empoisonneurs au 
The first documented work carried out by Glaser XVJJe Siecle.9 Unfortunately the title and the subject 
for the French was a series of trips to Florence in seem quite inappropriate; but Glaser is treated with 
about 1657 on behalf of Fouquet to look for respect and his skills are properly acknowledged and 
poisonous plants which were better known there than described. 
in France. This may have happened just before or Legue did not mention where he had found 
soon after his permanent move to Paris, and someone inspiration for his description of Glaser's pharmacy; 
has suggested that this was because Fouquet was but some decades earlier Paul-Antoine Cap had 
planning to poison someone important in Paris, described Charas's pharmacy in a very similar way, 
possibly cardinal Mazzarino. 8 referring to the works of Jean de Renou10 published 
For whatever reasons Glaser moved to Paris; as an in the early 17th century. Renou included an 
apothecary he almost immediately had some very illustration showing the front room of a pharmacy 
important customers, including King Louis XIV and where the best jars were on display and the 
his brother the Duke of Orleans. In fact, Glaser pharmacist was serving his customers. Probably both 
defined himself as Cap and Legue had this illustration in mind when 
'Apothiquaire ordinaire du Roy' in the title page of they were writing their descriptions. A small door at 
the first edition of his Traite de la Chymie (1663) and the back of the room concealed two furnaces and the 
as 'Apoticaire ordinaire du Roy & de Monseigneur le storeroom from the customers' view. 
Due d 'Orleans' in the second edition (1668) . Glaser did not hesitate to convey his inclination for 
It is disappointing that no genuine portrait of iatrochemistry, even using alchemical symbols and 
Glaser seems to exist, despite the fame he acquired in mottoes in the frontispiece of his book. He included 
Paris. There is one engraving taken from a painting a typical statement characteristic of iatrochemistry: 
that Franz van Mieris made for the Duke of Orleans what happens in nature also happens in the human 
when Glaser was the duke's apothecary. It has body. 11 By this he meant chemical reactions; and that 
beensuggested that the painter might have seen if they go wrong, they can be corrected with chemical 
Glaser at work and used the scene for his picture. But remedies. 
this chemist looks too old, considering that Glaser A second motto12 means that 'without fire we 
died at the age of 57 or even earlier. cannot accomplish anything' . This reminds us of the 
Another well known customer and supporter of importance that furnaces and the appropriate degree 
Glaser's was Madame Marie Fouquet, the of heat have in Glaser's book, as we are going to see 
superintendent's mother, who had an extraordinary later in this article. 
interest in pharmacy and wrote a 'charitable' book All of this appears to indicate that Glaser was a 
teaching the poor how to compose remedies cheaply willing disciple of Paracelsus, an interesting and 
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controversial figure of the 16th century. But despite 
his preference for this old author, Glaser is credited 
with the first precise description of the preparation of 
certain substances. The best known is sel polychreste, 
which means a salt that can be used for many 
therapeutic purposes. Glaser's salt is known today as 
potassium sulphate. 
Glaser's Traite de la Chymie 
Glaser's only book13 focuses more on chemical operations 
with minerals than with plants and animals. Organic 
chemistry had not been developed yet, and many operations 
(e.g. distillation) involving what today we call organic 
substances would now be classified as physical rather than 
chemical. See Fig. 3. 
At the beginning of the Traite Glaser explains the 
purpose of his book: first, to say only what he knows 
and to write only about what he has actually done; 
second, to provide a brief and easy method for 
accomplishing the most necessary chemical 
preparations. 14 The first part of the book contains a 
long list of all the known chemical procedures ( 42 of 
them) in alphabetical order. Their purpose was to 
separate and extract pure substances from natural 
compounds. Each operation is explained in detail 
Figure 3. Title-page of the first edition of Glaser's 
Traite de la Chymie. 
Universidad Complutense Madrid, http://www.ucm.es/BUCM/ 
and, according to Glaser, in terms comprehensible 
even for beginners. 
Glaser included two illustrations in the first edition 
of the Traite and added a third one later. The first 
table shows different kinds of apparatus for 
distillation; the second shows various tools and small 
furnaces ; the third shows large furnaces . As we have 
seen, fire and heat were very important to Glaser. 
Different Opi_nions about Glaser 
Over the centuries there have been many and diverse 
opinions expressed about Glaser. His colleague and 
successor15 Moyse Charas, who had benefited from 
Glaser's chemistry lessons, tried to obscure Glaser's 
importance by claiming to have been the real author 
of Glaser's Traite, but made his claim only after the 
end of Glaser 's career. We think Charas might have 
helped Glaser by taking notes during his lessons, but 
we do not believe Charas actually originated the 
concepts and techniques explained in Glaser's text. 
Also the famous Nicolas Lemery had been a pupil 
of Glaser's and accused him, through the 
academician Bernard de Fontenelle, of being obscure 
and unwilling to share his knowledge with others. 
But again in this case, too, it happened only after 
Glaser had disappeared. However the present authors 
are able to demonstrate, perhaps surprisingly, that 
Lemery's first and celebrated work, the Cours de 
Chymie, was almost entirely paraphrased from 
Glaser's Traite. 16 Lemery himself, in the preface of 
his Cours , conceded that many of his preparations 
had already been published (but he did not say by 
whom) and he did not think it was necessary to 
modify them because he saw nothing wrong with 
them.1 7 However it seems surprising that no 
historian, as far as we know, has remarked that 
almost everything had already been written by 
Glaser. The well known Fontenelle, who wrote 
Lemery's panegyric when the latter died,18 used the 
Figure 4. Hermann Conring in 1687 was the first 
author to publish biographical data about Glaser. 
Courtesy of the Smithsonian Institution Libraries, 
Washington, DC. 
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opportunity to cnt1c1se Glaser's alleged faults, 
clearly on the basis of what Lemery had told him. 
In the 19th century the distinguished scientist and 
professor of chemistry Jean-Baptiste Dumas 
ridiculed Glaser's supposed intricacy, comparing him 
unfavourably with his predecessor 19 Nicolas Lefevre 
and repeating Fontenelle's errors. 20 One might want 
to compare Glaser's exposition of chemical theory 
with the metaphysics of Lefevre,21 and judge 
independently which of the two is easier to 
understand. 22 
On the other hand Hermann Conring (Fig. 4) had 
published reliable information on Glaser as early as 
1687, praising his skills. In the following centuries 
some historians were influenced by Fontenelle and 
Dumas; but luckily other authors (mainly outside 
France) expressed more balanced views about 
Glaser 's value. 
The Case of the Marquise de Brinvilliers 
At this point we cannot fail to mention the events that 
coincided with Glaser's career's sudden end. In 1672 
a gentleman named Godin de Sainte-Croix died 
unexpectedly. The police found chemical substances 
and documents in his house, including some 
correspondence from his lover, the Marquise de 
Brinvilliers. In one letter there was a reference to 
poisons and to the so-called Glaser 's recipe. The 
Marquise's father and two brothers had all died 
recently and mysteriously within a short period of 
time. The Marquise immediately fled to Belgium and 
was convicted 'in absentia' for their murder. Glaser 
disappeared forever at aproximately the same time. 
The case produced much speculation that has 
continued for centuries. Fictional drawings were 
used to illustrate some of the many versions of the 
story. One of them shows Sainte-Croix (wearing a 
glass mask to protect himself against poisonous 
fumes) and Glaser preparing poisons together in 
Glaser 's workshop. 
In 1676 the French authorities managed to arrest 
the Marquise in Belgium and brought her back to 
Paris. She strenuously denied any involvement in the 
death of her relatives but eventually confessed. She 
exonerated Glaser but accused Fouquet as having 
attempted to poison cardinal Mazzarino. Semi-
fictional stories continued to be published about the 
case. One of the illustrations showed the distressed 
Marquise being comforted by her confessor Edme 
Pirot only a few hours before her execution. 
For more than three centuries, many well known 
people have been interested in the Brinvilliers affair. 
For example, Madame de Sevigne, best known for 
her correspondence with her daughter Comtesse de 
Grignan, immediately knew everything about the 
events of 1676 and wrote to her daughter that she 
believed in Glaser 's guilt and in Fouquet's 
innocence. She did not write why. It may sound odd 
that it was only selectively that she chose to believe 
in Brinvilliers's confession. 
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The famous writer and philosopher Voltaire was 
not very accurate in his research and thought wrongly 
that Glaser was German; but - unlike many other 
authors - rightly refrained from stating that Glaser 
had been personally involved in providing the 
poisons, or that he was imprisoned, because there 
was no certain evidence. 
In the 19th century the well known French novelist 
Alexandre Dumas included the case of the Marquise 
de Brinvilliers in his Crimes Celebres. He stated that 
Glaser had died earlier than Sainte-Croix while 
experimenting with poisons; but this cannot be found 
in any official document and looks very unlikely. 
For those who wish to investigate what has been 
written about Glaser, we can recommend the 
catalogue of James Young 's vast private library 
compiled by John Ferguson in Glasgow in 1906. It 
contains the complete details of some of the 18th 
century editions of Glaser 's Traite owned by Young 
and also a brief and generally correct Glaser 's 
biography ( on the basis of what was known about 
him at the beginning of the 20th century). In addition 
Ferguson has included a vast additional bibliography 
of books that refer to Glaser, which is the best sample 
available to present researchers.23 
Glaser's Disappearance 
The biggest mystery about Glaser must be what 
happened to him in 1672. Did he die suddenly, as his 
publisher wrote very clearly in the title page of a new 
edition of the Traite published that year? The King, 
his police, and even Madame de Brinvilliers believed 
so. But others have decided to ignore the publisher 
and the authorities, and have written that Glaser was 
arrested but soon released, or that he remained there 
for a long time, or even died at the Bastille. However 
there is no reliable record of any of these hypotheses. 
Or did Glaser return secretly to Basel, as stated by 
the local professor Hiifliger who did some further 
research there about 70 years ago? We suspect this 
was a case of mistaken identity. Glaser has always 
been a very common surname in Basel. 
We hope that more research on Glaser will be 
forthcoming. The best place to look for something 
new is still Basel, especially if Glaser really did 
return there in 1672, after vanishing from Paris. 
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Letter to Editor 
A Songze Jar 
During a recent trip to China I was reminded of the 
suggested ancestty of the classic concave-shaped 
albarello pharmacy jar. The sight of the casual use of 
simple sections of bamboo stem for containers 
verified their practicability and distinctive shape. 
However a subsequent visit to a remarkable museum 
excited my interest further. The Shanghai Museum 
contains a staggering collection of Chinese cultural 
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relics that emphasises the continuity of an ancient 
culture in bronze work, painting, calligraphy and 
ceramics. Among the artefacts was a familiar shaped 
jar, labelled as a 'Grey Pottery Bamboo-Shaped Vase; 
Songze Culture ' . 
The historic influence of the 'west' through the Silk 
Road is clear in China. This was most obvious during 
my visit to the city of Xi'an that was the ancient 
capital and eastern destination of the trade route. Not 
only was it the point of entry for Buddhist texts into 
the country but also for the pomegranate tree that was 
introduced from the Middle East and is a feature of 
the region. Along the long trade route from China, 
exports such as raw drugs arrived in Afghanistan, 
Persia and the rest of the Arab world stored in 
practical bamboo containers. It is not very likely that 
precious and fragile pottery containers, such as the 
Songze jar, would itself have been an item of 
transcontinental trade. However, its existence shows 
the step from 'plant technology ' to mimicking 
manmade artefact had already been taken in China. 
The same step is said to have occurred in the Arab 
world to create jars which were in tum to inspire the 
Italian pharmacy jars from the 16th century onwards, 
the most extravagant of which are the familiar 
majolica ware. In addition to supporting the theory of 
the bamboo origins of the albarello form, the Songze 
jar also prompts another theory, that the Silk Road 
might have carried the idea of making durable and 
desirable manmade copies in clay. But in what era 
of Chinese history was the finely-worked jar made? I 
recommend the Shanghai Museum if you wish to get 
some perspective of China's historical time scale: the 
exhibit's label explained that Songze culture 
flourished in the plains of the lower Yangtse river 
between 3800-3200 BC. 
Gareth Evans Member May 2008 
Review 
Chymists and Chymistry. Studies in the 
History of Alchemy and Early Modern 
Chemistry. 
Lawrence M. Principe ( ed.). Sagamore Beach, MA, 
USA: Watsons Publishing International, 2007 . 
Hardback, 274 pp. ISBN 978-088135-396-9. Price 
$45.00. 
So much has been published about alchemy and it is 
always important to distinguish which background 
motivated the authors to deal with this often 
misunderstood subject. In the case of the present 
volume, however, the reader can be convinced of the 
absolute expertise of editor and authors : they are 
among the most distinguished experts in the 
(English-speaking) world. The book summarised the 
results of an international conference held in 2006 at 
the Chemical Heritage Foundation in Philadelphia. In 
his introduction, the volume 's editor, Lawrence M. 
Principe, highlights the importance of alchemy 
research which has recently become a lively subject 
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in science. The 2006 conference with more than a 
hundred participants established a benchmark for 
state-of-the-art research. In total, 34 papers were 
presented there and 22 found their way into this 
remarkable volume. The chapters cover the time~ 
frame from early Paracelsism to the late eighteenth 
century and thus the period when alchemy and 
chemistry (or, as the title says, chymistry) were 
fighting each other strongly in theoretical and 
practical terms. Paracelsus himself, important 
successors or competitors and their works are 
stressed ·in several chapters . So information is given 
about Andreas Libavius (Bruce T. Moran), 
Paracelsism in France (Didier Kahn), Alexander von 
Suchten, Toxites, Adam von Bodenstein (Dane T. 
Daniel), Athanasius Kircher (Hiro Hirai), Giovanni 
da Correggio (Wouter J. Hanegraaf), Jean Perreal 
(Barbara Obrist), or Herman Boerhaave (John C. 
Powers) . Other chapters focus more on the 
competition of theories or exegetic problems of 
alchemical literature, i.e. the interpretation of the 
Emerald Tablet (Peter Forshaw) or the originally 
Arabic Liber de aluminibus et salibus (Gebriele 
Ferrario), the search for ' certainty' in chemical 
sciences (Stephan Clucas), the struggle with catholic 
objections against alchemy (Margaret D. Garber) or 
Newton 's theory of metallic generation (William R. 
Newman), ' gender malleability' and 'sexual fluidity ' 
(Allison B. Kavey), mechanism and alchemy 
(Bernard Joly), vitalism versus the materialistic 
world (Ku-Ming Chang), interpretation of Boyle by 
Samuel Cottereau Duclos (Victor D. Boantza), the 
relationship between Cartesians and chemistry (Luc 
Peterschmitt), occult tradition and enlightened 
science in Sweden (Hjalmar Fors) and Germany 
(Claus Priesner). It is correctly stated that ' the bulk 
of the history of alchemy and chemistry relies on 
treatises, correspondence and other writings [ . .. 
which may] have led to a bias towards theoretical 
speculations that tend to downplay the practical side 
of these disciplines ' (p. 149). Therefore, it is right 
that three chapters summarise recent results of 
archaeological findings giving insight into the 
practical side of alchemical procedures. Marcos 
Martinon-Torres and Werner R. Soukup discuss 
scientific information about early modem 
laboratories relying on excavations around the world, 
mainly Switzerland, Austria, France and Germany. 
That alchemical ' fraud might have some utility in 
practical, even entrepreneurial, terms ' is shown by 
Tara Nummedal. 
It is certainly a sign of outstanding expertise that 
the authors here, in contrast to many other English 
language publications, refer to foreign, mostly 
German language sources whenever appropriate. 
They are, throughout, quoted correctly, which is very 
unusual in English language literature. This 
demonstrates the care taken by authors and editors 
and suits well the high class content of every single 
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chapter. A comprehensive index and several well 
chosen illustrations complete the volume. 
This is undoubtedly: a ' must have ' for everybody 
seriously involved in alchemy research. 
Dr Axel Helmstaedter 
Review 
History of Pharmacy in India and Related 
Aspects. Volume 5: Builders and Awareness 
Creators of Modern Pharmacy 2 
Harkishan Singh. Delhi, India: Vallabh Prakashan, 
2008, pp.362 (hardback price £36.00). 
This is Harkishan Singh's fifth book in his series 
exploring the history of pharmacy in India. And there 
is still more to come; in his preface he tells us that 
'the work on more of the contributors to the 
organisation and development of pharmacy is in 
progress'. 
The book consists of a collection of twelve 
biographies, of varying lengths and presented 
alphabetically, together with a brief introduction. 
Pages 253 to 357 append the presidential addresses 
of seven of the subjects, and these provide a useful 
record of the progress made by pharmacy in India in 
the immediate post-independence period. 
It was in his fourth volume (since re-titled 
'Builders and Awareness Creators of Modem 
Pharmacy l '), which described the life and 
professional career of Mahadeva lal Schroff, that 
Singh quotes the New Zealand pharmacist Douglas 
Warr, who noted that 'while pharmacy has made few 
men great, a few great men have made pharmacy'. 
Warr was referring to individuals such as Jacob Bell 
and Daniel Hanbury, and Singh suggests that Schroff 
deserves a place alongside that group. However, in 
this book he is careful to avoid burdening his subjects 
with the mantle of greatness, suggesting only that 
they made valuable contributions. 
Singh demonstrates that, when the organisation of 
the pharmacy profession in India began in 1935, it 
was the department of pharmaceutics at the Banaras 
Hindu University, headed by Schroff, that emerged as 
'the citadel of pharmaceutical leadership'. Singh is 
himself a former professor of medicinal chemistry at 
that University. Four of Schroff's colleagues are 
profiled in the book: NK Basu, DN Majumdar, S 
Prasad and GP Srivastava. All the subjects were born 
between 1870 and 1916, and the focus is therefore on 
developments during the twentieth century, 
particularly the twenty years before and after 
independence in 1947. ; 
From 1941 onwards a group of pharmacists in 
Bombay (KC Chatterjee, ML Khorana, HR Nanji and 
BV Patel) also gained prominence, and RP Patel from 
Ahmedabad was closely associated with them; 
biographies of all five appear in the book. Finally the 
careers of three early pioneers, JC Ghosh, BN Vyas 
and SN Biswas, are also briefly described. 
The subjects of his profiles were pioneers in a 
number of different areas; for example, Singh credits 
JC Ghosh with being the instigator of the struggle for 
statutory control over drugs and pharmacy practice in 
India during the 1920s; GP Srivastava was the first to 
promote the idea of ethics in the practice of pharmacy 
in India; and BV Patel established the first new 
School of Pharmacy m India following 
independence. 
· As in previous volumes the emphasis is on 
description rather than reflection. Singh describes in 
detail the papers they wrote, the appointments they 
held and the committees they sat on. There are 
occasional glimpses of the personalities behind the 
achievements, but little to tell us what motivated 
them to do what they did. 
Close ties to Britain are apparent. Five of the 
subjects undertook their training in England. JC 
Ghosh was sent by the Government of India to 
qualify as a pharmaceutical chemist at Manchester in 
1910. Some years later KC Chatterjee sailed to 
England and also studied at Manchester University, 
obtaining his degree in 1940. BV Patel was awarded 
his degree by Chelsea Polytechnic in August 1940 
after three years study. HR Nanji obtained his PhD in 
organic chemistry from Imperial College London in 
1932; and RP Patel was awarded a PhD in 
pharmacological chemistry by University College 
London in 1936. 
But there are also hints of underlying tensions in 
the relationship with Britain. During his school days 
GK Srivastava 'took part in 1930-31 movement and 
received punishment for the participation' ; he 'was a 
true nationalist' and 'an ardent advocate for use of 
Hindi ' . OfDN Majumdar, Singh writes 'he not only 
had a very brilliant student career but was also full of 
patriotism. The latter zeal induced him to join some 
terrorist groups in the old Bengal of the undivided 
India, and thus he contributed his share to the fight 
for the Indian freedom. ' Yet issues such as how 
pharmacists managed their relationships with the 
Government of India on the one hand and nationalist 
leaders on the other are not explored. 
Singh's own contribution has been to raise the 
profile of the history of pharmacy in India, to restore 
key individuals to their rightful place in pharmacy's 
history, and to retrieve a great deal of valuable 
material from the archives . 
This book, like the previous ones in the series, has 
been rigorously researched and is meticulously 
referenced. The next step is to present this material in 
a broader social, political, cultural and economic 
context, and to locate it in the wider literature on the 
history of pharmacy and medicine; Singh has created 
an important legacy on which future social historians 
of pharmacy can build. 
Dr Stuart Anderson 
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Review 
The Extra Pharmacopoeia of unofficial drugs 
and chemical and pharmaceutical 
preparations. 
William Martindale and W Wynn Westcott. 1 st Edn, 
London: HK Lewis, 1883 . Reprint 2008, London: 
Pharmaceutical Press, 2008, 313 pp. ISBN 978-0-
85369-826-5 . Price £19.95. 
If you suggest that knowledge about pharmaceuticals 
increased by 25 times in the last 125 years, you are 
perfectly right: this is exactly the difference in 
volume between Martindale's first edition, dated 
1883, and the current one published in 2007. This is, 
by the way, far more of a difference than that between 
the brains of monkeys and men. What started as an 
'Extra Pharmacopoeia' is now called 'The complete 
drug reference ', roughly what it had always been, 
although the first editions were compiled to describe 
new drugs not yet listed in an official pharma,copoeia. 
As a sign of fruitful cooperation between a 
distinguished pharmacist and a physician, 
pharmaceutical knowledge, as usually found in 
pharmacopoeia! literature like solubility, appearance 
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or composition, is combined with therapeutic 
experience, initially compiled by Wynn Westcott. 
Certainly being ahead of their time, Martindale and 
Westcott gave literature quotations for all the facts 
mentioned, which makes the book so extremely 
valuable for the pharmaceutical historian. Thus, 
Martindale s early editions are an ideal starting point 
for research about the development of drug therapy, 
as one can easily move forward to the original reports 
if interested in detail. Therapeutic information in the 
first edition came from the most relevant medical and 
pharmaceutical periodicals including the BMJ, the 
Lancet or the Pharmaceutical Journal, and from 
contemporary pharmacopeieas. Most remarkably, 
formulas from some hospital pharmacopoeias were 
also included whose originally limited audience was 
expanded by being mentioned in Martindale and 
making hospital experience available to the general 
public. 
Old Martindale editions are rare and it is therefore 
highly acceptable that the Pharmaceutical Press has 
produced a reprint edition in the year of the book's 
125th anniversary. Not only professional historians 
but every pharmacist will gain a great deal of - in part 
totally unexpected - knowledge by simply browsing 
the pages. This refers to common 19th century 
preparations as well as to astonishing facts about 
therapy; so who knows that the cytotoxic drug 
podophyllin has been recommended almost 
exclusively as a 'powerful biliary purgative'? Almost 
unbelievable, six oral preparations are listed and -
according to the BMJ - are praised as 'one of the 
most satisfactory and reliable of our medicines .' 
Martindale s 2007 edition still refers to the 
gastrointestinal effects but of course strongly 
discourages oral (and even topical) administration of 
the substance, 'which is highly irritant to the 
intestinal mucosa and produces violent peristalsis 
resulting in a drastic purging action.' While today 
side-effects are a primary concern of the Martindale 
editors the original compilers were more enthusiastic 
about therapeutic efficacy. Another good example is 
the suggestion of Cannabis as a ' useful hypnotic'. 
So, one will learn a lot about therapy at the end of the 
19th century - in detail but also in general 
considering for example the contemporary attitude 
towards drug therapy. 
Thus to reprint Martindale s first edition was a 
brilliant idea, with only one minor criticism to be 
made: the reviewer 's copy was unsufficiently bound 
with some sheets soon being detached. The reprint 
certainly agrees with the look and feel of an ancient 
book and might not only be regarded as a technical 
weakness but as a sign of the high interest of the 
reviewer who enthusiastically turned the pages. 
Dr Axel Helmstaedter 
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BSHP members visit 17 Bloomsbury 
Square, WCI, on 18 June 2008. 
The'Square ' was the home of the Pharmaceutical 
Society of Great Britain 1841-1976 and the London 
School of Pharmacy 1842-1960. It is now occupied 
by the German Historical Institute, London 
(http://www.ghil.ac.uk) 
Below and clockwise: In the former Library, Mr 
Rajnikant and Mrs Marion Gamer-Patel with Doris 
Jones, a former assistant to Agnes Lothian Short and 
Robert Todd; climbing the cantilevered stairs to the 
second floor; members in the Library; Roy Allcorn 
(head of information services, RPSGB), Heather 
Maddin and Doris Jones; 17 Bloomsbury Square 
from Great Russell Street comer. 
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Catellani and Console: Christoph Glaser (from pp. 
40-45) further illustrations. 
Left, above: Moyse Charas, who was Glaser 's rival and 
claimed to be the author of his Traite de la Chymie. Courtesy of 
the Musee Georges Barias, Uzes. 
Left, below: The finance superintendent Nicolas Fouquet, who 
favoured Glaser. Wikimedia Commons, 
http://commons.wikimedia.org/. 
Centre: Bernard Le Bovier de Fontenelle, who criticised 
Glaser in a biased way in his Eloge of Nicolas Lemery. 
Wikimedia Commons, http://commons.wikimedia.org/. 
Right, above: Title-page of The Comp/eat Chymist ( 1677), the 
only English edition of Glaser 's 
Traite de la Chymie. Wellcome n=:::::=~======;:'ll 
Library, London. TH E , 
, Right, below: Madame de 
Sevigne believed that Glaser had 
provided the Marquise de 
Brinvilliers with the poisons 
used to murder several members 
of her family. Fine Arts Museums 
of San Francisco, Achenbach 
Foundation for Graphic Arts, 
Co1npleat Chymift, 
1963.30.22992. 
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Clarke Inquiry 
Response from the Committee of the 
British Society for the History of Pharmacy (BSHP) 
on behalf of the Society 
January 2008 
The BSHP was formed under the aegis of the Pharmaceutical Society of GB in 1967, having originated 
from its History of Pharmacy Committee, and is a registered charity. 
Aims 
To clearly indicate the basis of our comments, the aims of the BSHP are as follows : 
• To act as a focus for the development of all areas of the history of pharmacy, from the work of 
the ancient apothecary to today's ever changing role of the community, hospital, wholesale, industrial or 
veterinary pharmacist. 
• To promote historical studies related to pharmacy 
To advance knowledge and the propagation of understanding of the history of pharmacy 
• To publish the research work of pharmaceutical historians 
• To preserve pharmaceutical artefacts and historic pharmacies 
• To support the work of relevant museums and offer advice on establishment of other 
pharmaceutical exhibits 
• To co-operate with related professions and local historians on medico-pharmaceutical topics of 
mutual interest. 
The current membership includes both pharmacists and non pharmacists. 
Relationship with RPSGB 
The BSHP would wish to be affiliated to the emergent body from the Royal Pharmaceutical Society 
of Great Britain's (RPSGB) impending break up of function, in much the same way as at present, but 
would not wish at this stage to consider a merger and the potential merging of its own funds. The 
constitution of the emergent body would need to allow organisations such as the BSHP to retain their 
charitable status, their financial independence and a separate membership list. 
The BSHP is deeply concerned by the possible consequences of the politically driven Foster report, 
following which there appears to be little response from the Department of Health with regard to the 
serious financial implications which will arise. This could cause considerable uncertainty as to the 
future of the RPSGB 's unique museum and its collection. 
Publications 
There is also concern about the future of the leading international Pharmaceutical Journal, 
established in 1841 and published weekly since 1870, which plays an irreplaceable role in ensuring 
communication to and between the wide and diverse pharmaceutical profession registered in the· 
United Kingdom and also with many based overseas. It has always been crucial to the educational 
and updating needs of pharmacists, many of whom have to practice in relative isolation. 
Publication has been a major strength and vital role of the RPSGB, but as well as being over the 
years of considerable importance from a financial perspective, it has been of the greatest importance 
as a producer of internationally accepted and leading sources of information such as Martindale, the 
Extra Pharmacopoeia, and a range of books in various areas of specialisation, including the history 
of pharmacy. Pharmacy and indeed the nation, cannot afford to lose this service. 
Education 
The BSHP has and is working hard to promote the important and relevant aspects of the evolution of 
pharmacy as a modest core component of pharmacy undergraduate education. Every profession has 
a parallel need to address such issues, as it enables and helps the constructive understanding of its 
members when it comes to exercising their responsibilities and the protection and care of the public. 
It is wo1th reinforcing the point that a major driver in the founding of the Pharmaceutical Society in 
184 l was the need to urgently address education. Dr Jensen of the Royal Danish School of 
Pharmacy has said that 'history is a science that handles sequences and events'. 
The highly responsible and demanding role of the RPSGB as regulator, introduced by government 
legislation in 1933, and the effect of several case law decisions have had a profound influence on the 
RPSGB and some may see it as having possibly to some degree detracted from its professional 
support of its members. Be that as it may, for the emergent body to be a success, it will be essential 
to continue and further develop the educational role. Of particular importance is the accreditation of 
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all four year degree course programmes for the MPharm, and the organisation and running of the 
pre-registration year's practical experience programme and examination .required prior to 
registration. For the emergent body to retain pharmacist membership, it will be no less important to 
_ apply further emphasis on programmes for continuing professional development (CPD), which 
should give more attention to considering the introduction of post-graduate courses leading to 
diplomas in relevant areas of practice, which could include the history of pharmacy. Precedents 
have already been established with the RPSGB's Diploma in Veterinary Pharmacy (established in 
1981) and the Certificate in Public Health & Companion Animal Health Care, and there have been 
earlier examples. It is worthy of note that the Society of Apothecaries of London is an example of a 
long established professional body, which has successfully developed a wide range of diploma 
programmes of particular relevance to health care. The RPSGB framework for CPD is an essential 
framework for professional competence applicable to both pharmacists and to pharmacy technicians. 
The Carter Report 
The Carter report suggestion of a Royal college to replace the RPSGB would seem to be markedly 
flawed. The existing medical Royal colleges, which are presumably intended to be examples, now 
ave limited functions and are exclusive rather than inclusive when compared with RPSGB. For a 
realistic way forward in the time span available, there is little alternative to building on the residue 
of the RPSGB and if possible retention of the existing charter, much of which is based on the 
original charter of 1843, subject to any necessary amendment. A new college would be unlikely to 
be granted a royal charter for some years, which would detract from the recogn"ition and standing of 
pharmacy nationally. 
The Inquiry 
There are a number of questions asked by the Clarke inquiry which are of particular significance to 
BSHP and include: 
• Should a professional body act as the guardian of the archives and museum of the RPSGB? 
BSHP believes that they are an important part of our heritage and must be adequately supported by 
the emergent new body. BSHP recognises and supports the important summary document (copy 
attached [p. 52]) on the museum collections' status, which includes reference to governance 
safeguards and issues of trust and integrity. It is understood that the document will be integrated 
with the submission from the RPSGB Council. 
• What should the incentives for membership be? The main elements have already been 
referred to, namely the various aspects of education and CPD, the free weekly journal, library, 
museum resources and information service, local branch structure and support, and membership 
interaction through meeting programmes especially for specialised areas of expertise. There need to 
be worthwhile reasons for pharmacists in industrial, academic, regulatory affairs and veterinary 
pharmacy to continue their membership. The BSHP welcomes the proposal in the Carter report that 
the current Academy of Pharmaceutical Sciences and the Joint Pharmaceutical Analysis Group 
should be associated with the new body in much the same way as they have been with the RPSGB. 
The details will require careful attention as many members of both the Academy and the Group are 
non-pharmacists. 
e Question 2: are there any functions which should not be part of the role of a professional 
-body? Pharmacy does not have a trade union, unlike the medical BMA, dental BDA or the 
·veterinary BVA, but it would not be appropriate for the emergent body to take on such a role. The 
resent and earlier charters of the RPSGB prevented any such role, reinforced by case law, notably 
he Jenkin v PSGB case in 1920. 
• Question 3: are there any additional functions that the body should perform? In order to 
chieve a responsible balance between the support of pharmacist members and the public interest, 
emonstrable strategic leadership is necessary, notably nationally, at EU and in relation to the 
ommonwealth. This includes matters relating to government, the media and to interaction and co-
peration with other health professions. There is a need to continue to support appropriate research 
nd to publish in the wide range of areas ably developed over the years by the Pharmaceutical Press. 
Dr Michael H Jepson 
President. 
Mr Peter G Homan 
Hon Secretary. 
840 Melton Road 
Thurmaston 
LEICESTER LE4 8BN 
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24 January 2008 
Dear Mr Clarke 
Please find attached the response to your Inquiry, from the Committee of the British Society for the 
History of Pharmacy. We are appreciative of the opportunity which this has given to us. 
If there are any issues which you and your Committee may feel require further clarification, we will 
be pleased to respond. 
Yours sincerely 
Dr Michael H Jepson President 
Mr Peter G Homan Hon Secretary 
840 Melton Road, Thurmaston, LEICESTER LE4 8BN 
Briefing note: Royal Pharmaceutical Society of GB, Museum collections' status 
The Museum's collections number around 45,000 objects, primarily donations from members received 
since the 1930s. These provide the foundation upon which all of the Museum's activities rest. 
To abide by the Museums Association Code of Ethics (to which both the museum staff and the Council 
as its Governing Body are bound by the terms of Registration/Accreditation, and the Museum's 
constitution) the Museum cannot undertake financially-motivated disposal of its collections. If any 
disposal was undertaken, the money would have to be ring-fenced for re-investment in the Museum. 
Violation of the Code would result in expulsion from the Registration/Accreditation scheme which 
would therefore prevent the Society's Museum from access to funding sources and sectoral training, 
not to mention ostracising it from the rest of the museum community. 
The Museum's constitution, agreed by Council, is based on this premise and contains the following 
clause: 
5. The Museum's collections will be the property of the Society, but deemed to be held in trust for 
the benefit of current and future members and the wider public. The Museum's collections will not be 
treated as disposable assets, nor used to generate income for non museum purposes, nor used as 
collateral for loans. 
In addition, under the Society's Supplemental Charter, 2004 (section 13), if the Society is wound up 
or dissolved 
'any property or funds whatsoever, the same shall not be distributed amongst the members of the 
Society or any of them but shall, subject to any special trusts affecting the same, be given or 
transferred to some other body or bodies with objects similar to those of the Society and the 
distribution of whose income and property is restricted to the same or greater extent as that of the 
Society'. 
Beyond these governance safeguards in place against disposal, the Museum's collections represent 
trust placed in the Society to safeguard its members' donations over the last 80 years and more. 
Getting rid of the collections breaks this trust - and also with the many non-members who have 
chosen to give their objects to this Museum to preserve them for future generations. 
September 2007 Briony Hudson 
Keeper of the Museum Collections, Royal Pharmaceutical Society of GB 
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British Society for the History of Pharmacy 
. 840 Melton Road 
31 July 2008 
Thurmaston 
Leicester LE4 8BN 
bshp@associactionenterprises.com 
Mr Nigel Clarke 
Chairman 
The Transitional Committee 
53 Chandos Place 
Covent Garden 
LONDON WC2N 4HS 
Dear Mr Clarke 
The British Society for the History of Pharmacy (BSHP) wishes to ensure that TransCom and 
whichever of the Working Groups is/are considered most appropriate, will be fully aware of 
the BSHP's keen interest to be involved in any discussions which reflect their aims. The aims 
are summarised as follows: · 
Promotion of historical studies related to pharmacy, 
Advancement of knowledge and propagation of understanding of the history of 
pharmacy, 
Publication of the research work of pharmaceutical historians, 
Preservations of pharmaceutical artefacts and historic pharmacies, 
Support for the work of relevant museums and offering advice on establishment of 
other pharmaceutical exhibits and on the preservation of pharmacies, 
· Co-operation with related professions and local historians on medico-pharmaceutical 
topics of mutual interest. 
BSHP represents an integral part of the pharmacy profession and can continue to play an 
important part in education at both undergraduate and postgraduate levels and in research 
relevant to the 'new body'. The RPSGB Museum and archives are seen to be of great 
importance to our heritage and deserving of our collective unequivocal support. BSHP has 
been working with the museum staff to produce an extending series of educational leaflets 
addressing the evolution of pharmacy, notably for MPharm students and lecturers. 
Educational opportunities, additional to CPD, could be of considerable attractiveness to the 
retention and addition of members to the new body, especially if they facilitate pursuance of, 
for example courses leading to new certificates or diplomas in areas of specialisation and 
could generate financial support. . 
As you know, BSHP submitted a concise 3 page response to the Clarke Inquiry, which 
TransCom members may wish to re-examine, as it elaborated on several issues of on-going 
relevance, including our overseas and non pharmacist membership. 
The BS. HP Committee thank you in anticipation for considering our request and look forward 
to your response and in particular your advice as to which of the Workmg Groups we should 
be associated. 
Yours sincerely 
Dr Michael H Jepson President, and Mr Peter G Homan Hon Secretary, 
on behalf of the BSHP Committee. 
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Mr Nigel Clarke 
Chairman 
The Transitional Committee 
53 Chandos Place 
Covent Garden 
LONDON WC2N 4HS 
Dear Mr Clarke 
British Society for the History of Pharmacy 
840 Melton Road 
Thurmaston 
Leicester LE4 8BN 
bshp@associactionenterprises.com 
26th September 2008 
The Committee of the British Society for the History of Pharmacy (BSHP) thank you for the prompt 
acknowledgement of the two communications (ref l and 2) sent to you earlier this year, which we 
appreciated. We are much encouraged by the developments which have been taking place over recent 
months with regard to the new body, and thank you for your commitment and leadership in addressing 
such a challenging task. 
We are interested to hear that consideration is now being given by TransCom for affiliate status to the 
new professional body, which could be available to certain organisations with strong associations with 
pharmacy, but whose members may not all be eligible for full membership of that new body. 
Affiliation could well be the best arrangement for BSHP to be closely associated with the new body 
in order to continue its historic association as it has had with the RPSGB. Whereas the majority of the 
members of the BSHP and of its committee are phmmacists eligible for full membership of the new 
body, the committee is concerned about our non-pharmacist members, our overseas members and of 
our charity status. 
We would greatly appreciate the opportunity when possible, to share our unequivocal interest in the 
new body and issues such as affiliation, with for example a relevant Working Group, as and when you 
would feel it would be most meaningful. 
With all best wishes and we look forward to your response. 
Yours sincerely 
Dr Michael H Jepson President, and Mr Peter G Homan Hon Secretary, 
on behalf of the BSHP Committee. 
Ref 1: 25.01.2008 - Response from the Committee of the BSHP to the Clarke Inquiry. Includes, 
Aims, Relationship with RPSGB, Publications, Education & research, and particular reference to the 
museum and archives. 
Ref 2: 31.07.2008 - Summary of aims etc for reference to TransCom 
Review 
Burroughs Wellcome & Co: Knowledge, 
Trust, Profit and the Transformation of the 
British Pharmaceutical Industry, 1880-1940. 
Roy Church and E. M. Tansy. Lancaster: 
Crucible Books, 564 pp. ISBN 978-905472-04-8, 
hardback. Price £35. 
Burroughs Wellcome & Co. became the largest 
pharmaceutical manufacturer in the United Kingdom. 
In doing so it had a major influence on the industry and, 
in particular, led the way in the field of marketing and 
medical research. This book traces the history of the 
company from its beginnings through the period 
between the wars when it was a leader in the field. The 
formation of the Wellcome Trust and its influence on 
research is explained. The more recent history is then 
examined, when increasing competition and difficulties 
that arose between the marketing and research arms of 
the company led to the company's decline. 
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Burroughs arrived in England in 1878 as the agent 
of John Wyeth and Brother. He started his business 
S.M. Burroughs & Co. in a small rented office near 
the Strand . He had gained valuable experience in 
Philadelphia selling compressed medicines and 
quickly sold the advantages of this new form of 
medicine, which were 'accuracy of dose, ready and 
entire solubility, and perfect preservation of drug ', to 
his United Kingdom customers. He appreciated that 
the word 'tablet' was more acceptable than the tem1 
'pill' used in America and he registered 'tablet' as a 
trade mark. Burroughs also recognised the 
commercial possibilities of Malt Extract which was 
just being introduced into Britain and he invested in 
the Kepler Malt Extract company, which he 
subsequently acquired. 
Much of Burroughs ' success was due to his 
introduction of the American selling methods and the 
successful use of the travellers employed by the 
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company. The traditional means of selling at the time 
was the use of commission agents as salesmen. They 
did not have the interests of the company at heart, as 
there was no incentive to sell Burroughs medicines as 
opposed to any other lines they were detailing. This 
did not fit in witb Burroughs' methods. By March 
1879, the company was employing five of its own 
travellers on a full-time basis to promote their products. 
The business steadily expanded and this led 
Burroughs to offer a partnership to Henry Wellcome, 
an American colleague, who was working at the time 
for McKesson and Robins. This offer was dependent 
on Wellcome being granted the exc lusive agency for 
sugar-coated pills and other products of McKesson 
manufacture. This Wellcome was able to achieve and 
the partnership of Burroughs Wellcome & Co. was 
formed in 1880. Despite problems with the quality of 
McKesson and Robins products, which were 
subsequently discontinued, the company expanded 
the range of products they were ab le to supply. These 
were largely from American suppliers. Particularly 
successful was the range of pepsin and pancreatic 
extracts from Fairchild. 
Initially the company had a monopoly in the supply 
of compressed tablets. However competition grew 
rapidly, and cheaper products, imported from other 
America manufacturers, placed the company at a 
disadvantage with their restrictive agency agreement. 
Their profits were severely affected by the new 
competition and it was decided to invest in 
manufacturing their own products, which enabled the 
company to improve its profitability and remain 
competitive. In addition they had a distinct 
commercial advantage because of their better 
marketi ng and sales methods. They also . had 
advantages through innovation and quality control of 
their products, enabling the company to expand their 
range of products and ensure consistent quality. They 
went to considerable trouble and expense to register 
their trademarks and to defend their use. One of the 
more notable was the word 'Tabloid'. 
Burroughs was a man of great energy and 
initiative. He produced many ideas for the company, 
but he lacked shrewd judgement and the care of 
detail, which were Wellcome's strengths. At the end 
of the 19th century the partnership came under a 
great deal of strain. Burroughs, on a world tour, made 
decisions and appointed agents without consulting 
Wellcome. Burroughs also tried to secure financial 
dominance of the company. These and other 
difficulties cu lminated in talks to dissolve the 
partnership, which was only avoided by the death of 
Burroughs in February 1895. ; 
The First World War had a significant effect on the 
British drug industry. Many of the medicines in use 
in Britain were sourced from Germany, including 
Aspirin. Initially there was some difficulty in 
obtaining licences to manufacture drugs which had 
been patented by German companies. Once this 
difficulty was overcome, Burroughs & Wellcome 
manufactured Salvarsan and Neo-Salvarsan under 
the name Kharsivan and then went on to produce 
other drugs including aspmn, phenacetin, 
pyramidon, emetine bismuth iodide and others. 
Boots took advantage of the increasing demand for 
chemicals to expand their fine chemical production. 
They employed a number ofB.W. & Co. employees 
in order to gain the advantage of their expertise. The 
most damaging was when F.H. Carr transferred to 
Boots. He had been Head of the Chemical 
department since 1898 and Boots built a plant for the 
manufacture of fine chemicals headed by Carr. By 
1917 they were manufacturing aspirin, phenacetin 
and atropine in direct competition with B.W. & Co. 
In the period after the First World War one of the 
most significant developments was the formation of 
the Wellcome Foundation. This took control of the 
research laboratories, library and museum. 
Following the death of" Wellcome in 1936, the 
Wellcome Trust was formed. According to his will, 
the Trust was responsible for the administration of 
the Wellcome Foundation, in addition to his personal 
fortune as well as managing the business, the 
research laboratories, library and museum and the 
other activities Wellcome was engaged in. 
This post-war period was one of increasing 
difficulty. Competition increased and this was not 
helped by the culture within the company. Wellcome 
wanted to promote scientific research in order to 
advance medical knowledge. This led to research 
discoveries being published and then adopted by the 
company's competitors, to the disadvantage of the 
commercial advancement of the firm. A split grew 
between the commercial aims of the company, on 
whose success the funding of research depended and 
its public role, which lead to a reduction in the 
company's profitability and its relative decline. 
Despite these later problems it has to be 
acknowledged that Burroughs Wellcome & Co. was 
at the heart of the development of our modem 
pharmaceutical industry. Its history and development 
are essential knowledge to an understanding of the 
industry in the United Kingdom. This book can be 
thoroughly recommended to anyone interest in the 
history of pharmacy and particularly, in the history of 
the pharmaceutical industry in Britain. 
p.worling@virgin.net Dr Peter M. Worling 
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Two Edwardian Face Cosmetics 
Andrew Hardy* and Sally Pointer** 
*Centre for Medical History, School of 
Hutnanities, and Social Sciences, University of 
Exeter 
**National Museum & Gallery of Wales, 
Cathays Park, Cardiff 
Queen Victoria was well known for her abhorrence of 
'painting'.' However, she did maintain the services of 
a perruquier (wig-maker), who made up her cold 
creams and her (exclusive) flesh-toned face powder. 
Her influence affected the sale of cosmetics and even 
by 1905, four years after her death, the new Harrods 
store in London's Knightsbridge had very few 
cosmetics openly on sale. However, gradually the 
reticence about cosmetic purchase relaxed, especially 
as a new generation of fashionable Royal patrons, for 
example Queen Alexandra, were open about their 
fondness for cosmetic preparations. In 1907 Helena 
Rubinstein (1870-1965) arrived in London to open a 
beauty salon, whilst in 1910 in America Elizabeth 
Arden (1878- 1966) started her cosmetic business, 
later opening her own London salon in 1922. Thus, 
when in 1908, the American Gordon Selfridge (1858-
1947) opened his (huge) first London store it 
contained a vastly increased range of cosmetics for 
purchase by fashionab le Londoners.2 The rise of the 
mass marketing of cosmetics had begun. By the 1920s 
the use of cosmetics by millions of Western women, of 
all classes, had become both more acceptable and 
widespread, partly from the influence of Hollywood 
actresses,3 and partly as more women entered the 
workplace and made decisions about the polished 
image they wished to project. 
In a previous publication4 we detai led the chemical 
composition of an Edwardian face cosmetic. 
Subsequently we obtained samples of two more such 
cosmetics. One, dated (by the RPSGB Museum) to 
1890- 1910, was a (rose-pink) rouge made by 
'Bourjois of London/Paris ' (Figure l). The other 
sample, dated to c.1910 (again by the Museum), was 
an orange-pink face powder made by 'Areco Ltd. of 
London/Paris ' (Figure 2). 
The use, or not, of rouge was a common dilemma 
for the fashionab le ladies of the early and middle 
Victorian period. Should one wear a modest amount 
of rouge - subtle and artful in application - and risk 
being found out (and thus being thought of as 
'fast' /not-entirely-proper)? Or risk having no rouge 
and then perhaps being thought plain? However, by 
the 1890s the use of rouge by the young and the 
fash ionable was becoming increasingly widespread. 
This continued into the Edwardian era, where the 
Victorian rose tints were often replaced by more 
yellow tones.s 
fo 1868 Monsieur and Madame Bourjois 
purchased the Paris-based cosmetic business of 
Joseph-Albert Ponsin, 'Maison Bourjois' as it 
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Fig. l . "ROUGE Rosette Brune" sample 
(© Ironbridge Gorge Museum Trust, Shropshire, UK). 
became known, expanded the product range, but 
remained faithfu l to the brand 's founding principles 
of 'good quality products for stage make-up and 
everyday make-up ' . The name of the shade of one of 
their later ' blushers ' (i.e. rouges) was 'Rosette 
Brune', a classic rose-pink colour. Our previously 
mentioned Bourjois sample is named 'ROUGE 
Fig. 2. "Poudre de Riz Bonami" sample 
(© Museum of the Royal Pharmaceutical Society, 
London, UK). 
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Rosette Brune' . This shade is still available from 
Bourjois today, with ' the same original formula' , but 
now named 'Cendre de Roses Brune.'6 
Our second face cosmetic sample is named 'Poudre 
de Riz Bonami '; and its name implies the presence of 
'powder of rice '. However, one author states that this 
'powder · of rice ' was in fact always well-washed 
potato starch powder. 7 Another states that it came 
from China and was rice powder,8 and yet another 
mentions that it was rice starch (i.e. the starch 
extracted from rice powder). 5 Whilst rice powder can 
be assumed to be chemically identical to rice flour 
(the latter being a finely ground and sifted form of the 
former); the same cannot be said for rice starch and 
potato starch.9 Unfortunately we were unable to 
unearth any information on the company that made 
this cosmetic (Areco Ltd. of London/Paris) or any 
details on this particular face cosmetic. 
The two face cosmetics were chemically analysed 
using the analytical techniques of LVSEM (Low 
Vacuum Scanning Electron Microscopy) and XRPD 
(X-Ray Powder Diffraction). The former gave 
quantitative elemental analysis on the samples, for 
atomic numbers (Z) of 6 and above; and the latter 
gave semi-quantitative results for the (crystalline) 
compounds present in the samples. For those readers 
wishing to know more about these two analytical 
techniques, especially as applied to cosmetic 
samples, we refer them to a recent publication by one 
of us.10 
The LVSEM results were (in decreasing order of 
weight percent and with those elements at 1 % or less 
being in brackets): 0 , C, Si, Mg, Ca, Zn, Al, Fe (Cu, 
Na, K, S) for the 'ROUGE Rosette Brune '; and 0, Si, 
Mg, C (Al, Fe, Ca) for the 'Poudre de Riz Bonami'. 
The XRPD results were (with approximate 
percentages in brackets) : 
'ROUGE Rosette Brune' 
Talc Mg3Si401o(OH)2 (81) 
Calcite CaC03 (11) 
Zincite ZnO (4) 
Kaolinite AhSi20 s(OH)4 (2) 
Hematite Fe203 (1) 
Quartz Si02 (1) 
'Poudre de Riz Bonami ' 
Talc 
Kaolinite 
Unknown 
Calcite 
(87) 
(7) 
(5) 
(1) 
The above 'unknown' is thought to be perhaps 
either an Aluminium or Magnesium hydroxide (i.e. 
Brucite, Mg(OH)2 or Nordstrandite, Al(OH)3), or 
possibly another silicate. 1 
The rose-pink colour of our Bourjois rouge sample 
was given by the presence of a small amount of 
Hematite, which was probably a component of some 
added calamine (i.e. Zincite plus Quartz plus 
Hematite). This is the same colourant as we found for 
the previously studied ' Freeman's Face Powder '.4 
However, for our other face cosmetic there was no 
evidence for the presence of an iron-containing 
colourant (i .e. Hematite or Goethite). We believe its 
colour ( orange-pink) is caused by a very small 
amount of an organic colourant such as carmine, 
madder or even saffron; possibly as part of a lake 
pigment. 11 
A recipe for a typical coloured 'Poudre de Riz ' face 
cosmetic of the Edwardian period is given by Koller7 
as follows: · 
Magnesia MgO 500g 3.3% 
Talc 4,500g 29.1% 
Rice meal* 10,000g 64.6% 
Various oils 250g 1.6% 
Eau de Cologne 200g 1.3% 
Carmine 20g 0.1% 
*This is lightly ground rice grains; the 'precursor' to rice 
flour) 
It is immediately clear just how little colourant is 
necessary to give the requir.ed tint, which can lead to 
difficulties in accurately identifying such colourants 
in later chemical analysis. Other face cosmetic 
recipes are also given in this reference: talc and/or 
rice meal/flour/starch are used as the powder's base 
and where the red/rose/pink colour was given by 
small amounts of cannine. Also, a named face 
cosmetic, 'Poudre de Riz de Java' (first produced by 
Bourjois of Paris in 1879), was analysed and found 
to contain 25.5% of zinc oxide and 74.5% of talc, but 
with no trace of any form of 'rice powder'. Similarly 
there was no evidence, from the XRPD data of our 
second sample, for the presence of any significant 
quantity of either rice flour12 or of potato starch. 13 
Clearly what the name implied as a primary 
ingredient of some face powders was not always 
what was actually used in their manufacture. 
Historically, more noxious ingredients might be 
found in cosmetics. Ceruse, here taken to be White 
Lead, that is basic lead carbonate of formula: 
2PbC03.Pb(OH)2, has had a long and often lethal 
history. Well known to the Romans, it was also used 
in England as a cosmetic base from at least the 1500s, 
reaching the height of its usage during the eighteenth 
century. Its poisonous properties were often well 
known, but it continued in use 'because it worked'. It 
did give a ' pale allure' to the skin plus good coverage 
( often using multiple layers to hide the scars of 
smallpox) and adhesion, and it could be easily 
coloured.5 It was replaced, eventually, by safer 
alternatives such as talc and 'rice powder' (though 
warnings against lead survive in Victorian beauty 
manuals, suggesting it was not uncommon even at 
this late stage). 
A good face cosmetic powder should have · 
covering power (i.e. the required degree of opacity) 
to mask any skin defects such as scars, birthmarks, 
blemishes and broken blood vessels, whilst still 
ideally allowing natural (and assumed to be 
unblemished) skin colour to be seen. The most highly 
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opaque material generally used now is titanium 
dioxide (Ti02) (its pure white pigment form was first 
mass-produced in 1916), with zinc oxide and calcium 
carbonate being progressively less opaque, until for 
the most translucent coverings talc is/was used. Other 
attributes fora good face cosmetic are: a degree of 
absorbency ( e.g. kaolinite or another clay); slip (i.e. 
the lubricant properties of such materials as talc) ; 
bloom (i.e. the matt, silky appearance given by such 
materials as chalk or starch); and adhesion (i.e. the 
ability to cling to the skin's surface, given by 
materials such as talc or insoluble soaps).14 
Thus a comparison of the major components of the 
three Edwardian face cosmetics studied by us 
indicates that the previously studied 'Freeman's Face 
Powder'4 was designed to be more opaque than the 
other two samples (as its percentage of zinc oxide 
was much higher). All three contained varying 
amounts of talc and kaolinite, but no observable 
amounts of insoluble soaps (i.e. zinc or magnesium 
stearates). That no ceruse/white lead was found 
indicates the relative safety of these cosmetics; and 
also perhaps shows that this noxious substance had 
finally been consigned to the 'dustbin ofhistory'. 15 
The ' less-made-up ' look requires less covering 
power (i.e. a high percentage of talc present), whilst 
the 'camouflage look' requires more opaque material 
(i.e. less talc and more zincite) to remove from sight 
the underlying skin. Which ' look' was used depended 
on both the current fashion and the user's (perceived) 
skin condition. For those who could afford it the first 
beauty salons aimed to deal with the latter, and 
sometimes even affected the fashionable trends in the 
process. However, as the containers of any purchased 
'named brand' cosmetics did not then contain a list of 
the ingredients or specify the degree of coverage 
given, then the obtaining of a suitable face powder 
depended on 'experimentation in situ' and/or on 
helpful shop/beauty salon assistants. 
Unscrupulous vendors certainly offered sub-
standard or occasionally dangerous products, and 
part of the slow move towards the acceptability of 
cosmetics was the ongoing issue of inexperienced 
users being misled and subsequently disappointed by 
the products they used. Brand names of this period 
went to some pains to promote the ' suitableness ' of 
their products, and it speaks well of our and other 
samples tested that the ingredients are/often were 
comparable to acceptable present-day ingredients. 
Conclusions 
Cosmetic usage is as old as vanity. Usage engenders 
positive feelings and various studies ( e.g. reference 
16) have shown that an increased attractiveness, real or 
imagined, does affect female lives socially and 
financially. Whether it was the increased chance of 
splendidly succeeding in the Edwardian 'marriage 
market' or an increased chance of promotion in the 
business world of a hundred years later, cosmetics 
'work' for women. 
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Face cosmetics, plain or coloured, play an 
important part in this hunt for, and display of, 
'attractiveness '. The two Edwardian face cosmetics 
studied here contain no toxic ingredients. One was 
coloured by an inorganic iron compound and the 
other (probably) by an organic colourant. Both 
contain high percentages of talc and so can be 
described as having a light/translucent coverage 
(rather than an opaque one); and so when used both 
would have given the 'natural look'/ 'less-made-up 
look'. They represent an important transition 
between· the often dangerous, highly coloured 
preparations of a century earlier, and the well 
researched, highly tested mix of ingredients found in 
present-day coloured face cosmetics. 
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Potatoes in Pharmacy 
Dr Christiane Staiger 
Neu-lsenburg , Germany 
The tubers ofSolanum tuberosum L. orthc Solanaceae 
family is one of the world's most popular vegetables. 
Native to South America, it made its way to Europe 
and had a profound phannaceutical career as a medical 
substance as well as an cxcipicnt. 
The Origin in the Andes 
The origin of the potato lies several thousand years 
back in time in South America. Potato skins were 
found within a hearth at an archcological site in Chjlc 
dating to 11,000 BC. 1 The first ai:chaeological 
evidence of potato culti vation is from approximately 
5,000 years ago with the natives of Peru. Wild tubers 
have been found in the Andean plateau and 
mountainous regions. 
In fact, the potato originated in the area or 
contemporary Peru and Bolivia, identified more 
specifically in 2005 as an area of southern modern 
day Peru, just north of Lake Titicaca.2 With 
phylogenetic analyses of 362 individual wild and 
landrace members of the potato, a group of scientists 
could identify the genetic history of the plant. The 
people of ancient Peru developed several techniques to 
improve the production and storage of potatoes. 
Archaeologists have also found remains of a 
dehydrated potato product, called chufio.3 To preserve 
the tubers for lo.ng-tcnn storage, they were left on the 
ground to freeze during the cold nights. Tn the 
morning, they were trampled to remove the trapped 
moisture. This process or freeze-drying was repeated 
over a period of4-5 days until all of the moisture was 
removed from the crushed potatoes. A potato flour, 
called tunta, was produced by a similar process. 
The potato played an important part in the lives of 
the South American natives both as an everyday food 
and as a cultural influence. The Quechua language 
records more than one thousand words to describe 
potatoes and potato varieties. Particularly in highly 
elevated regions where corn and wheat would not 
grow, the potato became the primary food . 
Ancient artefacts show that the people of the 
Andean highlands used potatoes as a theme in their 
art. Plotter pieces were made to resemble potatoes 
and sometimes showed potatoes with human 
characteristics. The potato was also believed to have 
medicinal qualities and was rubbed on the skin of 
sick patients as a remedy. 
The importance of the potato in the lives of Andean 
natives is evident in the religious ceremonies created 
surrounding the tuber. Further, the Inca people 
Portrait of Francisco Pizarro Gonzalez (oil 
painting by an unknown artist) Source: 
http:! /de. wikipedia. org/w iki/Francisco _Pizarro 
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worshipped potato gods and celebrated rituals to 
ensure the success of their potato crops. Rituals and 
sacrifices were offered to appease the gods especially 
in times of need. 
The early history of the potato in Europe 
The potato found its way to Europe during the 16th 
century.4 Although many crops were brought to 
Europe by Columbus and others soon after the 
discovery of the New World in 1492, the potato arrived 
several decades later. This is because Peru and the high 
Andes mountains were first discovered by Pizarro only 
in 1532, and potatoes were not mentioned for this 
region until Lopez de Gomara's account of 1552 and 
that of Cieza de Leon in 1553.5 In what is now 
Colombia potatoes were first recorded in 1537. Thus, 
Europeans were first aware of the plant about 40 years 
after Columbus ' discovery of the New World. 
Title page of Lopez de Gomara's La Historia 
General de fas Indias 
In 1934, Hamilton found what has been thought to 
be the first records of the potato in Europe. In 1573 
and 1576 the market archives of the Hospital de La 
Sangre in Seville, Spain mentioned the plant. These 
dates were used by historians as indicating that 
potatoes were already being grown in or around 
Seville by 1573 and that a likely date for this 
introduction could have been about 1570. 
However, John Gregory Hawkes from Birmingham 
University did much work on the early history of the 
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Flower of Solanum tuberosum L from the 
Original Linnean Herbarium Source: 
http: //linnaeus.nrm.se/botany /fbo/s/solan 
potato in Europe and he found evidence that the 
introduction of the plant from South America went 
via the Canary Isles, and not, as previously assumed, 
directly into continental Spain.6 Hawkes and his 
group found records from November 28th 1567 in 
Las Pal mas de Gran Canaria. Barrels of 'patatas ', 
which are common potatoes, were exported from 
Gran Canaria to Antwerp and the bill of lading for 
goods mentions three medium-sized barrels 
containing potatoes, oranges and green lemons. The 
second record is from April 1574 referring to two 
barrels of potatoes that came from Tenerife and were 
shipped via Gran Canaria to Rouen in France. Thus, 
the potato was obviously being grown as a crop in 
Gran Canaria and Tenerife in 1567 and 1574, 
respectively. Taking into consideration that it would 
have needed some five years to bulk it up sufficiently 
as an export crop, it might well have been introduced 
in about 1562. This is only ten years after the first 
published account in 1552 by Lopez de Gomara, and 
only thirty years after its presumed first sighting in 
Peru by Pizarro in 1532. 
Sweet Potatoes 
For historians, one of the problems is to recognise in 
the literature whether the Solanum tuberosum potato 
or the Ipomoea batatas sweet potato is under 
discussion, or whether they are being confused with 
each other. 
The sweet potato species is Jpomoea batatas and 
the botanical family is the bindweed or morning 
glory family, Convolvulaceae. Besides simple 
starches, sweet potatoes are rich in complex 
carbohydrates, dietary fibre, beta carotene, vitamin 
C, and vitamin B6. In 1992, the Center for Science in 
the Public Interest compared the nutritional value of 
sweet potatoes to other vegetables. Considering fibre 
content, complex carbohydrates, protein, vitamins, 
iron, and potassium, the sweet potato ranked highest 
in nutritional value. According to these criteria, sweet 
potatoes earned 184 points, 100 points over the next 
on the list, the common potato. 7 
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Hawkes and his team have found evidence, that the 
early Span ish authors always seemed to have clearly 
distinguished between the two potato types and that 
the Canarian and the Seville records refer indeed to 
the Solanum potato. 
The focus of this paper is the common potato, 
Solanuin tuberosum. The nutritional value, as 
mentioned before, is also quite remarkable.s Raw 
potatoes with peel contain a number of important 
vitamins and minerals, in particular high amounts of 
Vitamin BG and C. Nutritionally, potatoes are best 
known for their carbohydrate content. Starch is the 
predominant form ; potatoes contain about 15%. A 
small but significant portion of the starch in potatoes 
is resistant to enzymatic digestion in the stomach and 
small intestine and, thus, reaches the large intestine 
essentially intact. This resistant starch is considered 
to have physiological effects and health benefits 
similar to fibre: e.g. to offer protection against colon 
cancer; improve glucose tolerance and insulin 
sensitivity; and lower plasma cholesterol and 
triglyceride concentrations. However, not all of the 
valuable ingredients are stable at higher 
temperatures; thus the cooking method used can 
significantly impact the nutrient availability of the 
potato. 
Spreading across Europe 
From Spain, potatoes slowly spread to Italy and other 
European countries during the late 1500s. By 1600, the 
potato had entered Spain, Italy, Austria, Belgium, 
Holland, France, Switzerland, England, Germany,9 
Portugal and Ireland. But at first, it did not receive a 
warm welcome. Potatoes were regarded with 
suspicion, distaste and fear. They were primarily 
grown in botanical gardens as an exotic novelty, also 
for the nice flowers, but not considered for human 
consumption. In many European countries, the potato 
carried a social stigma as the food of savages and 
peasants. Yet in England, the tuber was so despised 
during the reign of George III (reigned 1760-1820) 
that it took years of botanical experiments before 
people conceded that potatoes might be acceptable, but 
as cattle feed. 
However, the potato spread around the continent. 
Documents show that in Belgium in 1587, the Prefect 
of Mons, Felipe Sivry, received potatoes as a gift from 
a friend of the Vatican ambassador. He had brought 
them from Italy where they had arrived via Spain. 
The following year, the Belgian official sent some 
potato tubers and a berry to the botanist Caro lus 
Clusius (1526-1609), living in Vienna. Clusius is 
commonly famous for introducing the tulip to the 
Netherlands. In 1589, Sivry sent Clusius another gift, 
a watercolour of a potato plant that he had painted. 
The following year Clusius received two more 
illustrations of potatoes from the Swiss botanist 
Pierre Bahuin. In 1596, Bahuin published his book 
Phytopinax , which described the potato for the first 
time as Solanwn tuberosum, the name still used today. 
John Gerard 
The first description of the potato in English appears 
in The Herbal! or Generali Historie of Plantes (1597) 
by John Gerard (1545-1612), who corresponded with 
Clusius and provided him with samples. Gerard 
mistakenly thought the white potato to be native to 
America, calling it the 'Virginian Potato' to 
distinguish it from the red sweet potato. On the title 
page he appears in a noble costume, in his hands a 
potato bough with a large flower. 
Virginia potatoes hath many hollowe flexible branches 
trailing uppon the grounde .. , the whole leafe resembling 
those of the Parsnep .. . whereon do grow very fa ire and 
pleasant flowers, made of a entirely whole leafe, which 
is folded or plaited in such strange sort, that it seemeth 
to be a flower made of sixe sundrie small leaves ... The 
whole flower is of a light purple colour. lo 
The potato made its way further around the world. 
In 1613, the British took the tuber to Bermuda. From 
there it was shipped in 1621 to Virginia, in Britain's 
American colonies. Further, historical and genetic 
evidence suggests that the plant reached India not 
very much later than Europe, taken there by either the 
British or the Portuguese. 
In the mid- l 8th century, Frederick the Great of 
Prussia ( 1712-1786) saw the potato's potential to 
help feed his nation and lower the price of bread, but 
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faced the challenge of overcoming the people 's 
prejudice against the plant. An anecdote tells that ~e 
used a bit of reverse psychology to encourage his 
subjects ' interest in the crop: he placed a royal acre of 
potato plants and stationed a guard to protect the 
field . Nearby peasants naturally assumed that 
anything worth guarding was worth stealing, and so 
snuck into the field and snatched the plants for their 
home gardens. Of course, this was entirely in line 
with Frederick's wishes and the guards had order to 
ignore the thieves. 
Beside this anecdote, the breakthrough of the crop 
growing in Prussia came with a royal decree in 175?. 
Farmers were commanded to cultivate potatoes in 
their fields : 
Es ist Uns in hochster Person in Unsem und anderm 
Provintzien die Anpflanzung der sogenannten 
Tartoffeln, als ein niltzliches und so wohl filr Menschen, 
als Vieh auf sehr vielfache Art dienliches Erd Gewachse, 
emstlich anbefohlen .11 
Antoine-Augustin Parmentier 
It is a pharmacist, who is remembered as a vocal 
promoter of cultivating the potato as a food source_ for 
humans in France and throughout Europe. Antome-
Augustin Parmentier (1737-1 813) served as a French 
military pharmacist. During the Seven Years' War, he was 
captured, and in prison in Prussia was faced with eating 
only potatoes for two weeks. In the article of Brian Block, 
comprehensive information about the life of this 
outstanding pharmacist is given. 12 After his return to 
Paris, the prison experience came to Parmentier's mind in 
1772 when he proposed to use potatoes as a source of 
nourishment and breadmaking. The same year, the Paris 
Faculty ofMeclicine declared potatoes edible. . . 
In popular history articles, Partment1er 1s 
mentioned as the inventor or the populariser of the 
potato, but he was certainly not the first and only one 
who promoted the crop in France. Two other 
Frenchmen, Duhamel du Monceau and Mustel have 
an earlier claim than Parmentier, even in the making 
of bread from potatoes. But, as Block states, both did 
little work on the potato, each published a paper and 
went on to do something else. Parmentier however, 
worked on various aspects of the potato and its use in 
breadmaking, refining and publishing his results until 
the topic was exhausted. Later, even the cavaliers at 
court inserted a potato flower to their buttonhole. 
Potato famine 
But potato history was not always that glamorous. A 
much more tragic chapter is related to Ireland. There, 
the common potato found a perfect growing climate 
and the Irish people quickly embraced the crop as the 
common daily food . Poorer parts of the coµntry relied 
entirely on the potato. But in 1845 the blight appeared. 
The blight was the fungus Phytophthora infestans and 
was responsible for several crop failures until the early 
1850s. During the Great Hunger or Irish Potato 
62 
Famine the population of the island was reduced by 
20 to 25 percent; almost one million people died. The 
famine triggered the emmigration of another one 
million, mostly to Canada and the United States. 
Potato Year 2008 
However, the potato is today one of the m~st 
important crops of the world. 2008 is the official 
International Year of the Potato proclaimed by the 
United Nations .13 The mission of this International 
Year of the Potato is 
to increase awareness of the importance of the potato as 
a food in developing nations, and promote research and 
development of potato-based systems as a means of 
contributing to achievement of the United Nations 
Millennium Development Goals. Over the next two 
decades, the world's population is expected to grow on 
average by more than 100 million people a year. More 
than 95 percent of that increase will occw in the 
developing countries, where pressure on land and water 
is already intense. A key challenge facing the 
international community is, therefore, to ensure food 
security for present and future generations, while 
protecting the natural resource base on which we all 
depend. The potato will be an important part of efforts 
to meet those challenges. 
2008 has also been designated the National Year of the 
Potato in Peru. 14 
Medicinal use 
The potato when first introduced into Europe was a 
novelty and sold for a high price, and used as 
medicine. 15 
It was supposed to be an aphrodisiac useful in 
curing impotence or as an ingredient in love 
philtres. 16 William Salmon (1644-1713), in The 
English Herbal or History of Plants printed 1710 
praised potatoes highly claiming they stopped 
'fluxes of the bowel and could cure tuberculosis _and 
rabies.' He also promoted their aphrodisiacal 
qualities, asserting that eating potatoes would 
'increase seed and provoke lust, causing fruitfulness 
in both sexes.' In the literature it is also st~ted that 
Shakespeare mentions potatoes twice - once in the 
Merry Wives of Windsor, and once in Troilus and 
Cressida. It is scientifically proven that Shakespeare 
referred to the sweet potato. However, as sweet 
potatoes do not grow in the British Isles, several may 
have used the common potato instead in pre-Viagra 
times. 
Raw potato water was recommended against 
gastric ulcers, which seems to make sense, as the 
pH-value of potatoes and potato water is alkaline. 17 
For the same reason it was also recommended as a 
soap, for example by another famous pharmacist, 
Tobias Lowitz (1757-1804). 18 
In the Curious Cures of Old England is mentioned 
that for headaches one should apply a poultice ofraw 
potatoes to the temples, and cramp could be 
prevented by putting a potato under the m~ttress. 19 
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The book Curious Cures of Old Yorkshire 
recommends putting a little lump of hot potato in the 
ear for earache, and against sore throat apply boiled, 
mashed poatoes wrapped in a stocking. Olive or 
campborated oil could be added to the outside of the 
stocking, then wrapped around the throat.20 These 
applications refer to the good beat store qualities of 
the hot potato and seem to offer in fact some help. 
In 2006, I asked our late friend Bill Jackson if he 
knew other less rational medical virtues of potatoes 
and he wrote me a sincere letter with further 
information: 
My old G.P. cured some warts on the hand of his sons by 
cutting a potato in half, rubbing the warts with the cut 
surface, then burying the potato in his garden. The 'cure ' 
was successful and the warts disappeared. Audrey's 
grandmother always carried a potato in the pocket of her 
apron as a preventative from or a cure for rheumatism.2 1 
Another not evidence-based use suggests putting 
potato slices on broken bones. During the I 920s, 
several plants have been examined as a possible 
source of insulin , including the potato.22 As we know 
today, potaoes are not a 'vegetable source ' for 
insulin . However, they are always mentioned when it 
comes to administering a proper diet for patients 
suffering from diabetes. Further, potato diets were 
recommended for an abundant number of 
complaints. 
Such a diet has been found to possess remarkable powers 
of clearing away colds, fevers , bronchial and digestive 
troubles which, for the most part, are due to an excess of 
acid poison waste in the system. Obstinate skin disease 
of an intractable type and chronic nettlerash will yield to 
it when all other forms of treatment have failed. 
Influenza yields to potato treatment in four days, while 
rheumatic fever clears up in eight days.23 
Finally, Gyll Mothorby reported in his book of 
1775, that in Sweden leaves of the potato plants were 
manufactured for smoking instead oftobacco.24 
The idea that potatoes may help one to fall asleep 
is probably related to the alkaloid content of crude 
tubers, leaves, flowers and in particular the fruits of 
the plant. The glycoalkaloids, namely solanine and 
cbaconine, may cause headaches, diarrhea, cramps 
and in severe cases coma and death.25 However, 
poisoning from potatoes occurs very rarely. 
Starch 
From a pharmaceutical point of view, the potato is not 
a magic active ingredient. But it made a much more 
successful career as an excipient. Some readers may 
remember viewing different types of starch through 
the microscope. Rice starch is the smallest, corn and 
wheat are also different, but potato starch can be 
identified by irregularly shaped, ovoid or pear-shaped 
granules showing clearly visible concentric striations. 
Starch is used as an excipient primarily in oral solid-
dosage formulations where it is utilised as a binder, 
diluent, and disintegrant. Starch is also used in dry-
filled capsule formulations for volume adjustment of 
the fill matrix. Further, freshly prepared starch paste is 
used at concentrati9ns of 5-25% in tablet granulations 
as a binder. 
However, wafer-capsules (or cachets) have been 
the main dosage form for potato or rice starcb.26 The 
French retail pharmacist, Stanislas Limousin (1831-
1887) introduced many devices into pharmacy and 
medicine, among them the medicine dropper, an 
apparatus for the inhalation and therapeutic 
administration of oxygen; and most importantly the 
invention of glass ampoules that could be sealed and 
sterilised. The cachet has been another great 
contribution. 
It seems that starch capsules may face a return to 
modern pharmacy by those seeking alternatives for 
gelatin, which is an animal excipient. Modem 
processing feeds starch - in the form of powder, 
granules or pellets - through the hopper onto a 
rotating screw. 27 The feed material moves along the 
screw towards the tip · and the temperature is 
continuously increased. From the feed zone to the 
compression zone, the feed material is melted down 
and injected into the mould with preasure and the 
capsules are formed. The time for a complete cycle is 
usually only a few seconds; body and cap of the 
capsules are produced separately. 
A US Patent issued November 2003 describes 
flavoured vegetable starch capsules, flavoured e.g. 
with strawberry, chocolate, cocoa, vanilla, lemon, 
coconut, peppermint, banana, or even chili pepper in 
order to improve the palatability of fish oil or 
medicinals.28 Starch has been also been investigated 
as an excipient in novel drug delivery systems for 
nasal, oral, periodontal , and other site-specific 
delivery systems. 
Due to the starch content, potatoes can also easily 
be converted into vodka or alcohol, which is also a 
pharmaceutical excipient. In Ireland, illegally 
produced whiskey had been known as poteen or 
potheen, which normally contains a certain amount 
of methyl alcohol. It was also brought into England 
in bottles labelled 'Holy Water' .29 However, it would 
go beyond the scope of this paper to explain the 
virtues and properties of ethanol in medicine and 
pharmacy in detail. 
Vaccination 
Another very modem use of the potato in medicine is 
oral vaccination. In 2007, scientists showed that, for 
hepatitis B vaccine, genetically modified potatoes may 
be an alternative to the syringe and needle. Previously, 
researchers showed that potatoes can deliver vaccines 
for intestinal pathogens such as E. coli and Norwalk 
viruses, which enter the body via the mouth. 30 
It is a four-step procedure: First, a gene from a 
human pathogen is inserted into a bacterium that 
infects plants. Second, the bacteria infects potato leaf 
segments; third the leaf segments sprout into whole 
plants containing the gene for human pathogen, and 
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finally eating the raw potato triggers immune 
response to the pathogen. 
Clinical trials are already on the way. For the 
clinical trial, the researchers genetically modified 
potatoes to carry the gene for the hepatitis B surface 
antigen. The antigen as a foreign substance, namely 
a protein, is absorbed by the body, and triggers an 
immune response. In the trial of 42 participants 
previously inoculated with tht: traditional hepatitis B 
vaccine, about 60 percent showed signs of boosted 
immunity after eating bite-size pieces of raw 
genetically modified spuds. 31 
This paper was presented at The Annual Spring Conference, 
Reigate, Surrey, April 2008. 
Authors address: ch.staiger@gmx.de 
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Scotland and Medicine in Print - a new 
internet source 
The Scottish Museums Council maintain the web site 
www.scotlandandmedicine.com this gives details of the 
many resources for research into medicine in Scotland, 
including infonnation on current exhibitions, museum 
displays and exhibitions currently open to the public. 
In association with the Royal College of Surgeons an 
internet exhibition entitled 'Scotland and Medicine in 
Print' was opened in August 2008. This exhibition, part 
of the celebrations of 500 years of printing in Scotland, 
shows examples of the printing and publishing of 
medical and health-related literature in Scotland, over the 
past 500 years. Access to this exhibition can be gained 
either through the above web site or directly at 
www.scotlandandmedicineinprint.com Under the 
heading 'More Collections' some one hundred and 
eleven publications are illustrated and described as well 
as details of where the publication is held. Object number 
4 is Ane breve descriptioun of the pest quhair in the 
causis signis and sum special preservation and cure 
theirof ar contenit. This, the first medical book printed in 
Scotland written in Scot, is the subject of an article 
published in the Historian (2009; 38: 14). 
The web page Scotland and Medicine in Print also 
gives infonnation on two other exhibitions being held to 
celebrate five hundred years of printing. 
Dr Peter M. Worling 
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Aerated Waters: from natural to 
carbonated 
Peter G Homan, FRPharmS 
Epsom, Surrey 
Magical propertie were long ago associated with 
natural waters and springs. Early physicians 
recognised that these natural waters contained a 
'subtle spirit' that gave waters a refreshing taste and 
imparted a feeling of vitality. This spirit was assigned 
a variety of names including Spiritus Silvestris, Gas 
Sylvestre, The Soul of the Waters and an Elastic 
Aethered Spirit. 
Belief in the medicinal and healing properties of 
these waters spread and people went in search of 
cures. Demand was created for the waters to be 
available everywhere but transporting them was .a 
problem: firstly they seemed to lose the lively taste, 
and secondly the ingredients appeared to leave the 
water in the form of a sediment. It was believed that 
the gas evolved by the waters was a powerful aid to 
its efficacy and searches were begun to identify this 
magical ingredient to enable the creation of artificial 
waters. 
In the 1440s Michael Savanorola, an Italian 
physician, wrote a treatise on the hot baths ofltaly. In 
1560 Dr William Turner wrote an account of the 
waters at Bath. In 1572 Dr Jones , a physician from 
Derby, expounded the virtues of the waters at 
Buxton, and in 1602, Jacob Theodore mentioned a 
number of German mineral waters, including the 
famous Seltzer Water. None of these gentlemen made 
any attempt to analyse or comment on the contents of 
these waters. 
The first mention of an ingredient is from Dr 
Thomas Guidott, a Somerset physician, who in 1676 
wrote A Discourse of Bathe and the Hot Waters there 
in which he states 'I am apt to believe that great part 
of the acidity is breathed off in evaporation'. 
In the 1660s the chemist Robert Boyle increased 
the knowledge of chemical analytical research. He 
discovered a number of indicators for acids including 
syrup of violets which turned red in acids. Mineral 
waters, it was found, were acid but lost this property 
on standing as well as producing a precipitate which 
was not acid. In1685 Boyle published a book Short 
Memoirs for the Natural Experimental History of 
Mineral Waters in which he included 47 chapters, 
each with one method of examination. 
In 1726 Frederick Hoffman, 'a most excellent and 
consumnate physician and curious chymist' wrote 
that mineral waters consisted of three parts: 
I) a very subtile ( sic J matter - in all probability an 
extremely nioveable or subtile [sic] aether 
2) of moisture or what for distinction' s sake may be 
called elemental water. 
3) Of a solid body, whether of an earth or saline nature. 
He ascribed the most extravagant virtues to the first 
ingredient: 
this noble, native spirit, it is, which by its penetrating 
nature and admirable faculty, renders itself perceptible to 
the smell and the ·sense; not only affording a grateful 
odour in its exhalation, but also filling the whole head 
therewith. This principle we take for their {mineral 
waters} most curious and effective part, or as it were the 
soul. 
In the 1740s two men wrote notes on Pyrmont 
Water, found at Bad Pyrmont in Lower Saxony in 
Germany. F.G.P. Seif and a Dr George Turner 
described the 'spirit' of Pyrmont water as an agent 
holding the ingredients of the water together because 
they precipitate on standing. Both recognised the 
similarity of the gas to the noxious exhalations of 
caves such as the Grotto del Cane, the gas issuing 
from mineral springs and the gas produced by 
fermenting liquors. Animals and man had been 
asphyxiated both in Italy and at Pyrmont. 
The first complete analysis of a mineral water is 
attributed to a Dr Chrouet who, in 1713, analysed the 
waters at Spa in Belgium: He had a special pewter 
still to collect the vapour given off by the Spa water. 
He was convinced that the gas was air and not 
combustible spirits and that it was of such a nature 
that it was acidic and able to combine with potash. He 
called it aerial acid. 
An English translation of his analysis of the water 
reads: 
Thus a bottle of this water comes as a medicinal potion 
ready prepared from the bosom of the Earth, being 
composed of a great quantity of this airy acid lightly 
stuck to our salts, sulphurs, and to the matter of four 
grains of Mars (iron) divided into a million parts, of six 
grains of double salt ( aluminium potassium sulphate), of 
seven and a half grains of metallick [sic] sulphur (iron 
sulphide), and of a sample of a sulphurous spirit 
(sulphurous acid). 
Sometime before 1750 Monsieur G.F. Venel, a 
professor of chemistry in Montpellier, believed that 
the aerial acid was an extra part of the contained gas, 
as the amount of air in mineral water that had been 
standing, contained the same amount of air as 
ordinary solutions of chemicals. He found that by 
adding sulphuric acid until · the deposits had been 
dissolved, in a closed vessel, the vitality of the water 
was restored. He later added an amount of sodium 
carbonate to water to just detect the taste then added 
a small quantity of hydrochloric acid - the result was 
a liquid with a taste that resembled Seltzer water. 
The simplest way to reproduce mineral waters was 
to evaporate the natural water then re-dissolve the 
residue in sufficient plain water. This method was 
successfully carried out by Nehemiah Grew on the 
waters at Epsom and he marketed the product as 
Epsom Salt. Similarly, Hoffman extracted the same 
salt from Seidlitz water. Chemists could increasingly 
determine the contents of mineral waters by chemical 
analysis, but the quest was to add the sparkling 
vitality of the water. Hoffman tried to produce the 
sparkle by adding alkali and acid, but shaking to 
dissolve the ingredients dissipated the gas. 
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As stated earlier, Dr Seif found that the vapour 
given off by the water at Pyrmont in Germany was 
similar to the noxious fumes at Grotto de! Cane in 
Italy. It was Dr William Brownrigg who identified 
the vapour. Brownrigg was a physician in 
Whitehaven, in Cumbria. He investigated damps, 
vapours present in coalmines. He concluded that it 
was these vapours that impregnated the underground 
water to impart the taste and effervescence and was 
the same vapour as found in Pyrmont and the Grotto 
de! Carne. He also detected that the vapour was acid. 
In 1752, Joseph Black, who would later become 
Chair of Chemistry at the University of Edinburgh, 
was researching the cause of causticity of lime and 
the effects of heat and acid on chalk. He found that 
both effects had the same result of driving off a gas 
which he named as fixed air. 
Henry Cavendish, the English chemist and 
physicist, discovered that water could dissolve 
slightly more than its own volume of fixed air at 
room temperature and rather more at lower 
temperatures or under pressure, and that this 
combination could dissolve calcium carbonate while, 
at the same time, producing more fixed air. 
In 1767, Joseph Priestley started experiments on 
fixed air which he could find in abundance as he 
worked very close to a brewery. He added very little 
knowledge to the subject but confirmed other 
people's experiments and declared fixed air to be a 
combination of oxygen and phlogiston (a 
hypothetical element that was said to be given off 
when a substance was burnt). The 'phlogiston ' in the 
Figure 1. Priestley's apparatus. 
66 
case of fixed air was, in fact, a black substance which 
Priestley was not prepared to identify as carbon - this 
task was completed by Lavoisier who proved that 
fixed air was a combination of24% carbon and 76% 
oxygen. Lavoisier renamed fixed air as Carbonic 
Acid. 
It is thought that the first person to aerate water 
with carbon dioxide was Brownrigg, although he 
never published a paper. The gases from the local 
mine were passed to his laboratory by pipes and it 
may be inferred that aeration was effected by passing 
the gases directly into water. Venel had tried by 
adding hydrochloric acid and sodium carbonate but 
subsidiary products were left in the water. 
Joseph Priestley first impregnated water by leaving 
it near the surface of beer in fermenting vats. In 1772 
he used chalk and acid. At about the same time he 
heard of the work of Dr. Charles Irving, a naval 
surgeon and inventor from London, who produced 
distilled water from seawater. Priestley worked on a 
method of impregnating this water with carbonic acid 
gas and to use it for the prevention and cure of scurvy 
- an idea put forward by Dr David Macbride. 
Priestley produced an apparatus (see Fig. 1) that was 
accepted by the Admiralty and installed on two ships. 
He later produced a pamphlet which described his 
apparatus and how to use it. 
The bottle contains chalk just covered with water. Add 
sulphuric acid, press air out ofbladder, cork bottle, allow 
a little time to expel air, then insert pipe. When half full 
of air, agitate. Allow to fill again and agitate. Cork and 
remove bottle. 
The disadvantage was that although atmospheric air 
was removed, acid vapours were not. 
Lavoisier 
took this a stage 
further by 
adding a funnel 
with a valve to 
control the 
amount of acid 
added. 
Purification was 
done by passing 
the gas through 
water to remove 
sulphuric acid 
and through a 
vessel 
containing lime 
and water to 
remove other 
impurities. 
In 1775, Dr 
Nooth 
introduced what 
he called a 
.__ ___________ ____, Gazogene (see 
Fig. 2) for 
Figure 2. Nooth's Gazogene 
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making small quantities of aerated water. Gas was 
generated in the bottom chamber from chalk and 
sulphuric acid. It passed through a one-way valve to 
aerate water in the chamber above. Displaced water 
was returned via a bent tube into the aerated water. 
In 1781 , Thom:is Henry, an apothecary from 
Manchester, produced an apparatus that could 
produce I O to 12 gallons of aerated water in one 
operation. With his apparatus he prepared Pyrmont 
water, Seltzer water and something called Mr 
Bewley 's mephitic julep. 
His formula for Pyrmont Water was: 
To every gallon of spring water add one scruple of 
magnesia alba (magnesiwn carbonate), 30 grains of 
Epsom Salts (magnesium sulphate), I O grains of 
common salt, and a few pieces of iron wire or iron 
filings. The operation is then to proceed as in the process 
for impregnating water with fixed air; and the water, if 
intended for keeping, must be put into bottles, closely 
corked and sealed. 
Seltzer water contained magnesium carbonate, 
sodium carbonate and salt. Mr Bewley's mephitic 
julep contained sodium carbonate and the instruction 
was to take four fluid ounces with a draught of 
lemonade or vinegar water by which means the gas 
could be released in the stomach. This was probably 
the first 'Soda Water' . The first mention of Soda 
Water was by Tib~rius Cavallo, a member of the 
Royal Society, in about 1798, when he stated 
the soda water which is now prepared and sold in 
London by a Mr Schweppe, contains an incomparably 
greater proportion of carbonic acid gas. 
One refinement of Henry's apparatus was 
performed by the famous inventor James Watt. It was 
a hydraulic bellows or gasometer to receive and store 
the gas produced. 
The 1790s saw a sharp increase in the manufacture 
of artificial water, including Johann Schweppe's 
Soda Water and later his tonic water. Pumps were 
introduced and glass bottles replaced earthenware 
bottles. Bottles were filled using pressure and 
agitation. Specialised bottles were invented such as 
that by Hiram Codd that had a marble built into the 
bottle . The bottle would be filled and the pressure 
would hold the marble in the neck. A wooden 
apparatus would release the marble for emptying the 
contents. 
Continuous machines were produced to be used in 
pharmacies to make their own brands of mineral 
water. One such apparatus, as recommended in the 
Pharmaceutical Journal of 1849/50, is illustrated 
~I 
Figure 3. Mineral water apparatus 
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(Fig. 3). It was recommended that the man carrying 
out the task of bottling should wear a thick woollen 
sweater as the bottle might shatter when being filled . 
Other machines were developed for the over-the-
counter sales of carbonated drinks, produced in the 
pharmacy using flavoured syrups. 
For production at home of small quantities of 
aerated water the gazogene was further developed by 
various manufacturers using mainly tartaric acid and 
sodium bicarbonate to produce the carbon dioxide. 
These were eventually replaced by the soda syphon 
with its charged mini-cylinders of carbon dioxide. 
Other variations have included the 'SodaStream' 
apparatus that carbonates water that has been 
flavoured with a concentrated syrup. 
I cannot finish without mentioning a famous 
pharmacist who was arguably the worlds greatest 
beneficiary from the discovery of aerial acid, John S 
Pemberton, the inventor of Coca-Cola. 
This paper was presented at the BSHP Annual Spring 
Conference, Reigate, 4-6 April, 2008. 
Authors address: Peter Homan, 3 The Ridings, 
Epsom, Surrey, KT18 5JQ; peter.homan@lineone.net 
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Major Accessions to Repositories in 2007 
Relating to Pharmacy and Chemistry 
The National Archives in its annual Accessions to 
Repositories exercise collects information from over 
two hundred record repositories throughout the British 
Isles about manuscript accessions received in the 
previous calendar year. Details are available on The 
National Archives website (www.national 
archives.gov.uk). The information is also added to the 
indexes of the National Register of Archives (NRA), 
the central point for collecting and disseminating 
information about the location of manuscript sources 
relating to British history outside the public records. 
The NRA, which currently contains over 44,000 lists 
and catalogues of archives, can be consulted at the 
National Archives, Kew, Richmond, TW9 4DU. 
Local 
Barnsley Archive and Local Studies Department, 
Central Library, Shambles Street, Barnsley S70 2JF. 
Bilington & Sons, chemists, Barnsley: books and 
ledgers cl922-1991 (A/3147/F); Frank Dobson 
Sugden, chemist, Grimethorpe: books and ledgers 
cl922-1991 (A/3147/F) 
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Bolton Archive and Local Studies Service, Civic 
Centre, Le Mans Crescent, Bolton BLI ISE. FM 
Hughes, dispensing chemist, Bolton: business records 
cl940-1959 (ZZ) 
Centre for Buckinghamshire Studies, County Hall, 
Walton Street, Aylesbury, Buckinghamshire HP20 
I UU. FJ Janes, chemists, Aylesbury: prescription 
book 1844-59 (D-X 1824) 
Leicestershire, Leicester and Rutland, Record Office, 
Long Street, Wigston Magna, Leicester LE18 2AH. 
JL Bradley, chemists, Leicester: records incl 
prescriptions book, poisons registers and advertising 
material 1933-1980 (DE7280) 
Peterborough Archives Service, Peterborough Central 
Library, Broadway, Peterborough PEI IRX. Sturton 
& Sons Ltd, chemists, Peterborough: prescription 
books and accounts 1898-197 5 
Tyne and Wear Archives Service, Blandford House, 
Blandford Square, Newcastle Upon Tyne NEI 4JA. 
Brady & Martin Ltd, pharmaceutical, wholesale and 
manufacturing chemists and surgical instrument 
makers, Newcastle upon Tyne: minute book 1903-62 
(DX1261) 
West Sussex Record Office, Sherburne House, 3 
Orchard Street, Chichester, West Sussex P019 !RN. 
TJ Palmer, chemist, East Grinstead: prescription book 
1864 (Accl4747) 
National 
Jersey Archive, Jersey Heritage Trust, Clarence Road, 
St Helier, Jersey JE2 4JY. GHF Flory, pharmacist: 
additional financial records 1957-2003 (JA/1312) 
Special 
Wellcome Library, Archives and Manuscripts Section, 
183 Euston Road, London NWl 2BE. Lewis Herbert 
Llewellyn, pharmacist: scrapbook entitled 'Trials of a 
Pharmacist' 1916-1932 (MS.8568); Marthe Louise 
Vogt, pharmacologist: additional corresp, diaries and 
photographs, re! to Marthe Vogt and her family c 1890-
1960 (PP/MLV); Bath Drug Co: annotated catalogue 
and price list early 20th cent (MS.8567); HJ Logan, 
dispensing chemist: recipe book mid 19th cent 
(MS.8495) 
University 
Birmingham University Information Services, Special 
Collections Department, Main Library, Edgbaston, 
Birmingham Bl5 2TT. Frederick Howard Newth, 
lecturer in Chemistry: notebooks (5) rel to his 
undergraduate courses in chemistry and botany 1941-
1943 (USS34) 
Dundee University Archive, Records Management 
and Museum Services, Tower Building, Dundee, 
Angus DD 1 4HN. RG McKenzie, chemist and 
optician, Dundee: prescription registers 1932-1952 
(2007/268) 
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Review 
Calendar for Pharmacists 2009 
Prof Dr Werner Dressendorfer, 49 x 49 cm, 12 
four-colour prints with monthly calendar. 
With explanatory text in German and English (transl. 
Diane Blaurock). Stuttgart: Deutscher Apotheker 
Verlag. ISBN 978-3-7692-4743-5. Price 78 Euros. 
Order from service@deutscher-apotheker-verlag.de 
Mergentheim, Baden-Wi.irttemberg in 1530. 
February displays_ two unlabelled cylindrical jars 
from Bayreuth with wide blue cartouches, 
presumably made as spares for the labelling of new 
drugs. For April there two ordinary lead-glazed 
earthenware storage jars for use behind the scenes. 
Three more French faience jars with lids have their 
labels within a circle of roses and represent October. 
18th century glass bottles and jars from the 'Moor' 
.------------------,,,----------------~ pharmacies in Mainz and 
f-HHHHHHHHHH-IIHl'iFf'Ff'Ff'IFIFIFIFffff'F-~FFFFffffflfl"ll"ll=:t"ll+lll-ll-l~/4-l~ll-lh I M i.ihlhausen appear for 
lr ( 1 r~,,. C lr dAR foR Pl-1ARl\1Ac is1s 
June. Their labels are 
painted within cartouches 
depicting Moors, three 
supporting the arms of 
the Archbishop-Elector of 
Mainz. 
The December picture 
is of a fine display of 
· mid- l 8th century 
dispensary furniture and 
items collected from 
various Gennan sources 
which now adorns the 
pharmacy room in 
Seligenstadt Abbey near 
Frankfurt. 
Pages from a printer's 
catalogue offer coloured 
pharmacy labels for 
products sold and 
dispensed by various 
pharmacies, while 
September shows a 
collection of postage 
stamps illustrating 
pharmacy history 
subjects from Portugal, 
Paraguay and Brazil. 
November has two 
illustrations of the Grim 
t::=============================:::l Reaper from 
This year's Calendar continues the tradition of 
choosing beautiful coloured prints of pharmacy 
history. Prof Dressendorfer 's extensive German 
commentaries, together with their English translation, 
on the provenance and meaning of the objects pictured 
add considerably to the value of the Calendar. 
Documents are represented in January by a 1776 
certificate that Abraham Schwechten had served an 
apprenticeship of 8 years in Bayreuth and for July by 
a patient information leaflet for the use of terra 
sigillata printed in Prague in 1638. It had fortunately 
been preserved in a home-made family drug book. 
Jars and bottles are well represented. August has 
three unlabelled Nuremberg faience jars with their 
lids from about 1760, unusually decorated in blue 
with the emblems of the Grand Master of the Order 
of Teutonic Knights, who settled m Bad 
Schellenberg's 'The Incarnations of the Grim Reaper 
in the Manner of Hans Holbein'. One shows him 
exploding a monk's mortar and the other a physician 
in a pharmacy is being visited by Death : nobody is 
exempt. 
Finally for March, two pages from the 1500 Paris 
edition of the 'Hortus Sanitatis' have four coloured 
woodcuts illustrating trees and herbs used pharmacy, 
though it would be difficult to identify the plants 
without the accompanying text. 
Once again these annotated large-format 
illustrations provide interest throughout the year. 
Ainley Wade 
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Pharmaceutical Historian Back Issues 
Pharmacy Show, Birmingham, October 2008, where 
BSHP shared a stand with the RPSGB Museum 
Top left: They don't teach students pill making now; top 
right: general view; centre left, shared stand. Museum staff 
and BSHP committee members talking to visitors. 
Photos: Peter Homan 
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